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Abstract
Systemic Sclerosis (SSc) is a rare, autoimmune, connective tissue disease.
It has potentially severe physical and psychological impacts on the 
individual. SSc has two sub-types, diffuse cutaneous systemic sclerosis 
(dcSSc) and limited cutaneous systemic sclerosis (IcSSc). This study had 
three aims: to develop a framework to describe and understand the impact 
of SSc on Quality of Life (QoL) in SSc; develop a measure of QoL in SSc; 
and test the hypothesis that levels of quality of life will differ between 
disease sub-type.
To achieve the study aims a mixture of qualitative and quantitative methods 
were used. In order to develop the descriptive framework of QoL in SSc, 
qualitative data was gathered from 31 interviews and a focus group of 
people with SSc. The data was analysed using thematic analysis and the 
themes used to form the descriptive framework.
The descriptive framework of SSc QoL consisted of thirty themes which form 
four overarching themes of Emotion, Physical adaptation, Impact on/with 
others, and Self.
To develop the SSc QoL scale, potential items were identified through a 
process of item selection from the qualitative data. Together with comparator 
measures, a 90 item draft SSc QoL was posted to 336 patients randomised 
from the National Scleroderma Database (NSD), with a return rate of 61 % 
(203). Items not fitting the Rasch model of item response theory were 
deleted: 39 items were retained. The 39-item questionnaire was
administered to a second population of 369 SSc patients randomised from 
the NSD. 159 were returned and respondents received a second copy, 117 
of these were returned within four weeks (74% of first returns). Further 
Rasch analysis resulted in a 29 item SSc QoL measure.
The SSc QoL (29) showed reliability of 0.764 over two-time points. Non- 
parametric testing showed that sub-type of disease had no significant impact 
of levels of QoL (p, 0.836). However, Structural Equation Modelling revealed 
an indirect influence of disease sub-type on QoL, this being related to 
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Systemic Sclerosis (SSc) is an autoimmune disease with the highest 
disease mortality of all the rheumatological diseases. It has two sub-types, 
diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc (IcSSc). It can 
have a devastating effect on the heart, lung, kidney, blood vessels, skin and 
connective tissue leading, in some cases, to a premature death. Recent 
advances in treatment for some aspects of this disease have meant that 
more people are surviving to live with the long-term impact of SSc. Research 
into the physical and psychological effects of dcSSc and IcSSc continues to 
emerge. However, there is no framework to describe the impacts of SSc on 
patient’s perceptions of their Quality of Life (QoL), and little research into the 
effects of disease sub-type on patient-perceived QoL.
The aims of the study are to:
1. Develop a framework to describe and understand the impact of 
systemic sclerosis (SSc) on quality of life
2. Develop a questionnaire to measure quality of life in people with SSc
3. Use the questionnaire to test the hypothesis that there will be 
differences in the level of quality of life between people with different 
subtypes of SSc
The following methodologies will be used to generate the descriptive 
framework of SSc QoL and to test the research hypothesis:
Qualitative research methods will be used to explore the effect of SSc on 
patient-perceived QoL and generate a descriptive framework of SSc QoL.
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Qualitative data will be used to provide potential items for use in 
development of the SSc QoL measure. Quantitative techniques, including 
Rasch analysis, will be used to test the psychometric qualities of the SSc 
QoL
Both non-parametric and statistical modeling techniques will be used to test 
the study hypothesis, examining the relationship between disease sub-type 
and levels of QoL in SSc using the SSc QoL measure.
The thesis is structured as follows:
Chapter Two presents a review of the literature around SSc and its sub- 
types, outlining its diagnostic criteria, epidemiology, physical and 
psychological impacts, and its current and future treatments. Rationale for 
an exploration of patient-perceived QoL, and the research hypothesis is 
presented. Use of a system to classify the impact of SSc is explored, that of 
the World Health Organisation (WHO) classification structure, the 
International Classification of Functioning Disability and Health (ICF, 2001).
Chapter Three presents the developmental history and conceptual 
viewpoints of QoL in healthcare. The model of QoL chosen for this research, 
the needs-based model, is explored together with the rationale for its choice.
Chapter Four details the methods used to meet the three study aims. The 
three aims are met using three separate methodologies. The first study aim, 
to develop a descriptive framework of QoL in SSc is achieved using 
qualitative data collection techniques (interviews and a focus group). 
Techniques for data analysis are discussed and the method selected, 
thematic analysis, is described in detail. The second study aim, development 
of a needs-based measure of QoL in SSc is achieved by applying item
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selection techniques to qualitative data in order to produce the items of the 
SSc QoL measure. Rasch analysis is described as the tool used to test the 
psychometric properties of the SSc QoL and rationale for this choice is 
explored. Thirdly, in order to test the hypothesis that disease sub-type is 
reflected in levels of QoL in SSc, a description of statistical approaches is 
given. This includes exploration of Statistical Equation Modelling (SEM), 
together with a rationale for its selection in this study.
Chapters Five, Six and Seven present the study results. Chapter Five 
describes the descriptive framework of SSc QoL and the themes identified 
from the qualitative data. Chapter Six provides details of the development 
and psychometric testing of the SSc QoL, and the parametric testing of the 
study hypothesis. Chapter Seven presents the results of hypothesis testing 
through the use of Structural Equation Modelling (SEM).
Chapter Eight presents a discussion of the study findings and their 
implications for clinical practice. The chapter concludes with a summary of 
key findings and a plan for a future programme of SSc research.
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2. Systemic Sclerosis (SSc)
2.1 Introduction to SSc
This chapter describes SSc and demonstrates the potentially devastating 
nature of this disease and its sub-types. SSc is the systemic form of 
scleroderma (from the Greek, meaning ‘hard-skin’). Scleroderma represents 
a spectrum of diseases classified as connective tissue autoimmune 
diseases. The range of diseases labelled as scleroderma span from those 
which affect only local areas of skin (examples of this form of the disease 
include conditions called morphea and linear scleroderma) to systemic forms 
(SSc) which are classified into the sub-types of limited cutaneous systemic 
sclerosis (IcSSc) and diffuse cutaneous systemic sclerosis (dcSSc).
For many years knowledge of the physical and psychological impacts, 
pathology and treatment of this rare disease has been sparse. However, in 
recent years this body of knowledge has substantially increased and this 
chapter explores this literature, including a description of the diagnostic 
criteria, aetiology, pathogenesis, epidemiology and treatments for SSc, with 
particular emphasis on the impact of disease sub-type. A case study is used 
to illustrate the reality of living with SSc and the care pathway provided for 
that individual.
Use of the World Health Organisation (WHO) International Classification of 
Disease, Functioning and Health (WHO 2001) is explored as a framework 
for the classification of the impact of SSc.
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This literature review has been drawn from a search of key databases 
including Medline, Cinhal and Embase, these searches supplemented by 
key author searches and a snowball technique of reference discovery.
2.2 Systemic Sclerosis; definition, classification and aetiology
Literally meaning ‘hard skin', scleroderma describes a collection of diseases, 
which at their extreme can result in skin so tight that it can encase the 
patient making it difficult to move fingers, limbs or the face. This disease is 
succinctly described as an:
‘incurable and potentially life-threatening disease, often associated 
with a high degree of morbidity and suffering’
(Senecal et al. 2005) p. 1646
There is no single medical specialism taking sole care for these patients 
(Johnson et al. 2006). Care is commonly dictated by symptoms and 
therefore patients with SSc may be seen in a range of clinical specialities. In 
the UK, many patients with the localised form of the disease, (Table 2.1), are 
cared for by dermatologists specialising in the impact on their skin. Those 
with the systemic forms of the disease, (SSc), are more commonly cared for 
by rheumatologists.
There is evidence from a Spanish study that SSc has up to a four fold 
increase in mortality in comparison with what is described as the 
‘background’ population (Simeon et al. 2003). In recent years there have 
been key treatment advances in the medical management of people with 
SSc, particularly in the area of pulmonary artery hypertension (Williams et al. 
2005) and many more patients are surviving with this disease. This means
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that there are increasing numbers of people who live with the many 
potentially devastating consequences of SSc.
2.2.1 Diagnostic Criteria
Scleroderma is a term used to represent a spectrum of diseases. The 
systemic form of the disease is called Systemic Sclerosis (SSc), and has two 
disease sub-types, diffuse cutaneous systemic sclerosis (dcSSc), and 
limited cutaneous systemic sclerosis (IcSSc) (Black 1995).
An overview of scleroderma and ‘scleroderma-like diseases’ is presented in 
Table 2.1, and illustrates the range of conditions under the umbrella term of 
scleroderma.
As with many rheumatological diseases, SSc has diagnostic criteria 
developed by the American College of Rheumatology (ACR). It is these 
diagnostic criteria that are the internationally accepted definition of diagnosis 
for SSc, used in clinical trials, research and clinical practice:
American College of Rheumatology (ACR) Diagnostic Criteria for SSc:
• Major criterion: Proximal scleroderma
• Minor criterion: Sclerodactyly, Digital pitting,
• Bibasilar pulmonary fibrosis 
(Masi et al. 1980)
For the diagnosis of SSc, the major criterion and at least two of the minor 
criterion should be present. Thirty years on there is recognition of the need 
for review of these criteria, and the American College is currently 
undertaking this review.
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Table 2.1 Spectrum of scleroderma and scleroderma-like syndromes 
Adapted from (Black 1995)
Raynauds phenomenon Raynauds disease (secondary) 
Raynauds disease (primary)
Scleroderma: Systemic Sclerosis Sub-types:
Diffuse cutaneous Systemic 
Sclerosis (DcSSc)
Limited cutaneous Systemic 
Sclerosis (LcSSc)
Spectrum of scleroderma:
Scleroderma sine scleroderma (no skin involvement)
Localised - Morphea (plaque, guttae, generalised)











Mixed connective tissue disease 
Overlap syndromes
2.2.2 Anti-bodies associated w ith SSc
An understanding of antibodies associated with SSc has evolved over the 
past thirty years. There is an association between particular antibodies and 
autoimmune diseases, including dcSSc and IcSSc (Senecal et al. 2005). The 
first stage of autoimmune analysis in SSc is the examination of blood 
samples to look for the presence of general antibodies associated with
autoimmune diseases such as anti-nuclear antibody (ANA). The presence of 
ANA has been described as an almost universal feature of SSc with 96% of 
patients testing positive for ANA (Pudifin et al. 1991). Evidence of specific 
antibodies strongly associated with SSc is constantly emerging (Denton et 
al. 2006). Key antibodies identified are anti-centromere, which is associated 
with IcSSc, and anti Scl 70 (or anti-topoisomerase 1), which is associated 
with dcSSc.
In diagnostic terms, positive findings for these antibodies are hallmarks of 
the SSc subtypes. However, as with many diagnostic tests, the absence of 
these antibodies on testing does not exclude a diagnosis of SSc, and indeed 
there are many patients with SSc who are ANA positive but who do not have 
either of these specific antibodies. Other antibodies also aid in the diagnosis 
of SSc in that they may be associated with differential diagnosis such as 
Mixed Connective Tissue Disease (MCTD). Further developments also 
suggest potential links between antibodies and pathologies in SSc (Senecal 
et al. 2005; Denton et al. 2006). Therefore, antibody testing is a key part of 
the diagnosis and monitoring of patients with SSc, and offers useful parts of 
the jigsaw that make up the diagnosis and management of SSc.
2.2.3 Classification systems for SSc and its sub-types
Current literature describing SSc identifies two sub-types of the systemic 
form of Scleroderma, these being diffuse cutaneous systemic sclerosis 
(dcSSc), and limited cutaneous systemic sclerosis (IcSSc).
The sub-types of dcSSc and IcSSc are recognised as distinct disease sub- 
types with different severity and survival (Wollheim 2005; Wilson and 
Vincent 2006; Denton 2007).
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In order to understand the differences between the sub-types and their 
impact on the health of the individual, several sub-type classification 
systems have been proposed and detailed classification systems, as 
discussed by (Haustein 2002), have been published.
It is Le-Roy’s classification (Le Roy et al. 1998) that appears to be the basis 
of the modern classification system. This identifies the two SSc sub-sets 
identifiable in modern clinical practice and published literature. Le Roy’s 
classification is presented in table 2.2.
Table 2.2 Le Roy’s classification. (Le Roy et al. 1998)
Limited Cutaneous SSc Diffuse Cutaneous SSc
Raynauds phenomenon for 
years at presentation
Onset of Raynauds phenomenon 
within 1 year of onset of skin 
changes
Skin sclerosis limited to hands, 
feet, face and forearms or 
absent
Truncal and acral skin 
involvement
Significance incidence of 
pulmonary hypertension, 
trigeminal neuralgia, calcinosis, 
and telangectasia
Early and significant incidence of 
interstitial lung disease, oliguric 
renal failure, diffuse 
gastrointestinal disease, and 
myocardial Involvement
Dilated nail fold capillary loops, 
usually without capillary 
dropouts
Nail fold capillary dilatation and 
destruction detected by wide field 
nail fold capilliaroscopy
Presence of anti-DNA 
topoisomerase 1 (anti Scl-70)
Absence of anticentromere 
antibodies
A comparison of the Le Roy et al classification and the more modern system 
outlined by Denton (Denton et al. 2006), shows significant similarities in the 
distribution of skin thickening and the Raynauds history. The earlier Le Roy 
classification also includes reference to antibody status. Improvements in
techniques for immunological study enabling scientists to identify antibodies 
has introduced an exciting new dimension to the study of SSc. Denton lends 
further insight into the immunological links with SSc in his 2006 review of 
fibrosis in SSc (Denton et al. 2006). This review references many modern 
discoveries and theories of the association of antibodies with SSc, which are 
discussed in detail later in this chapter.
The sub-types of SSc are associated with different morbidities and impacts. 
These are summarized in table 2.3, a more detailed description following in 
section 2.2.3.1 and 2.2.3.2,
Table 2.3 Differentiation of LcSSc and DcSSc and their associated 
morbidities - Adapted from (Denton et al. 2006)
LcSSc DcSSc
Approximately 60% of SSc patients Approximately 30% of SSc patients
Skin involvement spares proximal 
limbs and trunk
Skin involvement includes proximal 
limbs and trunk and may reduce after 
18-24 months
Prominent vascular symptoms and 
Raynauds phenomenon
Prominent inflammatory symptoms at 
onset, including oedema, arthralgia 
and pruritus
Associated organ involvements 
include isolated pulmonary artery 
hypertension, severe bowel 
involvement and pulmonary fibrosis.
Associated organ involvement may 
include renal crisis, lung fibrosis and 
cardiac disease.
Long duration of Raynauds 
phenomenon
Short duration or simultaneous onset 
of Raynauds phenomenon
2.2.3.1 Diffuse Cutaneous Systemic Sclerosis (DcSSc)
The rarer of the two types of SSc (30% of SSc cases table 2.2), dcSSc is 
typically considered the sub-type with the greater degree of inflammatory 
disease and fibrosis, (Denton et al. 2006), although it still may have 
immunological and vascular involvement. As shown in table 2.3, dcSSc is
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associated with major organ involvement such as heart, lung and renal 
disease. Key research articles such as the Steen and Medsger study of 
severe organ involvement in dcSSc (Steen and Medsger 2000) found that if 
severe organ involvement occurs early in the course of the disease, the 
length of patient survival is reduced. This recognition of the early organ 
damage in dcSSc has led to close monitoring of this patient group and early 
intervention to slow disease progression.
2.2.3.2 Limited Cutaneous Systemic Sclerosis (IcSSc)
As indicated in table 2.3, IcSSc is the more common of the two SSc sub- 
types, with over 60% of SSc patients falling into this group (Maddison 2002). 
IcSSc is characterised by thickening skin which may occur on the face, 
hands, and distal to the knees and elbows. As discussed below, IcSSc is 
also associated with the anti-centromere antibody on immunological blood 
test. Typically considered the sub-type with the greater vascular involvement 
(Denton et al. 2006), it may be linked with vascular complications such as 
renal involvement, which until recent therapeutic developments, was a key 
cause of death in these patients (Maddison 2002).
It may be helpful at this point to explain some historical nomenclature 
associated with IcSSc. LcSSc has formally been referred to as CREST both 
in literature and in clinical practice, CREST being an acronym for its 
symptoms:
C - Calcinosis (lumps of calcium typically lying just under the skin)
R -  Raynauds (vasospasm)
E -  Esophageal (US spelling) involvement
S -  Sclerodactyly (tightened skin over the fingers)
T -  Telangectasia (a flattened red spot or rash)
(Denton and Black 2004)
This disease was renamed for pragmatic reasons. Clinically many patients 
diagnosed with CREST did not actually have all of the five elements of the 
condition and so, typically, patients notes and letters would be filled with 
diagnoses such as CREST without calcinosis, or CREST without 
telangectasia, which indicated that the term was not always representative of 
the underlying symptoms.
It may also have been noted that IcSSc is sometimes referred to as Limited 
Systemic Sclerosis. These two terms are used interchangeably.
2.2.3.3 Impact of disease sub-types
The literature described earlier in this section alluded to the difference in 
impact between the two disease sub-types of SSc. The difference in impact 
between the two disease sub-types, illustrated in Table 2.2, summarised 
current literature describing the differences between the two sub-types. The 
morbidities described in Table 2.3 are explored in sections 2.7,2.8 and 2.9 of 
this literature review. Together with a description of the morphology itself, 
these sections also explore the impact of these morbidities on the 
individuals’ activities and their ability to participate in life. Therefore, the 
morbidities associated with each sub-type may be linked with different 
impacts upon the life of the individual.
A clear message arising from this literature describing the sub-types of SSc 
is that disease sub-type is associated with different physical morbidities. This
message is incorporated into the review of impairments in SSc (section 2.7) 
and serves to inform the hypothesis development in this study which is 
discussed in detail in 3.5.1.
Whilst SSc research underlines the importance of the sub-types of dcSSc 
and IcSSc, (Denton and Black 1999; Barst and Seibold 2003), it is 
recognised that not all patients have their disease classified into these sub- 
types. A group of clinicians interested in the diagnosis, classification, 
assessment and treatment of scleroderma are promoting the importance of 
this classification (the UK scleroderma Interest Group, internationally linked 
with the scleroderma Clinical Trials Consortium (SCTC) and the Connective 
Tissue Disease International Scientific Advisory Board (Rubin et al. 2007)). 
There are guides for clinicians to help them make this classification (Black 
1995).
2.2.4 Aetiology
The cause of SSc is unclear but there is consensus that there is a trigger to 
the pathological processes associated with SSc (Mattucci-Cerinic et al. 
2007). There has been much discussion and laboratory research into the 
role of specific biological triggers of scleroderma. These potential triggers 
include microchimerism, oxidative stress, genetics and environment, each of 
which will now be explored in more detail to illustrate the many facets of 
possible causes of SSc.
2.2.4.1 Microchimerism
Persistent foetal DNA has been found in female patients with SSc who had 
been pregnant in their past (microchimerism), stimulating the theory that this 
may be a factor in developing SSc. There are significant questions to be
raised regarding this theory. Literature (appendix-!) appears to offer 
compelling support to the argument to explore microchimerism as a link to 
SSc.
There are some key questions to answer with regard to the feasibility of the 
microchimerism theory. For example, how does microchimerism apply to 
men with SSc? There are findings of Y -chromosome DNA being found in 
SSc patients who had not carried a male foetus (Arlett et al. 1997) which 
begs the question as to the origin of this Y-chromosome DNA. These are 
significant questions that remain unanswered. For readers with an interest in 
this area, more detail of studies of the theory of microchimerism can be 
found in appendix 1.
2.2A.2 Oxidative Stress
The theory that oxidative stress may play a part in SSc pathogenesis has 
been proposed across several research papers (see appendix 2). The theory 
proposed is that oxidative stress may be a key mechanism in triggering or 
maintaining abnormal features of cells involved in SSc pathogenesis. These 
abnormal features include vascular damage, immune activation, auto 
antibody generation or fibroblast activation (Denton and Black 1999). There 
have been several studies regarding this process. A summary of these 
findings for the interested reader is available in appendix 2; they are not 
presented in the main body of this text, as pathogenesis of SSc is not central 
to this study.
2.2.4.3 Genetics
Patients frequently ask if the disease can be passed on to their children. The 
evidence here is emerging. In British based research only one family out of
60 had more than one case of scleroderma within the family (Maddison 1986 
cited in (Briggs and Welsh 1991). There are case reports of two sisters with 
SSc (Molta et al. 1989), and identical twins with the disease (Dustoor et al. 
1987).
However, there are also reports of a pair of monozygotic twins where one 
had the disease and the other did not (Guseva et al. 1981). The debate in 
this area is further illustrated with the statement that SSc is not primarily a 
genetic disorder (Briggs and Welsh 1991), and twin research which suggests 
inherited genetic factors are not sufficient to explain the development of SSc 
in the affected twin, but that inheritance may influence the development of 
serum antibodies in the non SSc twin (Feghali-Bostwick et al. 2003).
More recent reviews of the genetic factors associated with SSc (Assassi and 
Mayes 2003; Mayes et al. 2003; Mayes and Trojanowska 2007) present a 
case for a genetic component to SSc. Links with the underlying pathological 
processes involved in vascular damage and fibrosis in particular are 
proposed, although the link between these two processes remains unclear. 
Also of significance to our understanding of the genetics of SSc is gene 
profiling. Profiling of SSc skin biopsies has revealed altered expression of 
approximately 1,800 genes in SSc skin as opposed to ‘normal skin’ (Gardner 
et al. 2006), thus giving impetus for further exploration of these differences.
Current literature therefore suggests a genetic link with SSc, but does not 
yet reveal full understanding of the mechanism of this link. This field of 




There are several environmental factors that have been proffered as 
potential effectors to SSc. Environmental agents proposed for implication in 
scleroderma (Silman and Hochberg 1996) include:
• Silica dust: seen in coal miners, gold miners, and stonemasons.
• Organic chemicals: aromatic hydrocarbons: toluene, benzene, 
xlyene, aromatic mixes: white spirit, dieselene
• Alphatic hydrocarbons:




• Biogenic amines: m-phenylenediamine
• Urea formaldehyde foam insulation
• Drugs: Bleomycin, carbidopa, L-5 hydroxytryptophan, 
pentazoacine, cocaine, appetite suppressants -  e.g. 
diethylpropion, fenfluramine hydrochloride
• Breast augmentation: silicone -  paraffin.
Silman and Hochberg, (Silman and Hochberg 1996), emphasize that no 
causal link has been established between this list of chemicals and SSc. 
Environmental exposure is suggested in some men diagnosed with SSc
(Haustein and Zeigler 1985). As early as 1914, links between silica contact 
and stonemasons was hypothesised (Bramwell 1914), moving through to 
Bleomycin, vinyl chloride monomer, epoxy resin compounds and organic 
solvents including toluene, benzene, xlyene and trichloroethylene in later 
research (Fagundus and Le Roy 1995).
Non-industrial associations have also been discussed, perhaps most 
significantly the potential link with breast augmentation. The suggestion of a 
link between breast augmentation and SSc was brought to the fore by a 
Japanese study (Kumagai et al. 1984). The broader literature was reviewed 
in 1996 (Wong 1996), including fifteen epidemiological studies on breast 
implants and connective tissue diseases. It was concluded that the available 
data did not provide evidence for a causal relationship between silicone 
breast implants and connective tissue disease (including SSc).
2.2.4.5 Cancer Risk
A suggestion of a link between SSc and cancer was proffered in a report 
which presented information of a cluster of cases of breast cancer in women 
with SSc (Lee et al. 1983). Whilst this was not backed up by a later, formal 
epidemiological study, the later study did suggest a time relation between 
the onset of the two diseases in a small part of their sample (Roumm and 
Medsger 1985). A more recent case control design study has been 
conducted exploring the characteristics of those people with breast cancer 
and scleroderma (Derk 2007). This research draws conclusions as to the 
demographics of those individuals with both diseases, but again, a 
categorical link remains unclear. What has been revealed is a link between
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lung cancer in SSc patients, unrelated to smoking but related to pulmonary 
fibrosis (Peters-Goldern etal. 1985).
2.2.5 Pathogenesis
The underlying pathology of SSc is emerging through recent advances in 
cellular research. It is clear that the process consists of three processes, and 




(Denton et al. 2006)
Whilst this is key to research into curative treatments for SSc, it is not central 
to the development of the SSc QoL or testing of the research hypothesis. 
Therefore, what follows is an overview of the pathogenesis of SSc with more 
detail available in appendices as referenced.
2.2.5.1 Fibrosis
Fibrosis is one of the three major interlinked pathological processes 
occurring in SSc, and it features excessive scarring and connective tissue 
remodelling. The stages of the process of fibrosis are complex and are well 
described in a review publication (Denton et al. 2006). Thickening and 
fibrosis of the skin are a key characteristic of this disease (Seibold 1993) 
with only 1-3 % of patients with scleroderma showing no skin changes 
(Clements et al. 1993; Black 1995; Silman et al. 1995).
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2.2.5.2 Vascular involvement
It is acknowledged that vascular Involvement is a central mechanism 
involved in SSc (Riemekasten and Sunderkotter 2006). Publication of 
research into the vascular aspect of SSc increased in the 1980s, and has 
continued to grow as an area of research. SSc vascular research has 
evolved in many areas such as Pulmonary Artery Hypertension (PAH) and 
Renal involvement, adding to the body of knowledge about vascular 
involvement in SSc.
Therefore, in order to present these diverse areas associated with the 
vascular involvement in SSc, specific areas of research will be presented in 
section 2.7, described as impairments associated with SSc. These specific 
areas are PAH, Renal disease, Cardiac disease, and Raynauds 
Phenomenon. More information on vascular involvement in scleroderma can 
be found in appendix 3.
2.2.5.3 Immunological component
Immunological involvement is a recognised component of the pathology of 
SSc (Le Roy 1992; Black 1995; Senecal et al. 2005; Denton et al. 2006), 
however knowledge of the area continues to emerge. Clinically, 
immunological evidence has played a helpful role in the diagnosis or sub­
typing of SSc since the discovery of antibodies related to SSc, and 
laboratory methods of testing for them have been developed (Denton and 
Black 2004). It is proposed by these authors that not only are these 
autoantibodies useful in diagnosis, but that some of them have a pathogenic 
role in SSc. It is proposed that anti-topo1 can react with the cell surface in 
SSc patients. The argument is developed by considering other auto
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antibodies such as anti-RNA polymerase 1/111 which is associated with 
renal crisis in SSc, but not for instance, with fibrosis. The authors also argue 
that as auto antibodies are often present very early on in the disease and in 
large numbers that they may be involved in the pathology of SSc; a point 
further made by the link between the serum concentration of these auto 
antibodies and SSc severity (Naparstek and Plotz 1993). In contrast, this 
view of a primary pathogenic role for auto antibodies in SSc has since been 
questioned (Denton et al. 2006).
The presence of T cells in SSc skin lesions demonstrates immunological 
associations with SSc. This presence of T cells may vary in intensity and 
distribution, but the location of these infiltrates around blood vessels and at 
sites of active deposition of connective tissue re-enforce the link between the 
immune system and the pathogenesis of SSc (Grand round 1996).
Emerging research is showing cellular moderators involved in SSc. These 
cellular pathways include:
• Transforming Growth Factor Beta (TGF beta)
• Connective Tissue Growth Factor (CTGF)
• Endothelin (ET)
• Platelet Derived Growth Factor (PDGF)
• Tumour Necrosis Factor (TNF)
(Le Roy 1992; Denton et al. 2006; Abraham and Distler 2007)
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2.3 Epidemiology
Fortunately SSc is relatively rare, with an estimated UK prevalence ranging 
from 20 to 100 per million (Silman 1997). In the USA figures of 276 cases 
per million adults have been reported (Mayes et al. 2003). This range in 
estimates of prevalence illustrates the limited data on this small patient 
group. Its effects are potentially devastating with data from the 1990’s 
showing approximately 50% of patients dying in the first ten years (Silman 
1997). Other reports of mortality from SSc found 26% of women and 32% of 
men to have died within five years of presentation (Bryan et al. 1999). 
Despite the success of treatments for renal failure (Maddison 2002) and a 
new era of treatments for pulmonary hypertension, fatal complications are 
still seen (Black 2005).
2.3.1 Incidence of SSc by age group, gender and ethnic group
The peak incidence of this disease is 45-55 years of age, and it is three to 
eight times more frequent in women than in men (Silman 1991). The time 
between onset of symptoms and diagnosis of SSc can range from days to 
years. Typically there is a long lapse time before diagnosis due to the 
heterogeneous nature of SSc (Denton and Black 1999), and its many 
presenting symptoms (Wilson and Vincent 2006). For instance, fatigue and 
joint pains are common symptoms seen by General Practitioners and it is 
often only the addition of further pieces of the jigsaw, frequently that of skin 
thickening, which prompts referral. Therefore, it may take many years for 
people to be referred into specialist services. Logically this infers that there 
may be more people living with SSc than currently diagnosed.
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A study of a defined SSc female American population reports a survival rate 
at 7 years from diagnosis as being 81% for those with limited disease, and 
72% for those with diffuse disease (Laing et al. 1997). Age adjusted survival 
was lower in black women than white; this was hypothesised to be because 
of increased diffuse disease at a rate of 49.6% in black women and 24.9 % 
in white women in the retrospective study.
A review of the epidemiology of scleroderma found there to be no difference 
between the distributions of SSc in rural or urban locations (Medsger 1978 
cited in (Silman 1991). SSc is found in many non-Western countries such as 
Japan, USSR, Nigeria, Mexico and in Polynesians in New Zealand (Medsger 
and Masi 1971). In the UK, higher incidences of SSc were found in small 
pockets of the population, and these areas were found to be adjacent to 
international airports (Silman et al. 1990).
2.4 A Patients Experience of SSc
The diagnostic process of SSc can be a long and complex route for many 
patients (Vincent and Wilson 2006). For others, diagnosis may result from a 
single acute medical event. The disease is classically defined as 
heterogeneous (Denton et al. 2006), underlining that its path varies for each 
individual. Heterogeneity of presenting symptoms may be a key factor in a 
long lapse time from symptoms to diagnosis. People may present with the 
consequence of any of the underlying pathologies associated with SSc, 
namely vascular damage, immunological involvement or fibrosis. In clinical 
terms, this means there can be a huge range of apparently unrelated 
symptoms which only amalgamate the diagnostic jigsaw to give the picture 
of SSc. In many cases, the diagnosis of SSc is finally made when the classic
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symptom of skin thickening is noted. A further complication in this diagnostic 
process is the existence of a group of ‘scleroderma-like’ syndromes as 
outlined in appendix 4.
2.4.1 How does SSc affect the individual? -  A case study
In order to illustrate SSc and how it may affect the individual, a case study of 
a person with SSc follows. This case study aims not only to illustrate the 
pathological effects of the disease, but also to give a sense of the impact of 
this disease on those who live with it.
Case study -  Svlvia.
Sylvia is a 42-year-old woman who is married with two children, Peter aged 
13 and Becca aged 11. She is married to John who works as a building 
labourer and Sylvia works part-time as a nurse. Six years ago Sylvia noticed 
her fingers swelling which was making some tasks at work difficult. She also 
felt increasingly tired and noticed that she had some flattened red spots 
appearing on her skin.
On visiting her GP, she was initially told that she may have some arthritis 
through ‘wear and tear’, and to take simple painkillers such as paracetamol. 
After three months of doing this, she described to her husband that she “felt 
terrible and she had to do something". She was now unable to perform many 
of the essential everyday activities such as driving, handling cooking pans, 
and her fatigue was such that she could no longer concentrate at work and 
needed to go straight to bed as soon as they had had their evening meal.
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Sylvia felt she was losing control over her life and felt too ill to do anything 
about it.
Her husband had become increasingly worried by Sylvia’s symptoms, she 
had lost her sparkle for life and he saw that she was just getting worse. He 
made a further doctors appointment and saw a different doctor. This GP felt 
that Sylvia may have an underlying condition giving rise to these symptoms 
and contacted her local rheumatology consultant for telephone advice and 
an urgent out-patient appointment.
In it ia l o u t-p a tie n t a p p o in tm e n t
At this appointment, the rheumatology consultant asked a lot of questions 
about how long these symptoms had been present, and how they had 
developed. The consultant also asked if she had any symptoms of 
breathlessness, ulcers on her fingers, hypertension or kidney problems, or if 
Sylvia had noticed any changes in her skin. The consultant pinched Sylvia’s 
skin on the back of her hands and on her face and asked if she had any 
problems with swallowing, heartburn, or with her bowels.
Sylvia told her of colour changes in her finger tips when they were cold, and 
the pain of the change of colour from white to red when they warmed up.
Blood tests were ordered comprising of:
• A full blood count (red cells, white cells and platelets -  testing for 
signs of anaemia, infection or abnormal platelets)
• Urea and Electrolyte levels -  testing for abnormalities in kidney 
function shown in altered electrolyte levels
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• Immunology tests - ANA, and ENA. Testing specifically for 
double stranded DNA, Anti-centromere, Anti Scl70 (indicators of 
Limited SSc, Diffuse SSc, Systemic Lupus Erythramatosus)
O th e r  te s ts
The consultant also requested:
• A chest x ray
• An ECG
• A test of kidney function
Sylvia was also asked to complete a questionnaire outlining her physical 
function and difficulties (a Health Assessment Questionnaire -  HAQ).
A follow up appointment was made for one month’s time.
F o llo w  u p  o u tp a tie n t a p p o in tm e n t
Sylvia and John both attended this appointment as they were anxious to 
hear the results of the test and desperate for some treatment to make Sylvia 
feel better. The consultant explained the blood test results and told them that 
there was some indication of auto-immune disease. By looking at the 
complete picture from her symptoms such as the rash, the colour changes in 
her fingers (which she called 'Raynauds'), her fatigue, and the swelling in 
her fingers a diagnosis of an autoimmune disease was indicated. The 
question of which auto-immune disease was also a key part of the 
conversation. Sylvia had heard of a condition called lupus as a work 
colleague of hers had been diagnosed with this several years ago, and she 
knew that these symptoms sounded similar.
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The consultant agreed that some of these symptoms were similar to lupus, 
however, there were two elements of her clinical picture which suggested 
another disease: scleroderma (Systemic Sclerosis). These two elements 
were a positive anti-centromere immunology blood test, and the flattened red 
rash (telangectasia) on her face. The consultant seemed to place particular 
importance to the anti-centromere blood test. It was explained that some 
symptoms varied, and it was possible to have symptoms which overlapped 
between autoimmune diseases. A preliminary diagnosis of limited cutaneous 
Systemic Sclerosis (IcSSc) was made.
T re a tm e n t fro m  h e r  c o n s u lta n t
Sylvia and John had never heard of IcSSc. The consultant explained this 
was a condition that involved the immune system. The doctor said that 
Sylvia would need close monitoring of her condition for the foreseeable 
future, in order to monitor any changes in her condition and instigate 
appropriate treatment at the earliest opportunity.
More investigations were ordered including a CT scan of Sylvia’s lungs to 
check for any signs of fibrosis, and an echocardiogram to check for any 
indication of pulmonary artery hypertension. It was explained that there was 
another, more accurate test of this, known as a cardiac catheterisation, 
however, this was not available locally but was available at the regional 
specialist centre if indicated. Treatment was instigated for Sylvia’s Raynauds 
in the form of medication and advice. The medication was 10mg of 
Nifedipine MR (modified release) twice a day in order to improve her 
underlying circulation. She was told that the specialist nurse would give her
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advice on how to manage her Raynauds. Sylvia and John then went to see 
the scleroderma specialist nurse.
T re a tm e n t fro m  th e  s c le ro d e rm a  s p e c ia lis t n u rs e
The nurse took Sylvia and John into a room in the clinic and asked how they 
were feeling and if they had any questions. They said they felt relieved that 
they had a name for the condition: Sylvia had been worried that she had 
cancer and felt relieved that it wasn’t. However, neither of them had heard of 
LcSSc or scleroderma.
The nurse explained that this was a condition known as ‘autoimmune’, 
referring to the persons own immune system and that it was one of a group 
of conditions collectively called ‘scleroderma’. She explained that it involved 
a collection of potential symptoms including the flattened, reddened rash 
called ‘telangectasia’, fatigue, skin thickening, swollen puffy fingers (in the 
initial phases of the disease), Raynauds (described as a spasm of the blood 
vessels), and other symptoms which Sylvia didn't have signs of. These were 
not listed at this point in order not to overload them with information, but it 
was explained that this information would be included in a booklet they could 
have to take home, which came from one of the two patient charities who 
provided support and information.
The nurse then asked them several further questions about how they were 
coping with the symptoms. She talked about fatigue and its association with 
LSSc, and about pacing and grouping of activities in order to preserve 
Sylvia’s energy. She gave them this initial information but said this would be 
something she would go into in more detail at their next visit. This session 
was then brought to a close, with a further appointment being made. Sylvia
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was given the telephone number of the ‘helpline’ to ring if she had any 
queries and to write down any questions they had for their next appointment. 
The nurse also said that just to be aware that if they sought further 
information on the disease, many sources of data were out of date or very 
individual, suggesting scleroderma charity websites if they wanted to seek 
extra information.
F o llo w  u p  a p p o in tm e n t
The appointment was the following week. Sylvia came on her own as John 
had already taken a lot of time off work and was concerned that his 
employers would not like him to be off again. They had talked together about 
the information they had been given, and about the questions they wanted to 
ask. When Sylvia came in she had a lot of questions, she said she was 
really worried as John had looked at the literature and websites and it looked 
as though she may lose her fingers if the Raynauds was bad, and that 
people had said their relatives had died of kidney failure or lung or heart 
disease. The first question Sylvia had was ‘can this kill me?’
The specialist nurse explained LSSc had a different path for different people, 
that it was individual. However, it was known that for a small number of 
people this condition would be life shortening, but that the treatments for 
SSc were continually improving. For many people it was a case of treating 
symptoms as they were identified, hence the need for lifelong monitoring.
This answer was further explained then Sylvia asked about the treatments 
which were available for the management of SSc. The specialist nurse 
explained that there were treatments available for many of the complications 
of SSc, and that although there was no one single drug to cure the disease,
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there were many treatments in use for its potential complications. It was also 
stated that not everyone with SSc had every complication, that it was very 
much an individual journey and a matter of finding out how it affected her, 
and developing strategies to cope with it.
The nurse then went on to explain why Sylvia had been commenced on 
medication for her Raynauds, that it was modified release to widen (dilate) 
the blood vessels continually in order to minimise the effects of the 
vasospasm. The nurse asked Sylvia what sort of things or situations 
triggered these colour changes in her fingers and together they created a list 
of the situations which triggered these attacks. This list included such things 
as going out of the house first thing on a cold morning, walking through the 
freezer section of the supermarket, and standing on the touchline while 
watching her son play football. They talked about ways of ensuring that 
Sylvia kept her hands constantly warm, avoiding these changes in 
temperature for example with the use of layers of gloves and hand warmers.
A plan of care was then developed with Sylvia by identifying the key issues 
for her and a strategy of self-care to manage these symptoms. The nurse 
explained key symptoms which required urgent notification, for example: 
ulcers which wouldn’t heal or appeared infected; prolonged Raynauds 
attacks lasting hours; symptoms of high blood pressure (such as 
headaches); or prolonged nausea which may be a symptom of kidney 
disease.
The nurse also referred Sylvia to the occupational therapist, physiotherapist 
and podiatrist in order for them to make baseline assessments of Sylvia’s 
health and to help her with elements of her self-care such as exercise
-32
therapy, adaptation to any difficulties with her daily activities (such as 
cooking), problems with her work role and pacing of activities to cope with 
her fatigue, and how to manage foot care and identify any potential for foot 
ulceration. Follow up appointments were given for both the specialist nurse 
and the rheumatology consultant.
C o m p lica tio n s  o f  S S c
Two years following diagnosis Sylvia developed sudden onset of 
breathlessness. She rang the scleroderma helpline run by the specialist 
nurse and received an urgent outpatient appointment. PAH was suspected 
and Sylvia was referred to her specialist tertiary centre for cardiac 
catheterisation that would diagnose this condition if elevated pressures were 
found within the chambers of the heart.
T re a tm e n t fo r  S y lv ia ’s  p u lm o n a ry  a r te ry  h y p erten s io n
Upon referral to a tertiary referral centre Sylvia had a cardiac catheter 
examination, this revealed a pulmonary artery pressure of 57mmhg, 
diagnostic of PAH. She was counselled about these results and her 
diagnosis. John was with her and they were both alarmed by this diagnosis 
as they were aware that this a potentially life threatening complication of her 
LcSSc. They were reassured by the consultant that there was treatment for 
this condition, and an anti-endothelial drug, (Bosentan), was commenced. 
This was a tablet to be taken daily which was designed to control the PAH. 
Sylvia was relieved about this as she had read about people having lines 
into their heart through which drugs were infused 24hrs a day (lloprost), and 
she was relieved she didn’t need to have a line in her chest. She had heard
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of the associated risk of infection and thought the line might also alter the 
way John saw her.
M o n ito rin g  o f  t re a tm e n t
Sylvia had to have her blood taken regularly to ensure that there were no 
effects on her blood chemistry which the Bosentan could potentially cause.
T h e  F u tu re
Sylvia faces an uncertain future. For as long as the Bosentan continues to 
be effective and she doesn’t have any side effects, she continues to be able 
to do most of the activities she needs to do, although walking up hills or 
running with the children is still out of the question. She enjoys each day and 
just hopes that she will see her children through their school years to 
adulthood.
Sylvia’s story gives a sense of how many people experience SSc and the 
potentially devastating effect it can have on their lives and the lives of those 
around them.
2.5 A Framework to Classify the Impacts of SSc
SSc is clearly a complex disease and, as illustrated by the previous case 
study, its impact on the individual can be just as complex. In order to 
describe the impact of the disease, an internationally recognised 
classification system, the World Health Organisational International 
Classification of Functioning, Disability and Health (ICF), (WHO. 2001) will 
be used. The ICF classification offers a useful biopsychosocial framework 
for classifying the complex consequences of SSc.
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First published in 1980 and known as the International Classification of 
Impairments, Disabilities, and Handicaps (ICIDH), it was revised in 2001 in 
response to criticism of its conceptual limitations, and renamed the 
International Classification of Functioning, Disability and Health (ICF).
The International Classification of Diseases (ICD) is considered to be 
complementary to the ICF. The ICD is primarily a classification of health 
conditions (diseases, disorders, injuries etc), providing what is described as 
‘an etiological framework’ (WHO. 2001). The ‘ICD-10’ is the version currently 
used, the ‘10’ referring to the 10th edition. The ICD-10 presents the condition 
in a numerical form. SSc is classified as a systemic connective tissue 
disease identified as M 34 (systemic sclerosis) with subdivisions of M 34.0 
(progressive systemic sclerosis), M 34.1 (CREST syndrome), M34.2 
(systemic sclerosis induced by drugs and chemicals), M34.8 (other forms of 
systemic sclerosis) and M34.9 (systemic sclerosis, unspecified).
In a move to make the ICF easier for use in clinical practice, the concept of 
ICF core sets has been developed. This involves working groups developing 
a set of ICF components which are considered core to a specific condition. 
Core sets are not in existence for all conditions, but an ICF core set 
represents some of the more prevalent rheumatological conditions
(Scheumringer et al. 2005; Scheuringer et al. 2005; Stamm et al. 2005).
The ICF has developed considerably from its predecessor, the ICDH 
(Marijke and Vrakrijker. 2003). The ICF now aims to provide classification of 
components of health which are considered from a body, person and 
societal level. It is described in its documentation as the conceptual basis for 
the definition, measurement and policy formulations for health and disability
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(WHO website 2002) and is intended for use across five areas: research, 
clinical practice, statistics, education and social policy. Written with the intent 
to provide a positive emphasis, more traditional terms such as handicap are 
replaced to recognise the need for incorporation of the social as well as 
medical model. It is the intention of the WHO by development of the ICF, to 
move away from being a consequence of disease classification and become 
a classification of components of health (WHO. 2001). The ICF therefore 
classifies the position of the person or population, rather than the disease.
The diagrammatic representation of the ICF which follows (Figure 2.1) is 
important as it visually displays the ICF and its base in a biopsychosocial 
model of disability. A key element is that the ICF is based upon a 
biopsychosocial model of disability, and not a purely medical model (Cardol 
et al. 2002; WHO website 2002; Sibley et al. 2006).









This illustrates the ICF as a dynamic model where there is interplay between 
the key aspects of body function and structure, activities and participation. 
The contextual factors identified by the ICF have sparse description, which 
has led to further explorations of this element of the ICF (Badley 2006).
2.5.1 Definition of terms
A wider description of the ICF is included in appendix 5, however a summary 
of each key term (WHO 2001) is now given.
P a r t  1 - F u n c tio n in g  a n d  D is a b ility
Within the ICF, the term ‘functioning’ refers to all body functions, activity and 
participation, and ‘disability’ refers to impairments, activity limitations and 
participation restrictions.
2.5.1.1 Impairment
Definition: Impairments are problems in body function or structure as a 
significant deviation or loss.
Impairments represent deviations away from certain generally accepted 
population standards in the biomedical status of the body and its functions.
2.5.1.2 Activity
Definition: Activity is the execution of a task or action by an individual.
Activity limitations are difficulties an individual may experience in 
involvement in executing activities
2.5.1.3 Participation
Definition: Participation is involvement in a life situation.
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P a r t  2  -  C o n te x tu a l fa c to rs
2.5.2 Environmental and Personal Factors
In an effort to recognise factors which lie outside of the patients control, such 
as social support, work, laws etc, the ICF addresses contextual influences 
with the description of personal and environmental factors (WHO 2001). 
Whilst the ICF does not go any further than recognition of the potential 
influence of personal factors due to its diversity, environment factors are 
explored in more detail.
Environmental factors are considered to make up the physical, social and 
attitudinal environment in which people live and conduct their lives. These 
factors are external to the individual and their influence on the performance 
of the individual as a member of society, on the individual’s capacity to 
execute actions or tasks or on the individual’s body function or structure, 
may be positive or negative (Wang et al. 2006). There is some debate 
regarding the success of this incorporation of environmental factors, (Cardol 
et al. 2002; Nordenfelt 2003), with the ICF described as a disability model 
which fails to adequately explore the relationship of external factors to the 
disability pathway.
2.6 Impact of SSc using the ICF
The ICF presents a framework in which disabilities or health conditions can 
be associated with all three elements of the ICF, impairment, activity 
limitation and participation (WHO website 2002). Mapping the impacts of
LEEDS UNIVERSITY LIBRARY
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SSc across the ICF structure of impairment, activity limitation and 
participation, clarifies the biopsychosocial impacts of this complex disease.
2.6.1 SSc in terms of the ICF
The picture of SSc revealed so far in this study is one of a disease which 
has both diverse and potentially devastating effects. These effects include 
impact on the individual’s skin, gut (gastrointestinal tract), kidneys (renal 
involvement), energy levels (fatigue), lung, heart, circulation and 
psychological profile. Whilst differences between the two sub-types of SSc 
have been illustrated (2.2.3), there is insufficient literature to discuss their 
impacts as separated entities. Therefore, the impacts of SSc as a whole will 
be presented using the structure of the ICF.
2.7 Impairments of SSc
Key aspects of SSc are now presented in relation to their impairment. This 
will be followed by description of their relation to activity limitation, and then 
to participation.
2.7.1 The skin
SSc usually effects the skin of the fingers and face (Balbir-Gurman et al. 
2002). People who have had this disease for a while say that they look in the 
mirror and see a stranger looking back at them. Some facial affects of this 
disease are thinning of lips, beaking of the nose, reduction in lines and for 
some, small, flattened red spots called telangectasia which can manifest 
themselves in other areas of the skin.
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Sclerodactyly, or tightness of skin over the fingers, is a common skin 
symptom leading to both reduced function and altered appearance. The skin 
over fingers appears shiny, taut and often oedematous (puffy and swollen). 
Oedema and infiltration of inflammatory cells around the blood vessels of the 
dermis are part of the underlying pathological process within the skin 
(Denton et al. 2006).
Figure 2.2 -  Photographs of skin involvement in SSc
Later phases in the disease often see this oedema settle, but the fingers 
often remain contracted by the tightness of the skin and tendon contractures 
(Mayes 1999). This can lead to severe reduction in the range of movement 
and practical use of fingers with all associated problems with activities of 
daily living, work and household tasks. The face is also frequently affected 
leading to characteristic visual symptoms of the disease such as 
microstomia, and a beaked nose. Patients frequently experience the 
functional impact of microstomia (DiMarinao et al. 1973) where the ability to 
open the mouth is reduced.
This aspect of SSc is classified to both IcSSc and dcSSc (table 2.2), what 
differs is its distribution in each sub-type; in dcSSc the skin can be affected
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anywhere on the body whereas in IcSSc it is restricted to the face, arms 
distal to the elbow and legs distal to the knee.
Therefore, skin impact in hands and face is common across sub-types. 
However, the impact of skin thickening on the upper arms, legs and on the 
trunk, and the impact associated with this thickening, is specific to those with 
dcSSc.
2.7.2 Gastrointestinal (Gl) effects
Patients with SSc frequently suffer from symptoms of both upper and lower 
Gl involvement with the majority, 85%, of complaints being linked to 
dysphasia (difficulty swallowing) and oesophageal hypomotility (Fagundus 
and Le Roy 1995). Effects on motility (movement of the gut to pass food 
down through the Gl tract) may be found throughout the Gl tract with an 
abnormal response to neurogenic signals being noted in both the large and 
small intestine (Heyt et al. 2004). In a study of thirty-five patients with SSc 
twenty-five, (74.1%), demonstrated an impaired or absent rectoanal 
inhibitory response. This is closely correlated with faecal incontinence. No 
relation was found between this finding and the disease duration. In relation 
to this finding and disease sub-type, no link was found (Mayes 1999). 
However, in the summary of disease sub-type in table 2.2, diffuse bowel 
disease is associated with dcSSc.
Reduced downward pressure within the oesophagus allows acid to reflux 
back through the cardiac sphincter of the stomach leading to profoundly 
painful ‘heartburn’ symptoms, particularly at night (Denton and Black 1999).
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Other associated complications are that of primary biliary cirrhosis and wide 
mouth diverticular in the large intestine (Fagundus and Le Roy 1995) and 
effects on the lower bowel such as the rectal sphincter.
2.7.3 Renal involvement
Renal crisis occurs typically early on in the disease process with estimates 
ranging from the first 3 years of diagnosis (Fagundus and Le Roy) to the first 
5 years (Denton and Black 1999) and possibly in association with worsening 
skin involvement (Steen and Medsger 1998). Early symptoms of renal 
disease are described as malaise and headache. Until recent years, renal 
crisis was the main cause of death in patients with SSc, occurring in 20% of 
patients with dcSSc (Steen et al 1990 cited in (Maddison 2002)). This is a 
significant finding, and supports the for the difference in impact between the 
two disease sub-body of evidence that there is a different disease impact 
between sub-types
The cause of renal disease in SSc is vascular damage, thought to be 
endothelial injury. Intimal thickening of renal arteries leads to decreased 
renal perfusion affecting the juxtaglomerular apparatus which in turn leads to 
increased rennin production causing hypertension (Maddison 2002). SSc 
renal disease is thought to be marked by RNA polymerases (Okanao 1993 
cited in (Denton and Black 1999).
2.7.4 Fatigue
Fatigue has been recognised as a major debilitating problem for patients 
with rheumatic illness (White 1998; McKinley et al. 2005; Hewlett et al. 
2007). Fatigue is described as having far-reaching impacts on the life of the 
individual, and an appropriate outcome measure for fatigue in rheumatoid
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arthritis is currently being investigated (Hewlett et al. 2007). Within the field 
of SSc, fatigue is mentioned as a key symptom on patient organisation 
websites, but is markedly absent from healthcare publications.
This review found no literature describing the impacts of fatigue in SSc by 
sub-type.
2.7.5 Interstitial Lung Disease (ILD)
The pathogenesis of ILD has several components such as alveolar 
inflammations, interstitial fibrosis and vascular abnormalities, with the 
hypothesis that there may be another event or process as yet unclear (Silver 
and Clements 2003). Survival for those with SSc and interstitial lung disease 
is inversely proportional to the amount of restriction present for that 
individual: 10 year survival ranging from 87% for those with no ILD, to 75% 
with moderate ILD, and 58% 10 year survival in those with severe ILD as 
cited (Khanna et al. 2007).
ILD has been associated with the diffuse sub-type of SSc (table 2.2). The 
most recent, large, randomised control trial of the treatment of ILD in those 
with SSc (Khanna et al. 2007) did not identify the sub-type of its study 
participants and therefore no conclusions can be drawn as to the incidence 
or impacts of disease sub-type and SSc from that work.
There is a strong case for early detection and early treatment of ILD 
because for those with severe ILD, their loss in lung function occurs more 
significantly in the earlier years of the ILD diagnosis, therefore commencing 
early treatment may help to preserve more lung function. Treatments for ILD 
in SSc are being reviewed. A recent study of oral cyclophosphamide showed 
the requirement to treat six to seven patients in order to achieve a clinically
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meaningful improvement in one persons functional ability above that of a 
placebo drug (Khanna and Merkel 2007).
2.7.6 Cardiac involvement and Pulmonary Artery Hypertension
Cardiac involvement in SSc includes pericardial effusion, myocardial 
inflammation or fibrosis and conduction (Kahan and Allanore 2006) with 
cardiac complications seen in 10% of SSc patients (Denton and Black 2004). 
Described as a pathology which has silently killed people with SSc, cardiac 
disease is a key issue, however there is still much to learn of the pathology 
of myocardial ischaemia in SSc (Mattucci-Cerinic and Seferovic 2006).
PAH is associated with cardiology as it requires right heart catheterisation 
for accurate diagnosis and therefore patients are frequently referred into 
cardiac services for their diagnosis and treatment. PAH is defined as a 
mean pulmonary artery pressure (pap) exceeding 25mmHg at rest, or 
30mmHg during exercise (Faber and Loscalzo 2004; Black 2005). It may be 
classified as a stand-alone condition (Primary PAH) and as such has a 
mortality of 45-60% within the first two years from diagnosis (Magliano et al. 
2002). However, there is a known association of PAH with autoimmune 
rheumatic disease (Mukerjee et al. 2003) and when associated with SSc 
(SSc PAH), the survival is suggested to be 55% (Kawut et al. 2003) although 
an element of this perception may be accounted for by research design and 
clinical technique (Black 2005). PAH is the most prevalent complication of 
SSc, affecting approximately 15% of SSc patients (Black 2005). SSc PAH is 
of prime concern for clinicians and their patients.
PAH is diagnosed clinically by use of cardiac ultrasound, or more accurately 
by cardiac catheterisation to estimate the pressure within the right ventricle.
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Its cause is associated with the vascular impact of SSc or secondary to 
interstitial lung disease (Hachulla and Coghlan 2004). Until recent years 
there was little treatment for SSc PAH. However pharmacological 
developments have meant that treatments are available (Riemekasten and 
Sunderkotter 2006). These treatments include drugs such as prostacyclins 
(such as lloprost), which may be administered via continuous intravenous 
infusion and more recently by inhalation, lloprost has been the stalwart of 
therapy until the evolution of the current new era of therapies. The use of an 
endothelin receptor antagonist (ERA) is revolutionising therapy (Veale and 
Belch 1993; Hachulla and Coghlan 2004).
2.7.8 Raynauds phenomenon (RP)
First described by Maurice Raynaud in the 19th century, RP is a spasm of 
the blood vessels. RP presents in ‘attacks’ where the blood vessels are 
stimulated to constrict, commonly referred to as a spasm of the blood 
vessels. These attacks are commonly triggered by a change in temperature, 
stress or in some circumstances emotional stress (Belch 1991; Hennes and 
Wigley 2007). The areas affected by this vasospasm are commonly the 
extremities such as the fingers, ears, feet and end of the nose with affected 
areas undergoing a characteristic tri-phasic colour change. In the ischaemic 
phase the affected area appears white, then blue (cyanotic phase), then red 
(reperfusion) (Herrick 2005). There is increasing evidence to suggest that 
RP may affect internal organs such as the cerebral, coronary, pulmonary 
and mesenteric circulations (Marq et al. 1986).
RP is sub-divided into primary and secondary. Primary Raynauds is a stand­
alone condition being found in approximately 10% of the population (Olsen
-45
and Neilson 1978). Secondary Raynauds is where the RP accompanies a 
disease such as SSc, rheumatoid arthritis, and systemic lupus 
erythmatosus. RP links are seen at a clinical level in RP secondary to SSc. 
The time of onset of RP may also give diagnostic clues in SSc with a sudden 
onset of RP in middle age or later life being a warning sign of the potential 
association with a secondary condition such as SSc.
The pathogenesis of Raynauds phenomenon is outlined in a review of this 
subject (Herrick 2005), where the vascular, neural and intravascular 
elements of pathogenesis are explored.
2.7.9 Ulceration
People with SSc may also be affected by the secondary consequences of 
the disease as may be seen in the lower limb with vascular pathology (Wan 
et al. 2001) which lead to reduced blood flow manifesting in reduced Ankle 
brachial pressure index or ABPI (La Montagna et al. 2002). The foot may be 
affected by this vascular insufficiency leading to ulceration which in turn 
affects mobility (Milio et al. 2006). Ulceration may be painful and this can 
lead to insomnia, the inability to carry out paid or unpaid work, and the 
inability to participate in social and family activities. At it’s worst ulceration 
may lead to amputation of part of the foot, or even the lower limb.
Ulcers of the extremities are often linked with prolonged or profound RP 
attacks. Digital ulceration is frequently sited on the fingertips and over the 
interphalangeal joints. They are often painful and limit the activities of the 
patient. If infected, they can lead to osteomyelitis and soft tissue infection 
(Korn et al. 2004). Treatment for digital ulceration should be prompt in order 
to avoid amputation. A mainstay of hospital based treatment is intravenous
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lloprost (Denton and Black 2004), with more modern treatments such as 
Bosentan offering promise of prevention of new ulceration (Korn et al. 2004).
2.7.10 Pain in SSc
Research into pain in SSc patients has not been widespread but is 
documented in the typically small studies seen in the SSc population often 
documented as a comparison measure amongst others (Faber and Loscalzo 
2004). Pain (measured by visual analogue scale reported in a value of 0-3), 
is reported as correlated with both the physical and mental components of 
the SF36 Health related QoL measure (Georges et al. 2006). A ’bodily pain’ 
question is one of the eight questions within the SF 36, however the authors 
report pain as a high correlation across several aspects of the SF 36.
2.8 Activity Limitation
The impairments of SSc are now shown in their impact upon activity 
limitation. The literature in this area is less abundant than that published 
around impairment. There is little information available on the activity 
limitation associated with renal disease, Raynauds phenomenon, ulceration 
and fatigue in SSc. More general information on these impacts is given 
where available.
2.8.1 Physical function
Physical function is a key feature of much research in SSc, as measures of 
function such as the Health Assessment Questionnaire (HAQ) (Fries et al. 
1980), and its derivation, the Scleroderma Health Assessment Questionnaire 
(SHAQ) (Steen and Medsger 1997) are frequently used as outcome 
measures in SSc studies. The importance of this is the Disability index
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element of the HAQ and SHAQ which provides a body of evidence of the 
effect of SSc on physical function.
Impairment of physical function have been shown in many SSc studies 
(Steen and Medsger 1997; Khanna et al. 2005). Research has illustrated 
that those with dcSSc report poorer physical function that those with IcSSc 
(Steen and Medsger 1997; Benrud-Larson et al. 2002).
2.8.2 Skin involvement
Microstomia frequently leads to difficulties with day activities such as eating 
(those with SSc often struggling with the cold remains of a meal while those 
around them have finished), dental care, and kissing. Whilst this information 
may be recounted by individuals on SSc websites, no publications were 
found in this area. The effect of skin thickening on fingers, sclerodactyly has 
been mentioned in relation to its pathology, and there are wider SSc studies 
using function as a comparison, (Benrud-Larson et al. 2002; Richards et al. 
2003; Johnson et al. 2006). However, there is little mention of the direct 
effect of skin involvement on activity limitation save a mention that it can 
make day to day functioning difficult (Vincent and Wilson 2006).
2.8.3 Gastrointestinal involvement
The activity limitation associated with Gl tract involvement in SSc include the 
requirement to alter eating habits (not eating late at night, avoiding spicy 
food) and sleeping position in combination (Mayes 1999). In a qualitative 
study of disease and symptom burden in SSc, (Suarez-Almazor et al. 2007), 
patients identified difficulty swallowing and digesting some foods, 
constipation and diarrhoea, pain and bloating.
-48
The use of medication such as Proton Pump inhibitors is frequently required 
to control these symptoms (Khanna et al. 2007). Symptoms found in the 
lower Gl tract include altered bowel habit such as constipation (Mayes 
1999), combined with reduced responsiveness of the rectal sphincter which 
may lead to faecal incontinence (Heyt et al. 2004). The activity limitation 
associated with this, or the fear of incontinence is not documented.
2.8.4 Pulmonary Artery Hypertension (PAH)
The pathological mechanisms of PAH have been described (Faber and 
Loscalzo 2004). Clinically the disease may present with symptoms of 
breathlessness on exercise or a reduced ability to exercise, this may lead to 
breathlessness on climbing a hill or the stairs and at later stages also occurs 
at rest. Other symptoms, which occur at the later stages of the disease, 
include chest pain or syncope (faint) on exercise.
2.8.5 Interstitial Lung Disease (ILD)
Activity limitation in SSc patients with ILD Is focused around outcome 
measures of disability such as the Health Assessment Questionnaire, Short 
Form 36 and dyspnoea scores such as Mahler’s dyspnoea index (Khanna et 
al. 2007). Unfortunately detail on the activity limitations found in SSc 
populations with ILD is not explicit, however breathlessness and a cough are 
characterised as common symptoms of lung disease in SSc (Mayes 1999).
2.9 Participation
The body of literature relating the impact of SSc on participation is minimal. 
This is in contrast to the growing literature regarding impairment in SSc and 
the associated links made with activity limitation. Minimal information is
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however available in some areas of participation, much information arising 
from a single qualitative article, (Suarez-Almazor et al. 2007), which explores 
potential effects on the participation of the individual. This body of literature 
is now described.
2.9.1 Skin involvement
There are potential psychological associations with these skin 
manifestations such as altered body image (Benrud-Larson et al. 2003), and 
reduced self-esteem (van Lankveld et al. 2007). Each of these has a 
potential effect on the individual and their desire or ability to participate in life 
as they would wish. No explicit evidence in available in this area but 
appearance self-esteem appears to be linked to acceptance and anxiety 
(Benrud-Larson et al. 2003), and body image is a significant factor for 
women with SSc (van Lankveld et al. 2007). A qualitative study exploring the 
experience of living with scleroderma (Joachim and Acorn 2003), explicitly 
explored the effect of the rarity of the disease and its visible signs. This 
research revealed that patients with visible signs of scleroderma were 
conscious of being different from others.
2.9.2 Gl effects on Participation
The symptoms of Gl involvement have been documented. It is logical to 
assume that these symptoms lead to problems in participation, and this is 
supported by a qualitative study of the disease and symptom burden in SSc 
where Gl symptoms were identified as the most prevalent and disruptive 
physical symptoms (Suarez-Almazor et al. 2007).
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2.9.3 Renal impact on participation
Whilst there is little information on the renal impact upon participation in SSc 
patients, more general renal literature suggests that patients with chronic 
kidney disease experience fatigue, nausea and vomiting, headaches, the 
need to urinate frequ en tly , n u m b n e s s  in hands and fe e t amongst other 
impacts (F o u n d a tio n  2 0 0 6 ) .
The effects on the individual’s ability to participate in life can only be 
surmised but the breadth of the effects of renal disease indicate significant 
potential effects upon the individual’s ability to participate as they would 
wish.
2.9.4 Fatigue
The implications of fatigue extend far beyond the more common experience 
of tiredness that cannot be compared, w ith  S S c  patients reporting both 
mental and physical fa tig u e . P a tie n ts  w ith  S S c  h a v e  stated that due to their 
fatigue they don’t feel like going out, and they had become a ‘couch potato’ 
(Suarez-Almazor et al. 2007). This links with the social life aspect of 
participation described in the ICF (WHO 2001 ), illustrating this impact of 
SSc.
2.9.5 Work
Work is a participation listed within the ICF structure (WHO 2001) where 
aspects of work such as work preparation, training, acquiring, keeping and 
terminating a job, remuneration and types of employment are outlined. Work 
disability has been described as a common outcome in other 
rh e u m a to lo g ic a l conditions (De Croon et al. 2004), with im p a c t o n  both the 
ind iv id u a l a n d  so c ie ta l level. There is little research in to  w o rk  p artic ip a tio n  in
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SSc, however a study of pain and depression in SSc found that those who 
were unemployed reported poorer social adjustment than those who were 
not (Benrud-Larson et al. 2002).
2.10 Mapping of SSc Outcomes against the ICF
Having seen how some of the symptoms of SSc relate to the ICF, it is 
important to see how outcome measures used to assess these symptoms 
and their treatments map against this framework. The rheumatology 
outcome measures group, OMERACT (Outcome Measures in 
Rheumatology) 2002, considered outcome measures for SSc and applied 
the OMERACT filter (a set of criteria of validity which outcome measures 
must match) to SSc outcome measures (Merkel et al. 2003).
The measures identified by OMERACT are presented below in Table 2.4, 
together with additional mapping of the measures against the ICF. This 
illustrates that participation and QoL are not represented.
Patient-perceived QoL
Patient-perceived QoL refers to QoL measures which have been developed 
using the patient as the expert informant, providing the items which will form 
the measure. These differ from measures which have been developed with 
healthcare professionals in the role as expert informant providing their items 
to form the measure.
Despite further publication in the area of measures of response, or outcome 
in SSc, (Khanna and Merkel 2007; Valentini and Mattucci-Cerinic 2007; 
Khanna 2008), the gap in the availability of participation and patient- 
perceived outcomes of QoL in SSc perpetuates.
-52
The OMERACT outcomes do not include a measure of patient-perceived 
QoL in SSc.
Table 2.4 Mapping of OMERACT outcomes in SSc outcomes against the 
ICF
Domain Validated Response 
Variable
ICF Classification




HRQoL/Function The 20 item disability 




Raynauds Raynauds Condition 
Score (RCS) MD 
Global for Raynauds.




Complete blood count 
(fragmentation of RBC, 
haemolytic anaemia) in 
Renal crisis.
Impairment
Skin Modified Rodnan Skin 
(thickness) score
Impairment









2.10.1 Disease specific outcome measures in SSc
There is evidence that patient questionnaire scores are able to predict 
mortality more effectively that other traditional methods (Carreira 2006). 
Therefore, literature beyond OMERACT was reviewed to identify further
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disease specific measures for use in SSc using key databases such as 
Medline, Embase, Cinhal and key author searches. Once identified from the 
literature, the measures were subjected to a process of critical appraisal.
This appraisal aimed to identify any measure which was a patient-perceived 
measure of quality of life developed with SSc patients as the expert 
informant. This appraisal took the form of a checklist of key elements:
1. Was the measure developed specifically for use in the SSc 
population?
2. Were patients/participants with SSc acknowledged as the expert 
informants in the development and testing process?
3. Was the measure based on a taxonomy of QoL? If a QoL taxonomy, 
which approach to QoL, such as Subjective Well Being (SWB)?
The measures identified in the literature are outlined in table 2.5, together 
with their appraisal. To describe this appraisal in more detail, each measure 
is now explored.
The Self-administered Systemic Sclerosis questionnaire (SySQ) (Ruof et al.
1999), is based on a disability taxonomy and therefore measures a range of 
physical symptoms such as pain, stiffness, coldness, complex functions, 
strength of hands and rising. Whilst it was developed from patient input, it is 
a measure of disability, not a measure of QoL.
The UK Functional Index is an eleven-item questionnaire focused around 
physical function in scleroderma whilst developed specifically for use in SSc; 
again it is not a QoL measure
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The SHAQ has already been mentioned (2.8.1), this being a measure based 
upon the Health Assessment Questionnaire (Fries et al. 1980), but with the 
addition of five visual analogue scales to measure Raynauds phenomenon, 
digital ulcers, gastrointestinal symptoms, lung symptoms and overall 
scleroderma respectively. Interestingly, the disability index of the 
HAQ/SHAQ has been referred to as a Quality of Life measure in one study, 
(Johnson et al. 2006), although it consists purely of physical activity 
questions. Therefore, the SHAQ, whilst including a vas of QoL is not 
designed as a QoL measure, and its sole QoL question does not have a 
stated QoL approach.
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A small study in SSc utilizing the World Health Organisation QoL 
(WHOQOL) measure was identified, which revealed there was no significant 
difference between the HRQoL (as described in Chapter 3) of people with 
dcSSc, and IcSSc (Hyphantis et al. 2007). This was not included in table 2.5 
as it is not a disease specific measure.
The analysis of disease specific measures for use in SSc presented in table
2.5 found no measures which met the criteria as a patient-perceived 
measure based on a QoL taxonomy. Therefore, this presents a gap in the 
toolkit available to assess the impact of SSc on the individual.
2.11 Psychological burden of SSc
Having demonstrated the physical impact of SSc, the area yet to explore is 
the psychological impact of the disease. Studies published about the 
psychological aspects of SSc appear to come from a mixture of two 
methodological backgrounds. Firstly there are papers which present an 
exploration of the personality or psychological characteristics of the 
individual with SSc such as depression and body image. Secondly are 
papers which explore the association between the physical and 
psychological impact of the disease. The effect of disease sub-type on 
psychological burden in SSc is discussed in some papers, but has not been 
addressed as the focus of research.
2.11.1 Psychological characteristics of people with SSc
Publications which have explored the psychological characteristics of people 
with SSc, frequently use a methodology where patient reported outcome 
measures (PROMs) are administered to patients supplemented by
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occasional physician led assessment of their psychological characteristics 
(Straszecka et al. 1996; Angelopoulos et al. 2001). The rationale for the 
choice of each PROM is frequently based on literature from existing 
research in other medical conditions, rather than an existing theoretical 
framework. The volume of literature exploring the psychological associations 
of SSc is far outweighed by that focusing on the physical aspect of the 
disease. This is despite broader medical evidence of the relationship of 
emotion and psychological issues to patient outcome (Sireling et al. 1985; 
Dorian and Garfinkel 1987).
However, various aspects of psychology have been studied in SSc patients 
for example Angelopoulos, (Angelopoulos et al. 2001), who found 
significantly increased levels of depression, anxiety, somatization, 
interpersonal sensitivity and obsessive-compulsiveness in females with 
scleroderma, in comparison with a healthy female population. Hostility, in 
particular guilt, was also significantly higher in the scleroderma group. Whilst 
this was a small study (thirty women with scleroderma, not specifically SSc), 
and thirty-five healthy women, these results generate initial information 
suggesting the psychological impacts in SSc.
Several aspects of the psychological burden of SSc have been studied in 
more detail, including depression, body image and adaptation.
2.11.2 Depression in SSc
A systematic review of depression in SSc (Thombs et al. 2007), concludes 
that symptoms of depression are common in those living with SSc and 
suggest routine screening for depression in these patients. A body of 
evidence has been growing regarding the impact of depression in SSc.
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Studies in SSc focusing on depression or including depression as an 
outcome measure have supported the evidence that depression (and often 
anxiety), are present at significant levels in those living with SSc (Roca et al. 
1996; Straszecka et al. 1996; Matsuura et al. 2003; Legendre et al. 2005)
2.11.3 Body image
SSc is associated with classic changes in appearance previously discussed 
in section 2.7.1. In addition, there may also be effects on how people feel 
about their sexuality, or their physical ability to have a full sexual relationship 
(Mayes 1999). The impact of this can be broad. In terms of SSc research 
this has been presented as ‘body image dissatisfaction’ (Benrud-Larson et 
al. 2003) or ‘appearance self-esteem’ (Malcarne et al. 1999). This latter work 
focused on the effect of skin thickening distribution and its associated impact 
on self-esteem and psychological distress. Body image is an aspect of SSc 
that is not commonly addressed in clinical care, other than by provision of 
limited voluntary services providing ‘camouflage’ make-up. The fact that only 
two studies were identified around this area of SSc illustrates the low priority 
this is given within health provision. For individuals living with SSc this may 
well be a key issue for which they can find little support or help.
2.11.4 Adaptation in SSc
Adaptation or adjustment emerges as a theme from the literature regarding 
psychological aspects of SSc. Demographic variables have been found to 
explain little of the variation seen in patient adjustment to SSc (Moser et al. 
1993); with this study of ninety four SSc patients showing educational level, 
functional ability, illness-related uncertainty, hardiness and social support as 
significant predictors of adjustment in SSc. A larger study of two hundred
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and forty two people with SSc in the same year, (Malcarne and Greenbergs 
1996), found wishful thinking, blaming self, and problem-focused coping 
appearing as predictors of psychosocial adjustment in SSc.
From the perspective of research into QoL in DcSSc and LcSSc, it is of 
particular interest that disease sub-type whilst related to distress, was not a 
predictor of distress, (Malcarne and Greenbergs 1996), nor indeed were 
demographics. In a later, UK based study of forty nine patients with SSc, it 
was found that physical elements such as disease sub-type, skin score and 
functional ability did not determine the beliefs and symptoms of those with 
SSc (Richards et al. 2003).
2.11.5 The relationship between physical and psychological impacts of 
SSc
Several studies have been conducted exploring relationships between 
psychological and physical measures in SSc populations. In line with the 
ethos of linking the physical and the psychological, many authors use the 
HRQoL model of QoL (explained in chapter 3). These studies, including 
(Moser et al. 1993; Malcarne and Greenbergs 1996; Roca et al. 1996; 
Benrud-Larson et al. 2002; Richards et al. 2003; Danieli et al. 2005;
Legendre et al. 2005; Eklund and Sandqvist 2006; Malcarne et al. 2006), 
use a wide range of measures of disease impact. Findings from such 
studies appear mixed, but many present some level of association between 
the physical and psychological impacts of SSc. For example, a strong 
correlation with disability and depressive symptoms was found in SSc 
(Danieli et al. 2005), and reduced physical function and abnormal Gl function 
were found to be significantly correlated with depression (Nietert et al. 2005).
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There appears to be variation in the literature as to the strength of links 
between the physical and psychological impacts of SSc, with findings that 
psychological characteristics seen in SSc patients, such as anxiety and 
depression, are not directly related to the physical impact of the disease 
(Roca et al. 1996). Also, beliefs of SSc patients about their disease, are not 
ruled by disease sub-type, skin score, functional ability or severity of digital 
ischaemia (Richards et al. 2003).
In conclusion, evidence of links between the psychological and physical 
characteristics of those with SSc is varied and remains an area of research 
which requires further development.
2.12 Current Treatments for SSc.
Treatments for SSc have broadened due to an increased focus in this 
clinical area over the last five years. This is reflected in the formation of 
groups of interested clinicians such as the Scleroderma Clinical Trials 
Consortium (SCTC) and the UK Systemic Sclerosis Interest Group. 
Treatment strategy consists of regular assessment of organs which may 
become affected, combined with early treatment of disease once it has been 
identified. SSc affecting a single organ may trigger drug therapies, but 
treatments often take the form a systemic therapy.
Whilst in the past there have been some broad treatments used to reduce 
underlying inflammation, currently treatments are usually focused around the 
organ or symptom affected in each individual patient. The new generation of 
therapies for symptoms associated with SSc include drugs such as the 
endothelial inhibitor Bosentan, used in people with PAH. A key issue in the
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treatment of PAH is its diagnosis. It has been an issue that the most 
commonly used screening tool for PAH, echocardiogram, may not be 
accurate enough to detect PAH (Mukerjee et al. 2003).
In SSc renal disease angiotensin converting enzyme (ACE) inhibition has 
been a focus for research and clinical practice. The search for therapies 
which can protect injured endothelial cells, which in turn prevent platelet 
aggregation and the release of platelet and endothelial derived mediators 
continues (Maddison 2002).
Until recent years, the mainstay of treatment for PAH has been continuous 
infusion of prostacyclins, such as lloprost. However, there are issues with 
their administration, as they are frequently administered through a central 
venous line in-situ, entering the patient through an incision in the chest wall. 
These lines are a potential risk of infection and also may become blocked. 
Researchers have sought other routes of delivery for prostacyclins (Wigley 
et al. 1998) and also for development of new therapies such as endothelial 
receptor blockers. Such drugs are now commercially available. These 
endothelial antagonist drugs such as Bosentan are in tablet form making 
them much more flexible to a patients lifestyle. Their administration by daily 
tablet is a major breakthrough in the treatment of SSc PAH (Hachulla and 
Coghlan 2004).
2.13 Future treatments for SSc
The focus for future therapies in SSc is to address the key pathological 
pathways, (Table 2.6), which if investigated may prove to be successful in
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producing a targeted therapy that addresses the underlying pathogenesis of 
SSc.





Bosentan E T a/ E T b pathway (Endothelin)
Imatinib PDGF receptor signalling
Infliximab TNF -  alpha
Adalimumab TNF -  alpha
Etanercept TNF -  alpha
CAT-1 9 2 TGF beta




M LM -1202 CCR2
Efalizumab LFA/ICAM-1
Key:
Transforming Growth Factor Beta (TGF beta); Connective Tissue Growth 
Factor (CTGF); Endothelin (ET); Platelet Derived Growth Factor 
(PDGF);Tumour Necrosis Factor (TNF);Lymphocyte Function Associated 
(LFA);Chemokine Receptor (CCR)¡Intracellular Adhesion Molecule (ICAM)
2.14 Summary of Chapter 2
This chapter has presented a review of the literature around SSc and used 
both a case study, and the framework of the ICF, to illustrate its profound 
physical and psychological impacts. There appears to be a lack of clarity in 
the evidence regarding links between the psychological and physical 
impacts of SSc, and a paucity of qualitative literature regarding patient- 
perceived effects of SSc was revealed.
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The disease sub-types of dcSSc and IcSSc have been described together 
with emerging evidence of their individual associated morbities. The physical 
impact of disease sub-type on the individual has been identified, raising the 
question as to the wider potential impact of disease sub-type.
The chapter has concluded with a summary of current treatments for SSc 
together with a description of future treatments under development.
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3. Quality of Life
This chapter discusses the concept of Quality of Life (QoL). The history of 
QoL is outlined and the two underpinning contexts of QoL assessment, the 
societal and individual, are discussed. In relation to assessment of QoL 
within healthcare, the concepts of health related quality of life (HRQoL), and 
Subjective Well-being (SWB) are discussed in more detail.
The rationale for selection of a conceptual model of QoL for use in the 
development of the SSc QoL is explored. The chapter concludes with 
exploration of the needs-based model of QoL as the model of choice for the 
SSc QoL.
3.1 QoL
It is customary to begin exploration of a concept with a definition. In relation 
to QoL, definition is perhaps one of the most challenging aspects of this 
exploration. There is no one commonly accepted definition of QoL, rather a 
variety of definitions, their use based upon the ideology of each author. 
Therefore, this section will begin with an exploration of the history of the 
concept of QoL and some Key approaches to QoL before returning to the 
issue of definition and the definition to be adopted for this research.
It has been commented that:
The quality of life construct has a complex composition, so it is perhaps 




The lack of consensus around a definition of QoL illustrates the many 
different ways in which this construct is interpreted. In turn, this has led to 
many different conceptual bodies of thought within the field of QoL research, 
each passionate about their own view. A commonly agreed definition of QoL 
for reference and use seems beyond our current grasp. However, definitions 
of QoL are not difficult to find (Bowling 2001; Rapley 2003). Definitions range 
from those that acknowledge the individual nature of QoL to those that focus 
on specific areas of the range of things that can influence QoL. They vary so 
much that a review has proposed a taxonomy of the definitions of QoL. This 
taxonomy divides definitions into:
• Global definitions (general and all-encompassing)
• Component definitions (definitions which break QoL down into
components or dimensions)
• Focused definitions (definitions referring to one or a small number of
the components of QoL)
• Combined definitions (as the name suggests, a definition which
combines the over-arching and component elements of QoL)
(Farquhar 1995)
This taxonomy works well in illustrating the complexities and volume of 
definitions which populate QoL literature. It also makes some very clear and 
pragmatic points about QoL research. For example, it underlines the need 
for researchers to clearly define their own interpretation or definition of QoL 
for the reader. There is in fact a long history of QoL, and it is often defined 
differently. There may be several reasons behind this lack of consensus,
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which may become clearer with an understanding of the history of QoL 
development.
3.2 History of QoL
Our modern day views of QoL have evolved over many years. A summary of 
this development is given in Figure 3.1 which presents a timeline of the 
prominence of QoL models over the past fifty years.
Figure 3.1 A timeline of the prominence of QoL conceptual models in the mid 
to late 20th century. Abstracted from conference presentation (Tennant 
2006).
1950 1960 1970 1980 1990 2000
Subjective Well Being -----------------------------------------------------------
Health Status -------------------------------------------------------------
Health Related Q o L ---------------------------------------------
QoL has historically developed along two lines, firstly the social construct 
(Bowling 2001) which measures of the state of whole populations such as 
the social indicators movement of the 1960’s. Secondly, QoL measures have 
developed along the micro level, looking at QoL on an individual, subjective 
level. On a conceptual level, QoL publications appear to divide into health 
related and non-health related models, and on an application level they 
divide into those models applicable to populations and those applicable at an 
individual level (Wilson and Cleary 1995; Spilker and Revicki 1996; Rapley 
2003).
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These can be represented in a simple diagram (Fig 3.2) below, which is the 
author’s summary of the literature in this area.









/  Societal/ \ l Individual \
f Group ) l  level J
V Level J
This diagram illustrates the two key levels for the study of QoL, that is at the 
population or the individual level, and the conceptual approaches to QoL of 
Societal indicators, Health Related QoL and Subjective Well Being.
3.2.1 NHS healthcare and QoL
In some ways, this has been seen within the healthcare agenda for 
sometime. From a governmental viewpoint, quality of healthcare services 
have been measured in terms of accessibility, with mention of involvement of 
patients and the public in the development of services. The requirement of
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NHS healthcare services to ask the question of the effect of healthcare on 
the individual’s quality of life is a much more recent one.
Current NHS guidance for healthcare provision requires patient and public 
involvement in service planning and evaluation. This involvement should be 
on both an organisational and an individual level. Interestingly, individual or 
patient group QoL has seldom been specified as one approach to gathering 
this input. However, recent NHS initiatives such as that of the eighteen week 
initiative where a patient should wait no more than eighteen weeks from 
referral to initial treatment have actually specified QoL as a measure for this 
initiative (DoH 2007a). There is no further guidance or definition as to the 
type of QoL measure required. A current key driver within Primary care in 
the UK, is that of World Class Commissioning (WCC) (DoH. 2007b), and the 
NHS review, ‘Our NHS, Our Future’ by Lord Darzi, (Darzi 2007). These 
represent the direction of travel for the NHS in England over the coming 
years, and both documents contain drivers for the development and use of 
Patient Reported Outcome Measures (PROMs). The term ‘PROMs’ and 
‘Patient Reported Outcomes’ (PRO’S) are used interchangeably within this 
study.
As there are such pressures within NHS healthcare delivery, and indeed 
within private healthcare provision, requirements to show measures of 
‘success’ such as improved QoL are increasing. This has meant in some 
cases that, as previously mentioned, there may be a tendency to measure 
that which is easy to measure, hence the use in many cases of a health 
status measure of QoL such as disability. Also, it cannot be underestimated 
that the conceptual definitions of QoL may not be at the forefront of the
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clinicians or managers mind when considering the definition or tool to meet 
their QoL reporting requirements (as seen in the lack of specification in NHS 
guidance (Dazi 2007; DoH 2007a). Whilst this may address aspects of the 
drive for healthcare professionals to obtain information labelled as quality of 
life, it underlines that there is a huge potential for difference in perspective 
between those evaluating these measures. This point is illustrated by studies 
such as an interview-based study of people with chronic obstructive 
pulmonary disease (Leidy and Hasse 1999). The authors propose that what 
they term ‘personal integrity’, (interpreted as quality of life by Rapley 
commenting on their findings), is not an isolated assessment but related to 
the lived experience of the individual.
The Department of Health commissioned a large study, (Johnston and 
Pollard 1996), into outcome measurement in chronic disease incorporating 
the older WHO classification of emotional, impairment, disability and 
handicap (ICDH). This study examined several outcome measures used 
within chronic disease management and assessed if they should be used 
separately or brought together to represent a construct of Quality of Life. The 
research findings found little support for the WHO model of the time, the 
ICIDH (see section 2.5), and found that emotional outcomes and impairment 
were distinct constructs from the others studied.
3.2.2 Pharmacological drivers for QoL assessment
The US Food and Drugs Agency (FDA) exerts significant influence over 
current priorities within pharmaceutical companies wishing to use QoL as an 
outcome for their produce. The FDA controls the licensing of new drug 
therapies within the US, including setting criteria as to the outcomes
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expected for each pharmaceutical trial and in turn the claims which can be 
made with regard to the drugs researched. Therefore the outcomes selected 
by the FDA become core outcomes for pharmaceutical research which then 
spread across national boundaries. There is a history of debate regarding 
QoL and FDA guidance (Lewis 2001). In 2006 the FDA published an online 
paper ‘The Importance of Patient-Reported Outcomes... Its all about the 
Patients’ (FDA 2007), there was discussion by the FDA describing patient 
reported outcomes as ‘any aspect of a patient’s health status that comes 
directly from the patient, without the interpretation of the patient’s responses 
by a physician or anyone else’
Not surprisingly, this FDA publication discusses the push from 
pharmaceutical companies to claim an improvement in patients quality of 
life, and its own stance in seldom allowing these claims to be made in 
pharmaceutical literature.
3.3 Assessment of QoL
The development of QoL illustrated two levels of QoL assessment, (figure 
3.2), that is the societal level and the individual level. These are explored in 
more detail together with a description of some of the models used to 
operationalise them within healthcare.
3.3.1 Societal indicators
To explore these in a little more depth, the rapid development of what were 
to be termed ‘social indicators’ during the 20th century can be traced through 
a series of historical events and conceptual movements. Such a conceptual 
movement, commonly referred to as the ‘Chicago school’, (Rapley 2003),
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was at its height in1930s and 40s America. A commentator on the 
developments of social indicators, (Noll 2000), offers further insight into the 
social indicators movement.
For example, in the 1950s, the work of Drenowski (United Nations) was 
notable in its focus on ‘identifying components of welfare and by constructing 
retrospective indicators (Noll 2000). The political and social climate of the 
1960s and 70s was considered conducive to the rapid adoption of social 
indicators at a population level. Intellectual drive of the time also focused on 
social indicators. Social indicators remain a key focus of national information 
such as the UK Social Trends report, and indeed form a key part of much of 
the information gathered at census and in a wide range of other government 
data around health and social care in the UK on which health priorities such 
as National Service Frameworks (NSF’s) are based (DoH. 2008).
However, whilst the 1960s and 70s were a time of economic development, 
this brought with it a questioning of money and material status as the 
measure of success at a population level. It has been suggested that this 
questioning brought with it a much more complex concept of QoL which 
emerged as an alternative to the view of the societal goal being directly 
related to affluence (Noll 1996). This was known as the Individual QoL 
movement.
3.3.2 Individual QoL movement
The multi-dimensional view of QoL, which arose at this time, has been 
referred to as the American quality of life (Rapley 2003). This model moved 
away from the concept of societal indicators at a population level, but rather
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looked toward the individual level of QoL. In the ‘German’ approach 
described by Noll, individual welfare of QoL is defined as:
‘good living conditions which go together with positive subjective well- 
being’
(Noll 2000)
3.3.3 Health Related Quality of Life (HRQoL)
HRQoL is a model of QoL It is stated to measure impairment and activity 
limitation and, until recently, HRQoL was referred to as ‘Health Status’ 
(Tennant 2006). It is possible to see both terms in contemporary healthcare 
literature. The term HRQoL was introduced to restrict consideration to 
outcomes considered to be easily assessed. Akin to the broader term QoL, 
HRQoL suffers from a plethora of definitions. Perhaps the neatest definition 
offered is that of Carr and colleagues who conclude that health related 
quality of life is the gap between our expectations of health and our 
experience of it (Carr et al. 2001). Other definitions of HRQoL offer that 
common theme that this aspect of QoL is related to health or the experience 
of health.
There is some confusion regarding the terms of HRQoL and QoL within 
healthcare publications. Attempts to define Quality of Life have used the 
term QoL and HRQoL interchangeably to mean ‘the patients’ personal 
morbidity -  that is various effects that illnesses and treatments have on daily 
life and satisfaction’ (Muldoon et al. 1998).
HRQoL is focused around physical health and disability, assuming that they 
are the key factors influencing QoL. There have been two major drives 
towards the development of outcome measures based on HRQoL. The first
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of these was Karnofsky and Burchenal 1949 (cited in (Bowling 2001).
HRQoL measures are commonly seen both in clinical practice and research 
as assessments of clinical outcome such as the Stanford Health 
Assessment Questionnaire HAQ (Fries et al. 1980), or the EuroQoL (Group 
1990). They are based on the premise that QoL in the context of health is 
directly related to the physical or physiological impact of the disease on the 
individual.
Domains considered integral to HRQoL vary greatly depending upon the 
model of HRQoL being used. Medical practice in the UK traditionally favours 
a concept of HRQoL which focuses upon four main domains as described in 
a lengthy article published in the BMJ (Muldoon et al. 1998). These four 





The proposed domains of HRQoL range from the simple model presented by 
Muldoon and colleagues, to more complex models such as that offered by 









• Social well-being and functioning
• Sexual functioning
• Existential issues 
(Fayers and Machin 2000)
Whilst there appears no definitive list of the domains covered by these 
terms, the literature does appear to agree on a mixture of physical and 
emotional elements, and the ability to differentiate between domains.
3.3.4 Quality Adjusted Life Years (QALYs)
QALY measures are those where years of life are balanced with the QoL of 
those years, giving a statistic as a result. The work of Nord (Nord 1992a) 
offers a good description to the development of QALY measures. For health 
economists, these tools provide a method of comparison across medical 
interventions by giving a scale of 1.0 for healthy to 0.0 for dead through 
mathematical calculation of the respondents answers. The QoL information 
required for this calculation comes from measures of HRQoL such as the 
WHOQoL (WHOQOL 1998), or the EuroQoL questionnaire (Group 1990).
QALYs have been described as a common currency with which to assess 
the sustained benefits from interventions (Phillips and Thompson 1998), 
however their use presents an area of contention.
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This contention arises from the apparent application of a value to an 
individual’s life, with concerns that these may lead to interpretation that 
death is preferable to a low quality of life as related to euthanasia, and that 
QALYs may also be used to justify rationing of healthcare: debates 
presented in Rapleys review of QoL research (Rapley 2003).
3.3.5 Health Utilities
Utility measures are rated by the individual in response to individual goals, 
risk taking and preferences given set hypothetical states (Rapley 2003). 
Similar to the QUALYs, utility measures also give a numerical scale of 1.0 
for perfect health to 0.0 for death.
Three main techniques fall under the umbrella of utilities: time trade off; 
standard gamble; and direct rating scales all sharing a common element, 
that is that the respondent is given options which they have to rate. Health 
utilities receive similar critique as that presented for QALYs (Rapley 2003).
3.3.6 Subjective well-being (SWB)
SWB is an individual measure of QoL, considering life satisfaction: why and 
how people experience their lives in positive ways (Deiner 1984). It is 
associated with three key elements. Firstly, as suggested in the name, it is 
subjective and individual and has been described as residing within the 
experience of the individual (Campbell 1976 cited in (Deiner 1984). 
Secondly, SWB contains positive measures and does not focus on the 
absence of the negative, and thirdly, SWB measures include assessment of 
all aspects of the persons life, usually with the use of an integrated or global 
assessment of the individuals life (Deiner 1984).
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3.3.6.1 Domains of SWB
As seen in the previous section, a dominant author in the area of SWB 
research is Ed Diener. His publications are at the fore of the literature in this 
area and the model of SWB he describes is based on domains of happiness, 
pleasant emotions, life satisfaction, and a relative absence of unpleasant 
moods and emotions (Deiner and Biswas-Diener 2000).
There is some challenge to this model. A seven domain model of SWB 
consisting of Productivity, Intimacy, Safety, Community and Health has also 
been proposed (Cummins 1996). Whilst these domains could be seen to be 
in line with the twelve domains, Cumming’s key variation Is that of QoL as a 
biologically determined brain state.
This conceptual exploration presents us with two basic conceptual 
viewpoints underpinning SWB, one being temperament and personality as 
key influences on peoples happiness, the other that of adaptation, where 
over time people adapt to both the good and bad and therefore these have 
less or no affect on their SWB (Brickman and Campbell 1971). However, the 
reality of the wider literature around SWB is that these two basic viewpoints 
are expressed through a variety of proposed models. Examples of these 
models of SWB are presented in table 3.1.
The range of models of SWB described in Table 3.1 show not only the 
variety of thoughts on the Influences underpinning SWB, but also reveal 
several other aspects of this view of QoL, and more debate in this area is 
seen in review publications (Deiner and Biswas-Diener 2000).
-76











to whether people 
are happy
Considers extraversión and 
neuroticism as the personality 
traits important to peoples 




based on the 
‘Hedonic 
treadmill’
This model principally states that 
over time people habituate to both 
good and bad events so that these 
circumstances will no longer 
influence SWB. This is further 
supported with research into 
lottery winners in particular 
(Brickman et al. 1978) and 
seriously disabled people (Silver 
1982 as cited in (Deiner and 
Biswas-Diener 2000)
(McKenna 2004a) Goal theory People have more positive effect if 
they succeed at their particular 
goals, and indeed if they have 
important goals. This is supported 
by (Oishi et al. 1999) who found 
students valued good results as a 
predictor of their satisfaction.
Csikszentmihalyi 




Theory of Flow In this model, the key to happy life 
is seen as engagement in 
interesting activities, with 
interesting being seen as a 
balance of challenge and skill.
3.3.6.2 Schedule for the Evaluation of Individual QoL (SEIQoL)
Emerging in the early 1990s, an individual QoL measure tool was developed 
known as the Schedule for the Evaluation of Individual QoL (SEIQoL) 
(McGee et al. 1991). This is a QoL tool where the individual outlines the 
areas of their QoL they wish to address by means of a semi-structured 
interview with a health care professional. Evolution of the initial SEIQoL 
measure led to the Direct weighting procedure for Quality of Life Domains 
(SEIQoL-DW), the use of which is outlined in the schedule administration
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manual (Boyle et al. 1993). SEIQoL offers an individual measure of QoL. It 
does however have its limitations. For example it may be difficult to use in a 
cognitively impaired individual or one who cannot participate in the required 
interview process.
3.3.6.3 Needs based QoL
The needs based model of QoL is based on a theory of human need 
expressed in 1954, and reviewed in 1970 and 1987 (Maslow 1970).
Abraham Maslow, an American psychologist, was considered radical in his 
time for his belief in theories based on the concept that the individual is an 
integrated organized whole. In the context of Maslow’s motivational theory 
and the needs based model applied to QoL assessment, need is a construct.
This construct forms the basis of Maslow’s motivational theory, where needs 
are seen in a hierarchical design. The ‘push and pull’ of human motivation 
are described by Maslow as ‘drivers and needs’.
Motivational theories refer to those theories which seek to explain why 
people do what they do. For Maslow, his implicit belief in the wholeness of 
the individual influenced his motivation theory with the belief that the whole 
individual is motivated rather than just a part. His motivational theory also 
looked at what he called the ‘means to the end’ where he uses the example 
of buying a new car (Maslow 1970). Maslow describes a situation where we 
want a new car because our neighbour has a new car and we don’t want to 
feel inferior to them. The new car maintains our self-respect and so we can 
be loved and respected by others. There are however needs which are an 
end in themselves, for example the respect and love previously mentioned. 
These needs tend not be instantly obvious, but are described as a
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conceptual derivation of those things we desire. This leads to the conclusion 
that motivation must consider human desires or needs. Maslow’s motivation 
theory states that our human motivation is dependent on the need to fulfill 
need at various levels (Maslow 1970).
Maslow’s motivation theory and exploration of needs has been translated 
into the ‘needs based theory’ of QoL through the work of Hunt and 
McKenna. Their adaptation of this theory for the development of a needs 
based QoL measure was that of the QLDs or Quality of Life in Depression 
measure (Hunt and McKenna 1992). Hunt and McKenna identified that there 
was frequently a lack of theoretical base for QoL measures: their work 
looked to models of human motivation to provide this theoretical basis. This 
theoretical basis, that of Maslow’s motivational theory that we are motivated 
or driven by needs, forms the basis of the needs based QoL. Hunt 
expresses the premise of this model to be that:
‘life gains its quality from the ability and capacity of the individual to 
satisfy certain human needs’
(Hunt and McKenna 1992)
In the needs based model, QoL is high when most human needs are fulfilled 
and low when few needs are satisfied. The needs based model clearly links 
directly with the individual and their subjective view of QoL and the disability 
paradox. The model has been used in the development of several condition- 
specific QoL instruments which include measures of adult growth hormone 
deficiency (Homes et al 1995), recurrent genital herpes (McKenna and 
Doward 1995), migraine (McKenna and Patrick 1995), rheumatoid arthritis 
(RAQoL) (De Jong et al. 1997), and ankylosing spondylitis (Doward et al.
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2003). The model therefore has shown to be applicable across a range of 
chronic conditions.
Key to the needs based methodology, as developed from the literature 
review of Hunt and McKenna, is a list of ‘needs crucial to quality of life’.
These needs are described as:
• Food, drink, sleep, activity, sex, pain avoidance.
• Warmth, shelter, security, safety, freedom from fear, stability
• Affection, love, physical contact, intimacy, attachment, 
communication, sharing experiences, sharing goals, affiliation
• Curiosity, exploration, play, stimulation, enjoyment, creativity, 
meaningfulness
• Identity, status, recognition, approval, appreciation, usefulness to 
others, respect, competence, self-esteem, mastery, 
achievement, power, independence, freedom
• Time, structure
• Self-actualisation
(Hunt and McKenna 1992) p.312)
These were translated into a topic list for qualitative interviews required for 
the QoL development which is discussed in Chapter 4.2.
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3.4 Adaptation and response shift
Whilst it is not the focus of this research, the concept of adaptation to 
disease, reflected in research terms as a Response shift, is a key 
consideration in outcome measurement.
Literature around adaptation specifically in SSc, has already been presented 
(see section 2.11), demonstrating the many manifestations of adaptation. 
Wider theories of adaptation to changing health exist, suggesting that as 
people adapt to their disease and its consequences, they re-orientate their 
expectations of life (Schwartz and Sprangers 2000). Therefore, people who 
have adapted may assess their QoL differently due to their adaptation rather 
than to any fundamental physical change in the effects of their disease. In 
terms of measurement of QoL, this concept is proposed to relate to 
response shift.
3.4.1 The Disability paradox
The disability paradox focuses on the fact that many people with physical 
disability would judge themselves to have a good QoL and are not 
necessarily constrained by their physical handicap. It is based on a 
‘salutogensis’ theory of Sol Lavine (cited in (Albrecht and Devlieger 1999), 
who sought explanation of how people may manage well despite poor 
health.
The research of Albrecht and colleagues presents results of semi-structured 
interviews with 153 people with disabilities, showing 54.3% of their 
respondents with moderate to serious disabilities reporting a good or 
excellent QoL (Albrecht and Devlieger 1999), thus presenting a clear
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argument against direct relationship between physical disability and poor 
QoL, hence the disability paradox.
For those reporting a poor QoL in this study, interviews revealed QoL was 
dependent upon establishing a balance between body, mind and spirit in the 
self, and harmonious relationships in a social and environmental context 
(Albrecht and Devlieger 1999). This clearly illustrates that in this study, QoL 
was dependent upon much wider aspects of life than the purely physical.
An individual example of this paradox is that of Stephen Hawkins. A scientist 
of worldwide eminence, a husband and father, his disability leaves him 
wheelchair bound and unable to speak independently, but appears to have 
little effect on his perception of QoL (Hawking 2008). Here is distinct 
evidence that QoL is not directly related to the severity of the disease.
3.5 Impact of SSc and the needs based model of QoL
The impacts of SSc and its sub-types have shown to be diverse, with a 
biopsychosocial model of disability, (the ICF), being selected as the 
framework for classification of its impacts (section 2.5). A model of QoL, 
which accommodates this diversity, is required as the conceptual base for 
this study of QoL in SSc.
The needs-based model of QoL (discussed in section 3.3.2.3), has been 
shown to be applicable to a range of chronic diseases and precedence for 
its use is seen in a variety of publications (McKenna et al. 2004). It 
demonstrates a wider view of QoL than HRQoL, recognizing the internal 
interactions of need within the individual. It fits with the patient-perception
-82
model of QoL required for this study. Therefore, the needs-based model of 
QoL has been identified as the model of choice for this study.
3.5.1 The Hypothesis
The research hypothesis of this study has been drawn from the evidence 
presented in the literature review presented in this study (chapters two and 
three). This review has revealed the diverse and potentially devastating 
effect of SSc, particularly emphasizing the different morbidities associated 
with each of its sub-types, dcSSc and IcSSc.
The differences in impact of SSc by sub-types have been illustrated 
throughout the literature review described in chapter 2; specifically in section 
2.2.3, which explains the differences between the physical impacts of the 
disease sub-types. This literature gave a clear message that the sub-types 
of SSc have different physical impacts and therefore leads to ask the 
question does disease sub-type influence other impacts of the disease. 
Section 2.11 illustrated the psychological associations with SSc, but there 
were confused messages regarding links with disease sub-type and 
psychological impacts.
Literature exploring the conceptual basis for QoL revealed two key 
approaches, subjective well-being (SWB), and health related QoL (HRQoL). 
This review illustrated that the viewpoints differ, HRQoL associating QoL 
directly to health status, and SWB focusing on the patients perspective of 
their QoL. No studies of QoL led from the patient perspective of SWB were 
found, despite studies interviewing patients directly (Joachim and Acorn 
2003; Suarez-Almazor et al. 2007). No tool for measuring SWB in people 
with SSc was identified.
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In summary, the literature review has given three key messages. Firstly, 
there is little known about the impact of SSc on QoL from the patient 
perspective. Secondly, there is no tool available to measure QoL in SSc 
from the patients’ perspective; and thirdly dcSSc and IcSSc are associated 
with different physical morbidities but how this impacts on patient 
perceptions of QoL is not known.
Based on the findings of this literature review, the study will seek to fill this 
knowledge gap by setting three study aims:
1. Develop a framework to describe and understand the impact of systemic 
sclerosis (SSc) on QoL.
2. Develop a questionnaire to measure patient-perceived QoL in people with 
SSc
3. Use the questionnaire to test the hypothesis that there will be differences 
in the level of QoL between people with different subtypes of SSc.
3.5.2 Summary of Chapter 3
Chapter three has summarised concepts of QoL, and the key drivers for QoL 
measurement in healthcare. Two models of QoL have been explored in 
detail: Health Related Quality of Life (HRQoL) and Subjective Well-Being 
(SWB). The concepts of adaptation in healthcare, and the disability paradox 
have been described.
The QoL model of choice for this study has been identified as a patient- 
perceived model of QoL, that is, the needs-based model. The study will have 
three components. Firstly, there will be an exploration of patient-perceived
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QoL in order to develop a descriptive framework of SSc QoL, secondly 
development of the SSc QoL measure, and thirdly testing of the research 




This chapter outlines the methods used to meet the three study aims which 
were outlined in the introduction to this thesis. The study aims to:
1. Develop a framework to describe and understand the impact of SSc 
on quality of life
2. Develop a questionnaire to measure quality of life in people with SSc
3. Use the questionnaire to test the hypothesis that there will be 
differences in the level of quality of life between people with different 
subtypes of SSc.
The study will use both qualitative and quantitative methods as appropriate 
as outlined in a summary diagram in Fig 4.1 below. Figure 4.1 outlines the 
methods used within this study. Whilst these are presented as three 
separate processes, there were many actions which were carried out in 
parallel or were inter-dependent for example Figure 4.1 outlines the methods 
used within this study.
4.1 Developing the descriptive framework of QoL in SSc
The descriptive framework of QoL in SSc will provide insight into the impact 
of SSc from the patient perspective. The methodology selected to develop 
the descriptive framework of QoL in SSc is based on qualitative data 
gathered from those living with SSc. Methods of gathering qualitative data, 
and for its analysis, are now described together with the rationale for 
selection of the methods employed within this study.
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Fig 4.1 Summary of study methods
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Figure 4.1 presents three separate processes, however, there were many 
actions which were carried out in parallel or were inter-dependent such as 
the SEM process was dependent upon data gathered during SSc QoL (this 
inter-dependency indicated by use of an arrowed line from one process to 
another).
4.1.1 Methods for gathering qualitative data
As outlined in figure 4.1, the qualitative data gathered in this research will be 
used in two ways. Firstly, thematic analysis of the data will provide a 
descriptive framework for QoL in SSc. Secondly, an established approach 
for development of a needs based QoL measure, (Hunt and McKenna 1992; 
Tennant et al. 2004), will be applied, involving identification of statements 
which will become items for use in the SSc QoL. This later analysis is 
outlined in Figure 4.2.
There are many strategies available to gather qualitative data, (Morse and 
Field 1998). These range from one to one interviews between a researcher 
and participant to observation of situations or people by a researcher 
external to the experience (Miles and Huberman 1994).
The data collection methods within this study are based on recognition that 
the patient is the expert informant. Therefore, the qualitative data required 
for development of the descriptive framework of SSc QoL, and the SSc QoL 
measure, are gathered directly from patients living with this disease. This 
was carried out by one to one interviews and a focus group. The data 
collected from these interviews also formed the descriptive framework on 
which further data collection was based.
-88
4.1.1.1 Sample technique
Sample sizes in qualitative research do not apply rules of quantitative 
sample size calculation (Holloway and Wheeler 2002). This is because 
sample size within qualitative research is dictated by other factors such as 
feasibility and the depth and duration of interviews (Britten 1995).
This topic is discussed in more detail (Holloway and Wheeler 2002), where 
issues such as people, context and time, and description of access to the 
sample are identified through review of the literature in this area. To 
summarise, the purpose of this qualitative research is to explore the 
experience of QoL for those with SSc. Three things will therefore dictate the 
size of the sample based on:
• population traits considered potentially relevant to QoL in SSc
• data saturation
• resources of the researcher.
4.1.1.2 Qualitative Sample Frame.
The conceptual base for the needs based QoL is focused around the holistic 
needs of the individual. This would suggest that it is unnecessary for a 
sample frame based around purely physical characteristics of the population. 
However, the elements of the sample frame were adapted to account for the 
expectations of clinicians caring for these patients and precedent in selecting 
representative subjects for needs base QoL interviews (Doward et al. 2003). 
The sample frame for this study includes patients of both disease sub-types, 
of young and older patients, of those who have had their disease for a short 
or long time and, as far as possible, a mixture of men and women.
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The rationale for these groupings is closely related to literature review of 
SSc. SSc affects many more women than men (Silman 1991; Mayes 1997), 
therefore, it was recognised from the distribution of SSc, that there would be 
few males with SSc to approach.
There is evidence of the different paths of SSc, and that for some people the 
first few years of the disease may be aggressive and lead to poor outcome 
(Steen and Medsger 2000). This presents the rationale for including 
participants with both short and long disease duration within the sample 
frame. As Steen and Medsgers’ work used five-year criteria, a division of 
disease duration into above and below five years was used. With regard to 
age, the sample frame aims to represent age groups of younger and older 
people to include a sample representing the younger and older SSc 
population. Disease sub-type is included as an element as the sample frame 
to allow exploration of the effects of disease sub-type.
The population of SSc nationally is small (approximately three thousand 
patients being recorded on the UK National Scleroderma database). This 
means there are not enough potential participants to divide the sample into 
any more detailed grid squares. The sample frame used to identify patients 
for the qualitative interviews is presented in Table 4.1. It was aimed to fill 
each cell in this sample frame with at least one interviewee. Data saturation 
would then determine when recruitment ended.
4.1.1.2.1 Data Saturation
The question of how many interviews are enough is encapsulated in the 
concept of data saturation. In qualitative data this has been described as the 
point at which no new information is observed in the data (Guest 2006). In
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research using sixty in-depth interviews, saturation was reported to be seen 
in as little as twelve interviews (Guest 2006). Within the field of needs based 
QoL development a standard amount of qualitative interviews appears to be 
around thirty interviews (Hunt and McKenna 1992).
However, in development of needs based measures intended for use in 
different countries, sixty two to sixty five interviews were required in order to 
include interviewees from each of the countries involved (McKenna et al. 
2004)
Key issues for debate surround data saturation. For example, is the data 
saturation affected by the order in which data is collected from respondents, 
or the ability of the respondents to provide data. For example, if the first 
participants to be interviewed were people who were able to express 
themselves eloquently more data could be generated than from participants 
who were unable to express themselves. The order of participant interviews 
is arbitrary, and therefore this element of data saturation in qualitative 
research must be open to a large degree to chance.
In order to study data saturation in more detail, this study proposes an 
innovation to the standard QoL development protocol by tracking items 
(statements/items in the QoL questionnaire). This research will track items 
through from the interview transcript to the QoL measure itself. This process 
of item tracking will provide a new aspect to needs based QoL research that 
is identification of the point of data saturation required for the items of the 
QoL measure itself.
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4.1.1.3 Exclusion and Inclusion Criteria for the sample
Interview participants were required to be aged 18 or over, to have an 
American College of Rheumatology diagnosis of dcSSc or IcSSc (as seen in 
Chapter two), and be to able to participate in a verbal interview conducted in 
English. Participants were required to give written informed consent as per 
ethics approval.
Potential participants who did not fit these criteria were excluded. The 
criteria for English speaking interviewees were used for three reasons. 
Firstly, the SSc population of the rheumatology centre was solely English 
speaking. Secondly is the need to interpret closely not just the word but the 
intonation of the words expressed within the interview process. And finally, 
this was due to the cost, both in time and money, of advertising and 
conducting this research in multiple languages when there was no evidence 
of non-English speakers with SSc in the recruitment site.
Table 4.1 - Sample frame for qualitative data collection
DcSSc LcSSc
A ge 18 -5 0  fem ale  
disease duration  
(dd) of <  5  years
A ge 1 8 -50  m ale  
dd <  5 years
Age 18-50  fem ale  
dd >  5 years
Age 1 8 -50  m ale  
dd >  5 years
A ge 50  + fem ale  
dd <  5 years
A ge 50+  m ale dd 
<  5 years
Age 5 0 +  fem ale  
dd >  5 years
Age 50  + m ale dd 
>  5 years
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4.1.1.4 Research management and governance approvals
In line with the Research Governance Framework 2001,2005, ethical and 
research and development (R&D) approval was sought for this study. This 
approval was obtained from the Leeds West Ethics committee, and the 
Leeds Teaching hospitals R&D in 2003. A protocol amendment was 
received for methodological developments, which were the additional focus 
group, and extension to a multi-site study to enable the researcher to access 
the Royal Free Hospital in London. The Royal Free Hospital is the base for 
the National Scleroderma Database. R&D approval was sought and gained 
from the R&D department at the Royal Free Hospital London (2006), in order 
to access this database and send out the postal questionnaire required for 
development of the SSc QoL.
4.1.1.5 Sample recruitment
The aim of the recruitment process was to recruit at least one interviewee 
from each sample grid cell. Options for patient recruitment considered were:
• Advertisement in areas where patients congregate such as out­
patient waiting rooms
• SSc Patient organisations
• Patient SSc events
• Advertising in sites of healthcare provision such as GP surgeries
Due to the rareness of SSc and the potentially wide geographical spread of 
patients who were members of SSc patient organisations, these options 
were not followed. Interviewees for this study were recruited by advertising
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the research project amongst SSc patients attending a hospital based 
rheumatology outpatients department. Those who expressed an interest in 
participating were given study patient information in accordance with the 
inclusion/exclusion criteria. As the demographics within SSc patients are 
heavily weighted towards older females, it was accepted that the amount of 
participants in each cell may reflect these demographics, although every 
effort was made to recruit participants in each of the sample grid cells.
Participants who were given the Patient Information sheet (as approved by 
the ethics committee) had a minimum of 24 hours in which to consider their 
consent. If they wished to participate, an appointment was made at a venue 
of their choice, normally hospital or home. Informed consent was obtained at 
the time of interview.
4.1.2 Qualitative Interviews
Implicit in the needs based model of QoL is recognition of the patient or 
respondent as the expert informant of their own QoL. This recognition is 
consistent with the grounded theory approach to qualitative research (Glaser 
and Strauss 1967), but the methodology in this study is overlaid by the 
needs based concept of QoL. The patient is also viewed to be the expert 
informant in the generation of items for potential inclusion in the QoL 
measure itself (Hunt and McKenna 1992; Doward et al. 2003; Gilworth et al. 
2004; McKenna et al. 2004).
Interviews are traditionally an interaction between two people, with one 
person as the interviewer, the other the interviewee. The focus of the 
interview is usually pre-determined in that there is usually a reason for the 
interview, but the structure of the interview may vary. There are three key
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types of research interview: structured; semi-structured; and unstructured, 
(Parahoo 1997).
The interviews in this methodology are described in some publications as 
unstructured (Doward et al. 2003), and by the original methodological 
authors as taking a ‘conversational’ approach (Hunt and McKenna 1992). 
The interviews use a topic list (Hunt and McKenna 1992; Doward et al. 2003; 
Doward et al. 2004). The topic list is based that used by Hunt and McKenna 
in their original research, and is outlined in Figure 4.2.
Figure 4.2 Topic list
• Activities around the home




• Leisure pursuits and hobbies
• Sleep and rest 
(Hunt and McKenna 1992)
The topic list does not suggest an order for direct questioning, but rather a 
checklist for the researcher to work with during the interview to prompt 
participants if they do not introduce these topics independently. This is 
required to address all aspects of the needs based model of quality of life 
selected by the researcher. It does not, however, exclude any additional 
topics the interviewee wishes to introduce. The emphasis of the interview is
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that the patient leads the interview with their own experiences of how their 
condition has affected their ability or capacity to meet their needs. The 
structure of each interview may vary according to the participant and what 
they want to bring to the interview, but the core elements of the needs based 
QoL will always discussed.
4.1.2.1 Researcher bias
The researcher has been acknowledged as an instrument in qualitative 
research whose skills are reflected in the quality of data collected and the 
data analysis carried out (Morse and Field 1998). The researcher’s skills 
were key to the development of a rapport with participants during the 
interview and focus group: their facilitation skills were essential to eliciting 
information within the interviews, and to ensure equality of access for those 
participating in the focus group. The researcher in this study had a clinical 
relationship with the interviewees. The decision to invite a second 
researcher, who did not have previous knowledge of the interviewees, was 
made, and evaluated at the mid-point review of the interviews by both 
researchers. The researcher’s previous knowledge of the interviewees 
appeared to have no effect on the length of the interviews, or the emerging 
themes. Therefore, it would seem that the clinical relationship of the 
researcher to the interviewees was not a negative bias.
4.1.2.2 Ground rules
Ground rules are agreed protocols between participants in qualitative data 
gathering (Holloway and Wheeler 2002). They cover aspects of the interview 
such as confidentiality, recording, what happens if the interviewee wishes to 
end the interview or if they become upset. Within the interviews for the SSc
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QoL the researcher re-enforced the patient information leaflet by saying that 
the interview will be tape recorded and then transcribed at a later date by a 
transcriber. It was made clear that the tape will be numbered and would not 
contain the interviewee name as their name would not be used during the 
interview. It was stated that if the interviewee wished to stop they were free 
to do so at any time, and they did not have to talk about anything they didn’t 
want to. It was also explained that there would be opportunity at the end of 
the interview to discuss any issues which may arise from the interview with 
the researcher or with outside organisations such as the scleroderma 
charities.
The researcher encouraged the participant to lead the interview following an 
introductory discussion about how the interview would be recorded. No time 
length was explicitly stated for the interviews but previous experience in this 
established methodology suggests interviews ranging from thirty minutes to 
two hours (Hunt and McKenna 1992; Doward et al. 2003). In practice the 
interview length varied from 45 -  60 minutes until the participants felt they 
had no more they wished to discuss. The second interviewer, who 
interviewed one third of the participants, reported that the average time span 
of her interviews was also 45 - 60 minutes.
4.1.2.3 Transcription
In order to analyze the data generated at interview, each interview was 
recorded on audio-tape. The use of the recorder was explained to the 
participant, and an initial trial of recording was made prior to each interview.
Brief observation notes were also made of each interview to serve as a 
prompt to the memory of the researcher. Each audio recording was then
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transcribed ‘verbatim’ by an external transcriber, verbatim transcription being 
described as giving the ‘fullest and richest data’ (Holloway and Wheeler 
2002). No annotations were used.
The researcher then read the transcripts alongside listening to the tapes to 
ensure the accuracy of the transcripts. There were some aspects of the 
transcriptions that were ambiguous in their meaning and therefore the 
researcher needed to listen to the tape in order to understand the intonation 
behind some statements in the transcript. The researcher annotated the 
transcript with their interpretation of the meaning behind the statement in 
order to retain that information to aid later analysis.
4.1.2.4 Interim review of qualitative data
A hiatus in data gathering was planned in order to review the quality of the 
data being produced. This allowed the two interviewers to collaborate and 
exchange experiences mid point through the research. This was to allow 
reflection between the two researchers to consider any practical issues 
arising from the interviews, to make a preliminary assessment of the quality 
of data being generated, and to make adjustments to the method if required.
It appeared that interviews from both researchers were approximately 45 to 
60 minutes in length. This allayed concerns that interviewees may give 
substantially more, less or different information to the interviewer they had 
met previously in clinical practice.
The participants did not raise any issues or concerns regarding consent to 
the research, and the majority of the interviews were conducted in the 
participant’s home at a time of their choice. The interviewees appeared
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comfortable with the interview structure. Some interviewees required 
prompts; others were spontaneous with their information.
The use of a focus group was explored as another forum for participants to 
express their views. The rationale for this was firstly to compare a focus 
group setting with the one to one interview as a data gathering method. This 
was to be tested by comparison of the themes generated. A focus group was 
selected for this, as it provided a setting for people to discuss with each 
other, which may trigger off more information sharing. An example of a 
similar methodology is seen in a later qualitative SSc study (Suarez-Almazor 
et al. 2007), where both interviews and focus groups were used as data 
collection methods.
4.1.2.5 The Focus group
Focus groups offer the opportunity for interaction between participants that, 
if well facilitated, may stimulate discussion amongst the participants (Bloor et 
al. 2002). In order to see if this method promoted more discussion amongst 
participants, a pilot focus group was arranged following submission and 
approval was gained from the Leeds West Ethics committee for this protocol 
amendment (2006).
The pilot focus group was held to answer the following question:
• Does the focus group format bring up new data not previously 
mentioned in one to one interviews?
The structure and facilitation of focus groups is well documented in 
qualitative research literature (Miles and Huberman 1994; Parahoo 1997). 
The number of participants varies, but it is considered to be between six and 
eight (Bloor et al. 2002). In order to answer the question which was the
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purpose of the focus group, the ideal participants were those who had most 
recently taken part in the one to one interviews and whose life had remained 
stable since their interview, thus allowing some comparison between the 
data brought up at focus group with the data brought up in a one to one 
interview.
The most recent eight participants of one to one interviews were contacted 
by telephone and details of the focus group were explained. In all, five of the 
eight participants approached consented to participate in the focus group.
It has been stated that focus groups should have both a facilitator who 
undertakes the running of the group, and an observer who takes no role in 
the group but who observes the verbal and non-verbal interactions of the 
group, making field notes on their observations (Bloor et al. 2002). An 
experienced, independent observer was used for this focus group and their 
observational notes can be seen in appendix 6.
4.1.3 Analysis of the qualitative data to form the descriptive framework 
of SSc QoL.
Choice of analytical approach
There are several approaches to the gathering and analysis of qualitative 
data including grounded theory, phenomenological analysis and thematic 
analysis.
Grounded theory was developed from a sociological perspective to 
understand human behaviour. It is based on a quantitative paradigm and 
statistically average behaviour, and its analytical technique is based on 
constant comparison (Holloway and Wheeler 2002).
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The objective of a phenomenological approach is to describe the essence of 
behaviour; it has been described as both a method and a philosophy. In 
practical terms it identifies meta-themes and interrelationships between data.
Thematic analysis seeks to identify common threads in qualitative data, 
typically interviews. Themes may be ‘indicated’ by the data rather than being 
directly observed by the participants (Morse and Field 1998).
Of these three methods of qualitative analysis, the rationale for selection for 
use in this study was made by matching the method to the study aim which 
in this case was the development of a descriptive framework of QoL. 
Grounded theory and phenomenology were not selected as they seek to 
explore relationships between data, which whilst it this is of interest, would 
extend beyond both the study aim and the study resource.
Therefore, thematic analysis was identified as the qualitative analytical tool 
of choice as it identifies the common threads in the data which enables clear 
description of the interview content. The themes can then be brought 
together to form a descriptive framework of these common threads (themes).
Initial coding into themes
Thematic analysis is a process of identification of key codes or themes by an 
iterative process. Themes (or codes) are tags or labels for assigning units of 
meaning to the descriptive or inferential information compiled during a study. 
Themes or codes are usually attached to chunks of varying size, words, 
phrases, sentences or whole paragraphs, connected or unconnected to a 
specific setting (Miles and Huberman 1994). This process identifies the key 
themes of the data.
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4.1.3.1 Multiple coding or data and counting occurrence of themes
There may be certain blocks of text that contain a mixture of themes. Coding 
a statement under multiple themes becomes of debate if there is a plan to 
count the frequency of a theme as it occurs during transcripts. Counting of 
how many times a theme occurred during the data gathering may be 
suggested to intimate the ‘strength’ of the theme in terms of how often a 
theme is mentioned in the data. Therefore, if the researcher is counting the 
frequency of themes, coding a statement under several themes will ensure 
that each theme is fully represented.
Counting frequencies of statements relating to a theme was not employed 
during this research for two reasons. Firstly, the frequency of a statement 
was not relevant to this methodology as the items selected for the SSc QoL 
will be subjected to a wider sample of hundreds of people with SSc during 
the Rash analysis process. Secondly, from a qualitative research 
perspective, counting of code frequency is not part of the coding guidance 
commonly found in qualitative data analysis texts (Miles and Huberman 
1994; Silverman 2003).
Coding and thematic analysis may be done manually but many researchers 
use a computer software package to help them to organise their data.
4.1.3.2 Computer analysis techniques
The availability of computer analysis software has revolutionized the ease 
with which qualitative researchers can handle large amounts of qualitative 
data such as that generated by interviews or focus groups.
These software packages such as NVIVO, provide an alternative to the 
traditional method of coding each transcript with a pen, cutting each coded
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section into a slip and putting each slip with the coded quote into piles of 
quotes representing each code, or alternatively using reference cards 
documenting the place or actual quote representing each code (Pope et al. 
2000). The enormity of this process can only be imagined when dealing with 
multiple lengthy transcripts. Compounded with the difficulty of sections of 
text which fit into more than one code, is the problem of maintaining the 
context of the quote. In many cases this is imperative to ensure the correct 
interpretation of each statement.
Such software packages are a tool with which to manage large amounts of 
qualitative data. Whilst they can be set to search for terms, they do not aim 
to interpret or reflect upon the data (Morison and Moir 1998; Pope et al. 
2000). Computer analysis software was explored for use within this 
research, however a combination of manual coding and thematic analysis 
was selected for use, supported by data storage and item tracking using a 
Microsoft Excel spreadsheet. This spreadsheet offered the flexibility to 
record both themes and items through each stage of analysis and item 
selection. The spreadsheet then supported data analysis of thematic 
analysis and item tracking.
4.1.3.3 Second stage of thematic analysis, coding of sub-themes
It is important to avoid ‘premature closure’, that is leaping to a theme early 
on in the data analysis prior to full understanding of the text. In this study 
initial themes were identified on the second reading of the transcripts. 
Preliminary theme definitions were compiled at this stage. Constant 
reference was made back to the transcripts to check against these inferential 
leaps (Holloway and Wheeler 2002).
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At this stage, the data and themes were reviewed by a second researcher 
(supervisor) to ensure there was agreement with the themes.
4.1.3.4 Third stage of thematic analysis
At this point, themes and theme definitions were revisited and refined.
4.1.3.5. Identification of overarching themes
The third stage of the thematic analysis process was identification of 
overarching themes. This involved the researcher grouping together the 
themes identified into groups that shared an overarching higher construct.
For example, all those themes that related to an aspect of physical limitation 
were grouped into an overarching theme of ‘Physical Restrictions'. Again, 
these overarching themes were analysed by a second researcher 
(supervisor) and consensus achieved.
4.1.3.5 Formation of the descriptive framework of QoL in SSc
The descriptive framework of SSc QoL will be developed from results of 
thematic analysis of the interview transcripts exploring peoples’ experience 
of SSc and its effect on their QoL. The themes are presented in chapter five.
4.2 Attributes required in the development of the SSc QoL
It is suggested that a measure of QoL has certain key attributes (Medical 
Outcomes Trust 2002). This key article, written by the Scientific Advisory 
Committee of the Medical Outcomes Trust, suggests eight key attributes of a 
QoL instrument. Figure 4.1 (p.82) presented the methods used to develop 
the SSc QoL, Table 4.2, relates the eight attributes of a QoL measure and 
how they are addressed within the development of the SSc QoL.
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Table 4.2 -  The Medical Outcomes Trust attributes of a QoL measure 
(Medical Outcomes Trust 2002) - Summary of how these are met in the SSc 
QoL
Attribute of QoL measure How this is achieved in the SSc 
QoL
Conceptual and m easurem ent model T h e  concept to be m easured  is patient- 
perceived Q oL  In those with S S c . T h e  N eeds  
based m odel of Q o L  form s the  conceptual 
basis of the S S c  Q oL.
T h e  S S c  Q o L  will be developed for use with  
people w ho have lim ited or d iffuse S S c . T h e  
R asch m easurem ent m odel is the standard  
m ethod of validity testing in o rder to produce  
an interval scale.
Reliability D ata  to allow  test-retest reliability testing will 
be gathered  by adm inistration of the  S S c  Q oL  
over tw o  tim e points (section 4 .2 .6 ) to the  
sam e population.
Reliability of the S S c  Q o L  w ill b e  assessed  
using R asch analysis and param etric  testing.
In R asch analysis Differential Item  Functioning  
of the two tim e points w as  used; param etric  
testing using S p earm an s correlation of results  
over the two tim e points w as  also used.
Validity F ace  validity as patient is the expert inform ant 
(4 .2 .1 ) and cognitive debriefing process
(4 .2 .3 )
Responsiveness Person separation index of R asch analysis is 
designed to show  the  function of a  sca le  
across groups. Longitudinal study of the S S c  
Q o L  w as  not a  requirem ent of the  study  
hypothesis
Interpretability T h e  S S c  Q oL  will produce a  s im p le  sum  score; 
the higher the  score the higher the  im pact of 
S S c  on QoL.
Respondent and adm inistrative burden Feedback from  C ognitive debriefing will inform  
the respondent burden of the S S c  Q oL . T h e  
adm inistrative burden of the S S c  Q oL  is sm all 
as it is a  sum  score that can  be added  in the  
clinical setting.
A lternate form s T h e  study aim  is to produce one  form  of the  
S S c  Q oL  at this s tag e  that is a  paper based  
m easure  written in English.
Cultural and language adaptations This falls beyond the  requirem ents of this 
study but the  needs based  Q o L  m ethodology  
provides a  c lear protocol for cultural and  
language adaptations o f the S S c  w hen  
required
4.2.1 Item Selection
Items are the questions or statements that make up the QoL measure. The 
process of selecting these items for the SSc QoL measure follows an
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established in previous needs-based QoL measures (Doward et al. 2003; 
Gilworth et al. 2004). The process of item selection in the development of 
the SSc QoL was summarised in Figure 4.1 and is expressed in more detail 
in Figure 4.3 as follows.
Figure 4.3 Development of the SSc QoL measure -  Item selection
Item Selection from transcripts 
(Researcher, Independent assessor, application of criteria)
I
Item Reduction -  through the Rasch analysis process
1
Item Reduction -  Rasch (test/retest analysis)
1
Items in the QoL questionnaire
Key statements were identified by the researcher and mapped onto the 
Microsoft Excel database used for item tracking. A copy of each interview 
transcript was divided between a group of three researchers and healthcare 
professionals with experience of working with the needs based model of 
QoL. Each transcript was analysed by both the main researcher and one 
other member of this group.
The role of these independent researchers was to comment pn the 
operational definition of each theme and following discussion, and identify 
needs based items from the key statements. Consensus was also achieved 
on each themes operational definition. This is a similar process as described
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for development of previous needs based QoL measures (McKenna et al. 
2004).
The next stage of item selection consisted of each researcher applying the 
Item selection criteria. This criteria was based upon that used in needs 
based QoL development (Galen 2006).
Characteristics of items:
• Consonant with the needs-based model of quality of life
• Expressive of a single idea
• Applicable to all potential responders (i.e. not gender or age biased)
• Capable for being expressed in the first person
• Capable of being expressed in the respondent’s own words
• Is unambiguous
• Is short and simple
• Does not duplicate other items
• Appear suitable for future translation.
The researchers applied these criteria to the potential needs based items. In 
the majority of cases the application of the characteristics enabled a clear 
exclusion of items, however, there were some items that required group 
debate as to their suitability for selection. Each item was debated and a 
consensus obtained as to its selection. Following this item selection process, 
ninety items were selected to be included in the first postal questionnaire of 
the Rasch analysis process.
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4.2.1.1 Incorporation of the item bank into the SSc QoL
An item bank is a central place for the storage of items. These items may 
come from a range of measures, but it is essential that they share a 
conceptual base (McHorney 2003). In the case of the SSc QoL, the item 
bank needed to be one of ‘needs based’ items. Such an item bank has been 
developed and held by the Psychometric testing laboratory at the University 
of Leeds.
The use of item banks has been expressed as a key development in Patient 
Reported Outcome Measures (PROM's) (McHorney 2003).
The items in existing QoL measures form a needs-based ‘item bank’ (Lai et 
al. 2003; Tennant and Conaghan 2008). One of the purposes of an item 
bank is to find out which items are common across chronic diseases, and 
which are disease-specific. Any items in the ninety SSc QoL list which were 
the same or very similar to an item in these existing measures (item bank) 
were replaced with the item from the item bank.
An example of this includes:
Control:
SSc interviewee -  “It’s difficult to take control of my condition"
Item bank -  “I feel that I am unable to control my condition” (RA
QoL)
This process was undertaken for each of the SSc items selected from 
interview, with any items of the same meaning being replaced with an item 
from the item bank. Each of the final ninety items has been tracked back to
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its original source (e.g. table of item origins of the SSc QoL, Chapter 6) and 
this information was stored on the Microsoft Excel database.
4.2.1.2 Response format
The item statements must have the same response pattern, that is that they 
are all either dichotomous or polytomous (Bond and Fox 2001). This 
involves two processes. Firstly, a decision is made as to the response 
pattern for the items: this choice is between dichotomous responses (that is 
Yes or No), or polytomous responses (where there is a wider range of 
possible responses).
The SSc QoL uses a dichotomous (two options) response choice, that is 
‘True’ and ‘Not True’ to each item statement (appendix 7). It was necessary 
to ensure that each item response was in the same response pattern. This 
means that each type of response (True/Not True) represents the higher 
impact of the disease on the patients QoL. The higher impact should receive 
the higher numerical score. This ensures that when calculating the end 
score of the measures, it is possible to allocate a score of *1' to the ‘True’ 
responses and ‘0’ to the ‘Not true’ responses, with the higher score 
indicating the higher impact of the disease on the patients QoL. Each item 
was checked for the pattern of its response, that is which type of response 
(True or Not True) is a positive response. For example, if the question was 
phrased ‘Going out for a meal is difficult’ ‘True/ Not True’ -  here a ‘True’ 
answer would mean there was a problem with eating out.
4.2.2 Construction of Draft Questionnaire
A draft questionnaire was constructed to go forward for validity testing. The 
questionnaire was an A4 size ten-paged booklet. It consisted of the ninety
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items (statements) derived from item selection together with demographic 
questions and comparator measures. This draft questionnaire was 
developed on a small scale for use in the following scale development 
processes prior to post out of the First Postal Questionnaire (4.2.4).
4.2.3 Cognitive De-briefing in the SSc QoL Scale development
The development of needs based QoL measures has precedent for how 
issues of validity are addressed. Validity, the extent to which data collection 
methods measure the phenomenon under investigation, consists of several 
elements (LoBiondo-Wood and Haber 1994). Content validity is the degree 
to which the questionnaire or scale can adequately explore the phenomenon 
being studied. Face validity is a form of Content validity. It is the process of 
asking those not necessarily an expert in the area, to assess whether the 
questionnaire or measure reflects what is being studied (Parahoo 1997; 
Doward et al. 2004). In this case, the phenomenon being studied is QoL in 
SSc. The method chosen within the QoL development methodology is 
referred to as cognitive de-briefing (Doward et al. 2007). This process is 
described in development of QoL measures such as the Ankylosing 
Spondylitis QoL (Doward et al. 2003; Doward et al. 2007).
Within this study, cognitive de-briefing consisted of taking a draft of the QoL 
questionnaire booklet and introduction letter to people with SSc. Eight 
people were approached. Each person completed the questionnaire with the 
researcher present. They were asked to comment aloud to the researcher 
on issues such as understanding of the statements, applicability of the items, 
the relevance of the items and if there are any key statements/items that 
were felt to be missing. Participants were also asked to comment on the
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instructions for completion and appearance of the questionnaire to inform 
any changes prior to the first postal send out. The researcher noted these 
comments and as far as possible adapted the questionnaire booklet 
instructions and format accordingly.
4.2.4 First Postal Questionnaire
4.2.4.1 Sample
The population sample for the quantitative data gathering, that is 
administration of postal questionnaires, required two randomly selected 
groups with SSc. The first group received the initial booklet of 
questionnaires, that is the first postal. The second group received the test 
and retest booklets of the questionnaire.
Sample size
The UK National Scleroderma database was the source of the population 
sample for this study. Sample size reflected the population documented on 
the UK National Scleroderma Database (held at the Royal Free Hospital, 
London). The sample size was guided by the total population sample of 
whichever disease sub-type was the smallest, in this case dcSSc. This 
number was then matched by an equivalent number of patients with IcSSc.
Identification of the population from the National Scleroderma database
The process of sample identification is see in Table 4.3 which illustrates that 
the National Scleroderma database held information for 2932 patients with 
SSc; 1046 of those on the database did not have a disease sub-type 
identified. Of the remaining 1886 who had an identified disease sub-type, 
618 were patients with DcSSc, 1268 with LcSSc. Of these, 177 with LcSSc
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and 169 with DcSSc were deceased; therefore 11.67% of the database 
patients were deceased.
As there is no electronic link between the UK National Scleroderma 
Database and the patient administration system (PAS) of the Royal Free 
Hospital, a manual cross-check was made by the researcher. This was done 
to ensure firstly that questionnaire booklets were not sent out to those who 
were deceased, and secondly that the patients identified had the key 
demographic data required for later data analysis. A further 71 patients had 
to be removed due to lack of a complete postal address.
The remaining sample was then anonymised and randomised into two postal 
groups; each containing similar numbers of people with each disease sub- 
type. Following this randomisation (stage 5 in Table 4.3), those IcSSc with 
were checked against the PAS system against the same criteria as the 
dcSSc sample. This was not done at the same time as the dcSSc sample 
(pre-randomisation), due to the much larger IcSSc sample that would be 
reduced through randomisation to a number similar to that of the dcSSc 
sample.
Records management guidance
Due to records management guidance (DoH 2006), data was anonymised 
prior to electronic transfer to the statistician for computer randomisation. Due 
to this, the date of birth was removed from the data therefore sample age is 
not available for the sample group, and therefore for the non-responder 
group also. Disease duration, or date of diagnosis, was largely absent from 
entries on the National Scleroderma database, therefore disease duration is 
also not available for the sample group or the non-responder group.
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Table 4.3 Sample identification for the postal questionnaires used in 




Numbers in database Remaining sample 
available
1 Total in database - 2932 2932
2 1046 identified as having no 
disease sub-type documented
1886 remaining: 618 with 
dcSSc;1268 with IcSSc
3 Identified as deceased: 
169 with dcSSc 
177 with IcSSc
Total sample remaining: 
449 -  dcSSc 
1091 - IcSSc
4 Diffuse sample checked against 
the hospital Patient Administration 
System (PAS): deceased; 
insufficient postal details; outside 
of the UK -83 cases removed
366 dSSc patients 
1091 IcSSc patients
5 Cases anonymised and sent for 
randomisation
383 patients for group 1 (183 
dSSc, 200 IcSSc)
383 patients for group 2 
(183 dcSSc, 200 IcSSc)
6 PAS checking of those 
anonymised to leave final sample 
groups for the development of the 
SSc QoL
Group 1 -  First postal 
questionnaire for the draft SSc 
QoL
Group 2 -  Test/Retest of the draft 
SSc QoL
Group 1 (n= 336)
177 with dcSSc 
(36 Male, 141 Female)
159 with IcSSc 
(22 Male, 137 Female) 
Group 2 (n=369)
182 with dcSSc 
(33 Male, 157 Female)
187 with IcSSc 
(63 Male, 149 Female)
Randomisation of the sample into sample groups
Two groups (first postal questionnaire and test/retest sample) were to be 
identified from the remaining sample. Each group should have a comparable
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number of patients with dcSSc and IcSSc. There are various processes 
available for selection, randomisation presenting the option least susceptible 
to bias (LoBiondo-Wood and Haber 1994). Of the methods available for 
randomisation of data, randomisation by computer offers a system that is 
quick and transparent (Parahoo 1997). Therefore, randomisation of the 
population into two sample groups was carried out using computer software. 
Data of patients from the national database was anonymised in line with 
NHS Records management guidance (DoH 2006), and presented for 
randomisation in separate dcSSc and IcSSc Microsoft Word folders. These 
were sent electronically to the departmental statistician who randomised 
each folder into two groups, groupl for the first postal questionnaire, and 
group 2 for the test/retest data collection.
4.2A2 Potential measures identified for hypothesis testing
The descriptive framework of this study identified several key themes which 
participants associated with QoL in SSc. These themes were used to identify 
a range of measures or outcomes for incorporation into the postal 
questionnaires, results of which were then available for use in later 
modelling of QoL in SSc.
This modelling takes the form of Structural Equation Modelling (Schumacker 
and Lomax 2004), and is described in more detail in section 4.3.
Where available, themes within the descriptive framework were represented 
by a corresponding comparator measure. These are summarised in table 
4.4. For example disability, was part of the theoretical framework of SSc 
QoL, therefore the Scleroderma Health Assessment Questionnaire
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(Disability Index) and the UK Functional Index were included as a 
comparator measure in order to reflect disability in SSc.
Table 4.4 Comparator measures used and their link to theme of the 
descriptive framework, and element of the ICF







London Handicap Scale Participation Finance, social 
impact, hobbies, 
hygiene, work
Euro QoL EQ 5D Health status Physical restriction
UK Functional Index Disability Physical restriction
General Perceived Self- 
Efficacy
Not assigned Control, Family (role)
Rosenberg’s Self-Esteem 
questionnaire
Not assigned View of self
Hospital Anxiety and 
Depression questionnaire
Anxiety -  ‘Emotional factor’ 
covers all elements








Five criteria were used to select the measures for potential use in later 
modelling.
• The measure represented an aspect of the descriptive 
framework of SSc QoL developed from the SSc participant 
interviews
The measure had some evidence of previous reliability and/or 
validity testing, preferably within SSc patients
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• The measure was available for use with sufficient information of 
its content and scoring methods
• The measure was considered user friendly at the cognitive 
debrief stage
• The measure was not excessively long or complex
The measures which were explored, but not included in the questionnaire, 
are identified in detail in an appendix to this study (appendix 8).
Following the return of the first postal booklet, several changes were made 
to the booklet for use in the test-retest analysis stage. The rationale for these 
changes was two-fold. Firstly, some additions were made such as questions 
around pain and sexual activity due to reflections on the theoretical 
framework generated from the qualitative interviews. Secondly, changes 
were made to some response categories in order to simplify or clarify data 
analysis.
Changes made to the booklet for the test/retest analysis:
• Age and disease duration to years not categories to allow more 
precision.
• Removal of the question if the respondent had been ‘told their 
disease sub-type’, as this was felt to be open to response error 
due to the time elapsed since that information may have been 
given.
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• ‘Not applicable’ option considered for removal but kept in for the 
5 Visual Analogue Scales of the SHAQ, despite the potential for 
analytical issues, as this is it’s original format.
• Added ‘S’ questions which were original QoL items removed 
during the Rasch process of internal validity testing. They were 
included as they appeared conceptually meaningful to the 
interviewees, and may have represented a sub-scale.
• A marital status question for some indication of social network in 
the home.
• Pain Visual Analogue Scale (VAS) - this was not included in 
first postal data collection as not a ‘strong’ theme, but included in 
test/retest version of the booklet, as both pain items had been 
retained by Rasch analysis illustrating the relevance of pain to 
the first postal sample group.
• Sexuality single question added as this seemed to have a 
potential link with items which had been retained by Rasch, such 
as those around confidence, relationships, self-esteem.
4.2.4.3 Process of Questionnaire production, mail-out and data entry
A postal questionnaire booklet was the tool identified to gather the 
quantitative information required for the development of the SSc QoL, in line 
with previous needs based QoL development methodologies (Doward et al. 
2003; Gilworth et al. 2004). The booklet contained demographic questions, 
the items generated by the item selection process and comparator measures 
of the key elements of the SSc QoL theoretical framework.
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In order to encourage competition and return of the questionnaire booklet 
several issues were considered. Firstly, the length of the booklet was 
reviewed with the aim to minimise the task of completion. It may be logical to 
assume that the shorter the questionnaire, the less onerous the task to 
complete and the higher the return rate. However, literature does not support 
this assumption, showing that questionnaire length does not have a direct 
relationship with response rate (Subar et al. 2001). The questionnaire was 
designed to be visually neat, with precise instructions, easily readable text 
and using simple language. Hand written personalisation of the research 
introduction letter was considered in order to engage recipients to respond. 
However, questionnaire design literature, (Byrom and Bennison 2000), does 
not support the effect of personalisation on response rates, therefore a 
quicker, printed form was used.
Options for production of the booklet included payment for commercial 
printing or internal make up of the booklets using a high-powered 
photocopier. Due to the financial constraints of the study, a photocopier was 
used. The introduction letter for each stage of the postal administration 
included a formal departmental heading to show the academic support of the 
research. It also included an invitation to contact the researcher for 
discussion or question and information of financial support and academic 
role of the project. The postal questionnaire booklet had an estimated 
completion time (based on the construct validity testing process) of 20 -  30 
minutes.
The questionnaire booklets were colour coded to allow easy differentiation 
between disease sub-types and study stages. Each booklet was identified
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with numbers taken directly from the SSc database and a D/L added at the 
end of the number. The D/L label reflects the disease sub-type of the 
respondent as dcSSc or IcSSc. This ensured the researcher could identify 
diffuse or limited disease when responses were entered into the database. 
This identification number was hand written on each questionnaire to allow 
identification on return and inform the reminder list for non-respondents. A 
letter franking account was established with the university together with a 
Freepost address for return of the questionnaire booklets. Each envelope 
contained an introductory letter, a questionnaire booklet, an open sheet for 
respondent’s comments and a return pre-paid envelope.
4.2.5 Construct Validity Analysis (Rasch)
Validity, when related to research, has many definitions. Perhaps the most 
cited of these definitions is ’An account is valid or true if it represents 
accurately those features of the phenomena that it is intended to describe, 
explain or theorize’ (Hammersely 1987 cited in (Winter 2000). The view that 
validity is not a single or universal concept has been explored during a 
comparison of validity issues between qualitative and quantitative research 
(Winter 2000). Validity is often linked with the concept of reliability, reliability 
being described as ‘the consistency of a particular method in measuring or 
observing the same phenomena’ (Hoyle and Smith 1994).
Construct validity refers to the level to which the questionnaire or scale 
reflects the construct which is being assessed (LoBiondo-Wood and Haber 
1994). The method for assessing internal construct validity within the needs- 
based QoL methodology is that of Item Response Theory, namely Rasch 
analysis (Tennant et al. 2004). This 2004 article describes the use of Rasch
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analysis in the development and application of QoL instruments, illustrating 
the benefits of the Rasch model. These benefits including the ability of 
Rasch analysis to transform ordinal scores in interval level measurement 
and provision of a means of assessing a range of measurement properties.
4.2.5.1 Item Response Theory and the Rasch model
Item Response Theory (IRT) is a statistical approach to data used to test a 
measure’s precision in measuring a latent (hidden) construct, (Wilson 2005). 
This is done by testing the responses of individuals to the measure against 
the latent construct (US National Cancer 2006). A construct is the idea or 
concept that is the theoretical object of our interest (Wilson 2005). A 
construct map reflects the underlying construct being measured, in this case 
QoL. The items selected for use within the QoL measure represent this 
latent construct. Whilst Rasch analysis cannot itself make this direct link to 
identify the latent construct, the link is drawn from the conceptual basis of 
the qualitative data from which the SSc QoL is developed, and the cognitive 
debrief process described in section 4.2.3.
The structure of the qualitative data collection (interviews and a focus 
group), was supported by a topic list drawn from a conceptual approach to 
QoL, need based QoL. Also, it was explained prior to each interview that the 
focus of the interview was how SSc had impacted upon the individuals’ QoL. 
Therefore, the data from these interviews and focus group represents the 
view of QoL from people living with SSc.
Relating this to the latent construct of the SSc QoL, it can been seen that 
there is a direct relationship between the qualitative data gathered from 
those with SSc, through the item selection process, to the SSc QoL measure
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itself. The process of IRT (Rasch analysis) is designed to identify those 
items which represent other dimensions or latent constructs. This is 
explained further in section 4.2.5.2, which discusses the concept of 
unidimensionality in the Rasch process.
Precedent for a choice of IRT model is found in previous needs based QoL 
measures such as the Betchets QoL (Gilworth et al. 2004) and the 
Ankylosing Spondylitis QoL (Doward et al. 2003). This precedent is the 
Rasch model.
T h e  R a s c h  m o d e l
George Rasch, a mathematician, developed a model of Item Response 
Theory, (Rasch 1960), initially based within education. Rasch analysis sets 
out a mathematical model against which new or existing scales can be 
tested for psychometric (measurement) properties and therefore acts as a 
test of internal construct validity (Pallant and Tennant 2007). In short, Rasch 
analysis provides a statistical way of transforming the qualitative statements 
(ordinal data) into an interval scale measure (Rasch 1960; Tennant and 
Conaghan 2008). Measures that attain the requirements of the Rasch model 
are independent of variables such as the age, gender or disease sub-set of 
the respondent.
The Rasch model is based on an assumption that the probability (p) of a 
person affirming an item or statement is a logistic function of the difference 
between the respondents actual level (0) of, for example QoL, and the level 
of QoL expressed by the item ((3), and only a function of that difference 
(Pallant and Tennant 2007; Tennant and Conaghan 2008). To put this into 
mathematical language, the Rasch model would appear as follows:
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p ( X n i = l \ 0 n, f r )  = exp i f i n - P i )  
l + exp (0„-,# )
(Wright and Panchapakesan 1969)
The equation contains two key components; the person’s probability of 
affirming the item, and the item itself. The Rasch analysis process is carried 
out using software such as Rumm 2020 (Andrich et al. 2003), ConQuest 
(Wu et al. 1998), or WINSTEPS (Linacre 2007), which uses information 
gathered from the responses to the items. This means that the items to be 
tested are given to groups of respondents (usually in a questionnaire form) 
and the answers provide the information required to compare against the 
Rasch statistical model. In picture form, the end result of the Rasch analysis 
places the item along the ruler (Figure 4.4) at equal distances ranging from 
the item most easy to affirm to the item most difficult to affirm, the latter 
indicating a worse state of QoL.
Figure 4 .4  The Rash Ruler -  Interval scale
Best l_____ |_____ |_____ |_____ I_____ I_____ I_____ I I Worst
Possible QoL Possible
The Rash model places the items tested along this linear scale. Within the 
Rasch ruler or linear scale, each unit represents ‘an increase in the odds of 
a person succeeding on an activity by 2.716 times’ (Tennant et al. 2004).
R a s c h  a n a ly s is  a n d  F a c to r  A n a ly s is
Rasch has been compared with other statistical approaches, chiefly 
Classical Test Theory (CTT), and Factor analysis. CTT refers to statistical
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models that assess the performance of an item and has been applied to QoL 
instruments and compared with Rasch analysis (Nijsten et al. 2006). This 
includes traditional statistical methods such as Factor analysis. Factor 
analysis is used to identify a set of factors that represent the underlining 
relationship between variables (Pallant 2005). Rasch analysis and Factor 
analysis differ in their approach to analysis, Rasch analysis approaching the 
data with a pre-set model, Factor using the data to create a model. Factor 
analysis has been stated to be ‘confused by ordinal variable and highly 
correlated factors,’ Rasch analysis however, assumes a unidimensional set 
of items and is able to produce a linear scale from ordinal data (Schumacker 
and Linacre 1996). Rasch analysis is therefore a key statistical model for 
use in the conversion of qualitative ordinal data, into a linear scale.
M o d e ls  o f  R a s c h  a n a ly s is
The original Rasch model was dichotomous (Rasch 1960). There are two 
variations on the Rasch model, both of which accommodate the polytomous 
response, called the rating scale model (Andrich 1978), and the Partial 
Credit model (Masters 1982). The precedent within the needs based QoL 
measures are for the use of dichotomous responses, (Gilworth et al. 2004), 
therefore indicating use of the dichotomous Rasch model.
4.2.5.2 Unidemsionality
Unidemsionality is the concept that the data, and by implication therefore the 
items, are representing a single underlying higher order construct (Bond and 
Fox 2001). In the case of this study, the higher order construct studied is 
QoL. For example, if the data being analysed came from a questionnaire 
developed to measure depression, if an item in the questionnaire measured
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a different construct such as hope, this is likely to show misfit to the 
unidimensional Rasch model. This would enable the analyst to recognise 
this different underlying construct and deal appropriately with that item. This 
concept is automatically assumed in measurement of things such as height 
and weight, but is not always questioned in social sciences (Bond and Fox 
2001).
Rasch analysis assumes that the items, summed together, form a 
unidimensional scale. Tests of this assumption continue to develop, but the 
use of principal components analysis of the residuals of items is the method 
facilitated within Rumm 2020 software. This analysis consists of identifying 
subsets of the most negatively and positively correlated items and applying a 
t test (Smith 2002). A binominal test of proportions is calculated (again using 
software) and if unidimensionality is present the value should cross the 5 % 
expected value given (Tennant and Conaghan 2008).
4.2.5.3 Local Dependency
Local dependency of items means that there are associations between 
items, that is the success or failure of an item is dependent upon the 
success or failure of another item (Bond and Fox 2001). This has two forms, 
dependency of item response and multidimensionality. Response 
dependency as it suggests, is where responses from one item show links or 
will determine a response from other items. A clear example of this would be 
that if an item asks if you can climb 20 steps and the respondent has 
affirmed that item, an item asking if you can climb 5 steps will automatically 
be affirmed. The residual correlation matrix will identify this situation. This 
issue can be then be addressed by combining items (Tennant and
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Conaghan 2008). Local dependence through multidimensionality will be 
identified and managed through the process of unidimensionality testing 
previously described.
4.2.5.4 Assessment of Fit and Differential Item Functioning
Rasch analysis contains several tests of ‘fit’; that is a summary of how well 
the data fit into the Rasch model (Pallant and Tennant 2007). A summary of 
the key tests of fit is outlined in Table 4.5. These are the key measures of fit 
on which the development of the SSc QoL measure was based. More detail 
of each of these measures of fit are described later in section 4.2.S.4.
Table 4.5 Reference Tables of desirable levels measured during the Rasch 
analysis process - Summary and Individual Fit statistics
Fit statistic Desirable level
Summary Scale Fit Statistics:
Chi Square probability >0.05
Person Separation Index >0.7 for group 
>0.85 for individual use
Item and Personal Residual Mean 0, SD 1
Individual Item Fit statistics:
Chi Sq 0.05 (Bonferonni adjusted)
Residual +/- 2.5
DIF > 0.05 (Bonferonni adjusted)
Figure 4.5 shows the summary analysis screen of Rumm 2020 software 
which was selected as the software for Rasch analysis in the development of 
the SSc QoL, and has been widely used for this purpose in other needs- 
based QoL measures (Tennant et al. 2004).
The summary fit statistics shown in Figure 4.5, together with other attributes 
of Rasch analysis are now described in detail.
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4.2.5.4.1 Chi square probability
The Chi square probability figure is worked out on the basis of each persons 
observed and expected scores according to the model, and is considered to 
be required to be greater than 0.05 (Bland and Altman 1995). For both the 
summary statistics for the whole scale, as well as individual items this needs 
to be non-significant. Bonferonni adjustment may be required (Bland and 
Altman 1995).
Figure 4.5 Print screen of the summary statistics used in Rumm 2020
4.2.5.4.2 Differential Item Functioning (DIF)
DIF is a test of how each item works across the different groups identified in 
the data, evidence of DIF illustrating item bias (Bond and Fox 2001). For
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example, in the case of this study the groups identified were the age, 
gender, disease duration and disease sub-type of the respondents. DIF is 
seen in items which produce different response functions for two or more 
groups (Bhakta et al. 2005). If DIF is identified in a group for an item (that is 
a level of 0.05 and below), then that item could not be used uniformly across 
a population that includes that particular group. There are two types of DIF, 
uniform and non-uniform. Uniform DIF is where there is uniformity amongst 
the differences between the groups; that is all the men are performing 
differently to all the women. Non-uniform DIF is used to describe DIF which 
is not uniform across the class intervals (Tennant and Horton 2006).
4.2.5.4.3 Rasch transformed score
Given satisfactory fit to the Rasch model, a linear transformation of the 
ordinal raw score can be achieved. The availability of a Rasch transformed 
score derived from a valid, unidimensional ordinal scale also offers the 
opportunity for two-way comparison between the Rasch transformed score 
and the ordinal scale. Potential differences will be seen when changes are 
observed passing over the non-linear margins of the scale.
4.2.5.4.4 Residuals
This is the divergence from the Rasch model, where at the summary fit level 
a mean of 0 and a standard deviation of +-1 are expected. For individual 
items a value outside the +-2.5 level is considered misfit.
4.2.5.4.5 Class intervals
Rasch orders persons in terms of ability and then automatically splits them 
up into groups of approximately equivalent size across the sample in order
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to approximate ability groups. The number of the class intervals therefore 
depends on the sample size. It is important that there are sufficient numbers 
of people (cases) within each class interval.
4.2.5.4.6 Person Separation index
Power of test fit is a visual representation of the Person Separation Index 
(PSI), which is indicative of the power of the construct to discriminate 
amongst respondents. It is equivalent to classical reliability and the minimum 
accepted level is 0.7 meaning it can differentiate between two groups of 
patients, 0.9 means it can differentiate between four groups (Streiner and 
Norman 1995).
The PSI is also an indicator of how much we can rely on the fit statistics. If it 
is low then there will be an amount of error in the fit statistics, if it is high then 
the data is deemed to be more reliable (Fisher 1992).
4.2.5.5 Data preparation
Data from the returned postal questionnaires were coded by using a master 
copy of the questionnaire booklet. The questionnaires within the booklet 
were allocated a numerical label in order to identify missing data, not 
applicable responses, missing patient ID numbers etc.
Numerical labels:
QoL items - 0 -  Not true, 1 - True
8 -  not applicable
9 -  missing data
888 -  missing database number.
888/999 missing data for Visual Analogue Scales
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Data was checked for errors using recommended techniques (Pallant 2005). 
Demographic data of the responders such as male, female, age, gender, 
disease sub-type and disease duration were analysed using frequency 
analysis, checking in particular for errors in data entry and to identify key 
areas of missing data. This analysis was also applied to the QoL items. All 
person items (such as ID, age, gender etc) were moved together at the top 
of the SPSS spreadsheet under the ID (person factor) headings. Actual sub- 
type of the respondents disease (as obtained from the National Systemic 
Sclerosis Database) were entered with the coding of 0 -  Diffuse disease and 
1 -  Limited disease. All column widths were adapted to fit into the Rumm 
2020 software system i.e. 1 for all columns except Visual analogue 
responses where a width of 3 is required. This file was then saved as a 
‘Fixed ASCII dat file’ for use in Rumm2020, and the SPSS output saved for 
later reference. The ASCII dat file was read into the software and ID factors 
entered. As a maximum of seven ID factors only are allowed, responses to 
the questions ‘Have you been told your disease sub-type’ and ‘If so, what is 
your disease sub-type’ were removed from the ID section to limit the factors 
to seven. The data was read in as one item block as all items were 
dichotomous response items. Missing data was specified as ‘9’ and all item 
details were accepted. The template file was saved. A descriptor for each 
item was entered alongside the number of response categories. This was 
then saved as an Item template file. The Item template file was opened 
within Excel and the labels copied over from SPSS: Item a15 was given a 
reverse category.
Preparation of Data for entry into Rumm 2020
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Returning to the Rumm2020 programme, the Import template was selected 
and the data checked to ensure that the descriptors were correct and ensure 
item a 15 was reversed. Item numbers and headings in Rumm 2020 were 
checked against the master postal booklet to ensure that they were correct.
4.2.5.6 Protocols of Rasch analysis
Rasch analysis and the software used to support it is constantly developing 
and until recently there were no clear guidelines for the elements of the 
analysis which should be a standard when presenting results. However, this 
guidance was provided in 2008 (Tennant and Conaghan 2008). They 
proposed the following elements to be required in a ‘good’ Rasch 
publication:
• Model Choice
• Where polytomous, the appropriate ordering of categories and any
necessary re-scoring
• Fit of items and person to the model (including any relevant summary
statistics) and justification for fit levels chose, strategy for improving fit 
(e.g. item deletion) and subsequent fit statistics
• Test of the assumption of the local independence of items, including
response dependency and unidimensionality
• The presence of DIF and any action taken to adjust
• The targeting of the scale
• The Person Separation reliability
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Therefore, these form the reporting structure for the results associated with 
development of the SSc QoL which are presented in chapter 6.
4.2.6 Second Postal Questionnaire (Test/Retest)
The reduced item SSc QoL, together with other adjustments outlined in 
4.3.4.2.1, was sent out to the second postal group. Those who returned the 
completed booklet were posted out a second 2 -4  weeks following return of 
the first ‘test’ booklet. Those who did not return this were sent a postal 
reminder. The methods used to test scale invariance of the SSc QoL across 
time points, were two-fold; firstly DIF testing within Rasch analysis, and 
correlation of time 1 and time 2 questionnaire data.
4.2.6.1 Further item reduction
Further item reduction was carried out by use of Rasch analysis. The 
responses used within this second stage of item reduction were only those 
questionnaires where the respondents had completed and returned both the 
first and second postal questionnaire. This gave a total 119 questionnaires 
for analysis. This analysis was carried out as before with the additional DIF 
testing across time points of the questionnaire data. The ‘test’ 
questionnaires, that is those first send out were identified as ‘time point one’ 
in the database, ‘time point two’ were the retest (second), identical version, 
of the questionnaire sent out between two to four weeks following receipt of 
the test questionnaire return.
4.2.6.2 Item mapping
Item mapping is a further addition to the established QoL development 
methodology, and was outlined in section 4.1.1.2.1 (data saturation). The 
rationale for this innovation was the researchers aim to relate the volume of
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interviews carried out, to the actual amount of interviews required in order to 
produce the items which form the QoL measure. This is related conceptually 
to the discussion around data saturation. As previously described, data 
saturation is considered to be at the point where no new topics or data are 
generated although existing themes may be presented in different terms.
Item mapping will test this concept in relation to the item development 
process as it will allow each item which is in the final SSc QoL measure to 
be tracked back to its origin. This will allow the researcher to identify how 
many interviews had been required to produce the items which eventually 
form the SSc QoL (results shown in Chapter 6).
The difference between the point of traditional data saturation in qualitative 
data collection, and the analysis of transcripts for items require further 
exploration and this innovative exploration of the concept of saturation will 
form an additional analytical stream to this research.
4.3 Methods for testing the research hypothesis
Methods for testing the research hypothesis have been summarised in Table
4.1 stating that this will include non-parametric testing and SEM techniques. 
These techniques are now described in more detail.
4.3.1 Non-parametric testing of study data to test the research 
hypothesis
Non-parametric statistical techniques have been described as ‘ideal when 
you have data that are measured on ...ordinal scales’ (Pallant 2005). 
Therefore non-parametric techniques have been applied to the data in this 
study. The title ‘non-parametric’ describes several possible tests. The Mann-
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Whitney U test is a measure used to test for differences between two 
independent groups on a continuous measure (Pallant 2005). Therefore this 
was the measure of choice to test the hypothesis that there will be 
differences in the levels of QoL between those with dcSSc and IcSSc 
disease sub-types.
4.3.2 Structural Equation Modelling - a tool to test the study hypothesis
SEM is a statistical tool used to explore relationships among observed and 
latent variables in order to test a theoretical model or hypothesis 
(Schumacker and Lomax 2004). Emerging from key publications in the 
1970’s (Keesling 1972; Joreskog 1973), SEM explores the extent to which 
the data support the hypothesised model and allows the researcher to adapt 
the model and retest until SEM requirements are met. It uses a combination 
of statistical models including path analysis, regression and confirmatory 
factor analysis.
Selection of SEM as a tool in this study
Non- parametric testing has been identified as one tool for testing the 
hypothesis of this study. An alternative method of testing the hypothesis is 
also suggested, that being SEM. SEM has been selected for this purpose as 
is it considered to be a comprehensive, flexible approach to modelling 
relations between variables (Hoyle and Smith 1994). SEM provides a tool to 
facilitate modelling of several variables at once to create a model of QoL in 
SSc. SEM is more powerful than multiple regression as multiple regression 
doesn’t look at the indirect effects and is therefore unable to show what is 
happening behind the scenes; SEM gives that ability.
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Precedent for its use when exploring needs based QoL has been seen in a 
recent study of QoL in Osteoarthritis (Keenan 2008). SEM is considered to 
have four key reasons for its increasing popularity:
• Increasing realisation of the need to use multiple observed variables to
increase understanding of their research. SEM facilitates this complex 
modelling, and is therefore becoming a method of choice for 
quantitative testing of theoretical models.
• Increasing recognition of the validity and reliability of observed scores
from measurement instruments. SEM embraces measurement error 
within the statistical analysis and incorporates the use of both 
observed and latent variables.
• SEM provides a way of testing both main effects and indirect effects.
This increases the richness of the modelling processes allowing 
researchers to model both direct and indirect relationships between 
variables.
• Development of SEM software programmes such as LISEREL and
AMOS to become more user friendly providing both syntax and 
window based facilities and providing both a pictorial and statistical 
view of the model.
(Schumacker and Lomax 2004)
4.3.2.1 SEM and the SSc QoL
Modelling of QoL in SSc utilises the information gathered from measures 
(comparator measures) administered during the development of the SSc
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QoL. The range of comparator measures used in data collection was derived 
from the themes identified from qualitative interviews, these being described 
in section 4.2.4.2. Whilst there were nine comparator measures identified for 
the postal questionnaire, not all of these may be required for use in the 
modelling process.
Selection of measures for use in the SSc QoL model
SEM encourages the development of a ‘parsimonious model’; that is the 
simplest model which satisfies the statistical requirements of SEM. 
Therefore, although nine comparator measures were identified, the process 
of SEM modelling seeks to find a model which is the simplest possible. In 
order to achieve this parsimonious approach, a small group of comparator 
measures were selected for initial use in the model.
If it was not possible to achieve the statistical requirements of an SEM 
model with these comparators, then other comparator measures would be 
incorporated into the model.
Rationale for choice of the initial group of measures to be used in the 
modelling process was based on two aspects of the underlying construct 
they measured. Firstly, the strength of literature to evidence the relevance of 
the construct measured (for example the construct of depression), to people 
with SSc; secondly representation of each construct in the elements of the 
ICF. The observed variables included within the SEM modeling process are
outlined in Table 4.6.
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Table 4.6 Observed variables selected for SEM of the research hypothesis
Observed variable (comparator 
measure)
Element of the ICF
UK Function Index (UKFI) Disability
Fatigue Severity Scale (FSS) Covers all elements
Hospital Anxiety and Depression 
Scale (HAD) -  Anxiety and 
Depression scales
Anxiety - Impairment
Depression is not clearly categorised 
within the ICF framework but is 
included to its strength within the 
qualitative interview data
4.3.1 Measures of fit in SEM
Models developed in SEM must show adequate fit. This will require the chi- 
square value to be non-significant, the root mean square error of 
approximation, (RMSEA) to be <0.05 and the goodness of fit index (GFI) to 
be > 0.95 (Schumacker and Lomax 2004). These measures of fit are 
reported in chapter 7.
4.3.2 Summary of Chapter 4
This chapter has outlined the qualitative and quantitative methods used in 
this study. Interviews and a focus group were used for data collection in 
order to develop the descriptive framework of patient-perceived SSc QoL. 
Secondary analysis of the data identified the items for the needs-based SSc 
QoL measure which was developed using a standard methodology. This 
involved sending postal questionnaires to two randomly selected groups of 
patients with SSc, and the use of Rasch analysis to ensure internal construct 
validity.
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The strategy for testing the research hypothesis, non-parametric testing and 
Structural Equation Modeling (SEM), was outlined together with details of 
model requirements and rationale for selection of the elements included 
within the model.
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5. The descriptive framework of QoL in SSc
This chapter presents the results from the qualitative aspect of the SSc QoL 
development. This includes results from the interviews and focus group. 
There are two aspects to these results, firstly the descriptive framework of 
SSc QoL, and secondly the thematic analysis which informed its 
development.
Detailed analysis of the themes generated from the qualitative transcripts 
using examples from the transcripts to illustrate how interviewees presented 
the themes. Thematic analysis (as described in chapter 4), took place in 
three stages. Firstly, reading of the transcripts to become familiar with the 
data, secondly identifying emerging themes and creation of operational 
definitions of themes, and thirdly refinement of the themes and definitions 
together with description of sub-themes where present. Over-arching themes 
were also identified at this stage of analysis. These themes form the base of 
the descriptive framework of SSc QoL).
5.1 Profile of participants
The following table (Table 5.1) represents the demographic data of each of 
the interview participants in the format of the sample frame described in 
Chapter 4. Each cell contains the number of interviewees with those 
demographics. A ‘O’ represents a sample demographic to which no one was 
recruited.
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Age < 50 years
1 1
Male dd > 5 
years
Age > 49 years
0 1
Female dd < 5 
years
Age < 50 years
3 3
Female dd < 5 
years
Age > 49 years
3 2
Female dd > 5 
years
Age < 5 years
3 3
Female dd > 5 
years
Age > 49 years
5 4
5.2 Thematic analysis
5.2.1 First stage of thematic analysis
The researcher began thematic analysis by reading all transcripts in order to 
form an initial appreciation of the data.
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5.2.2 Second stage of data analysis - Initial identification of themes
The interview transcriptions were re- read by the researcher and underlining 
key statements used by the interviewees identified emerging themes. These 
phrases were then recorded on an excel database. On completion, the 
researcher read through the phrases and a second column of emerging 


























• View of self
• Work
• Weather
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At this stage, the researcher was seeking to understand the transcripts and 
to bring structure to the topics of the statements which had been made 
throughout all of the transcripts. In order to support a structure for the 
thematic analysis, operational definitions of the emerging themes were 
created.
5.2.3 Operational definitions of themes to allow consistency in 
statement allocation to themes
In order to ensure consistency within the thematic analysis process, 
operational definitions were made for each of the emerging themes. These 
definitions were created by the researcher, in order to define which 
statements should be related under which theme. This was an iterative 
process for the researcher throughout the analytical processes of the first 
and second stage of analysis.
Operational definitions of themes:
• Adaptation - A statement that refers to psychological or physical
adaptation/ lack of adaptation of the interviewee to SSc or its 
consequences.
• Anger / Frustration - An expression of negative aggressive emotion, or
the use of the words ‘anger’ and/or ‘frustration’. This includes 
statements referring to the interviewee themselves or those around
them.
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• Anxiety - A statement that refers to worry, anxiety or stress of the
interviewee.
• Attitudes - Feelings or perceptions of the interviewee or those around
them, including statements referring to the understanding and 
sympathy of others.
• Control - A statement which mentions their control including being in
control or loss of control in any aspect of their life which is related to 
their disease.
• Confidence - A statement that relates to the interviewees confidence
which has effected any aspect of their life. Therefore it is primarily 
representative of self-confidence. This theme includes statements 
which directly uses the word confidence or self-confidence.
• Dependence - A statement referring to dependence of the interviewee
including the fear of dependence or the loss of independence.
• Embarrassment - A statement which mentions embarrassment related
to the consequences of SSc.
• Fatigue - A statement which refers to fatigue or tiredness related SSc or
its consequences including fatigue related to breathlessness. This 
also includes statements that refer to methods for dealing with fatigue 
or psychological consequences of disease.
• Finance -  This includes statements which refer to any financial effect of
SSc, including that of insurance and financial planning.
• Future - A statement which relates to any expectations or feelings
regarding the future, this includes the negative or positive, and denial
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and the desire not to consider the future. It also considers the 
participants feelings for the future of those around them.
• Hand function - A statement which refers to the hand function of the
interviewee. This includes deterioration of hand function related to 
their disease or its consequences, and may include statements which 
give an example relating to reduced hand function such as ‘my hands 
are bad so I can’t manage coins’
• Hobbies - A statement that refers to the individuals’ interests or
hobbies.
• Housework - A statement that refers to housework in relation to the
interviewee. This includes the inability to carry out housework or the 
use of additional equipment.
• Information -  A statement which refers to the desire for, use of, or
witholding of information.
• Relationships- A statement which refers to the effect of the disease on
the interviewee’s family or close relationships. This includes the 
family/ partner reactions to the disease or the patient since the onset 
of their illness, and the participant’s reaction or feelings toward them. 
This also includes effects on close/intimate relationships
• Restriction/Mobility - A statement that refers to limits or restrictions on
the interviewees’ activities or life including restrictions on their 
mobility.
• Sleep -  Statements which referred to sleep and its impact
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• Slow/pacing - A statement that refers to having to slow down, pace
themselves or do things slowly. This theme is similar to the theme of 
Rest. The key difference in this operation definition is a longer amount 
of time taken to carry out an activity is ‘slow/pacing’, and a statement 
that refers to the need to break an activity sit or recline before or after 
an activity, or a regular rest/sleep falls under the theme of ‘rest’.
• Social impact - A statement which relates to the interviewee’s social
activity or restriction on social activity. This also includes interviewee’s 
feelings about social activity and specific issues such as meals and 
eating socially, and the social effects on relationships and the social 
life of others.
• Treatment - A statement which relates to medication or other therapies
utilised to address symptoms or the underlying disease. This includes 
side-effects of these therapies and interactions with healthcare 
professionals and institutions.
• View of self -  Statements which refer to how the individual saw
themselves or felt they as people had changed.
• Work - A statement that refers to paid or voluntary work. This will
include statements which mention the financial or social impact of 
work.
• Weather - A statement that refers to the weather and its effect on the
disease or its physical or psychological symptoms.
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5.2.4 Third stage of data analysis
The transcripts were re-read by the researcher and more detail was added 
to each of the themes in order to add a deeper layer of understanding to 
what is incorporated within each theme heading. The operational definitions 
were also adapted as required, although this was minimal. The large 
numbers of themes were reviewed, and a third stage of analysis conducted. 
This third stage of analysis was the grouping of themes into overarching 
themes.
5.3 Over-arching themes
The conceptual basis of each theme was considered and each theme was 
brought together with others of a similar conceptual background to establish 
the overarching themes of SSc QoL (as seen in Figure 5.1).
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These overarching themes represent groups of themes with a shared 
conceptual background. For example, those themes related to the over­
arching theme of Self were selected because the researcher assessed them 
to have an effect on Self. These over-arching themes are now explored in 
more detail together with detail of the themes of which they are composed.
Each overarching theme is followed by Its constituent themes. The themes 
are displayed diagrammatically In order to give a more complete 
understanding of the experience of living with SSc. The theme is presented 
on the left of the page, relating to the sub-themes on the right. Each theme 
and sub-theme is represented within an oval shape. No ranking or 
interpretation has been applied to the themes. Arrows linking the theme to its 
sub-themes are not intended to be representative of causation, as this level 
of analysis was not carried out.
Each diagrammatic presentation of the theme and sub themes are explained 
and examples of supporting quotes from the interview texts are presented. 
The interviews are identified by number (e.g. Int 25) with the quote following 














Figure 5.2 Physical Restrictions
The overarching theme of physical restriction represented a large number of 
the themes identified from the qualitative data of this study. Whilst many 
themes represented a purely physical aspect, others were much broader 
physical themes such as fatigue and sleep.
Many people discussed the physical restrictions SSc had placed on their 
lives. These were expressed both in terms of how the restriction had 
effected their abilities to meet their own needs in life such as in terms of 
housework, cooking, eating and dressing, but they were also expressed in 
terms of their wider implications. For example, in interview 1, the interviewee
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clearly expressed the difficulties of his reduced hand function in terms of 
opening tins or handling coins, however he also talked about how this made 
him dependent upon others, and also that it had meant him leaving his job 
as a joiner. It was clear from the transcripts therefore, that many themes 
were inter-related.
The themes which form the overarching theme of ‘Physical restriction’ are 
now discussed individually, including quotes from transcripts to illustrate how 
people described them.


















Figure 5.3 Bladder and Bowels
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On initial analysis, this section had been incorporated within that of hygiene. 
However on further exploration of the transcripts, the effects of SSc on the 
bladder and bowels of individuals, and the wide-ranging effect this had on 
their lives, it was considered that these themes should be separated.
For example;
Int 9
" / d o n ’t fe e l a s  th o u g h  I  c a n  d o  ju s t  w h a t I  w a n t to  d o  o r  g o  w h e re  I  
w a n t to  g o  o r  y o u  k n o w , e a t  w h a t I  w a n t to  e a t  o r  y o u  k n o w  th a t w a y , its  
a ffe c ts .. . .  I t ’s  n o t th a t I  w a n t to  g o  o u t a ll  th e  t im e  ju s t  th a t I ’d  lik e  to  b e  a b le  
to  g o  a n d  n o t h a v e  to  th in k  o f  ta k in g  s p a re  k n ic k e rs  a n d  p a d s  a n d  y o u  k n o w  
o n e  th in g  a n d  a n o th e r  w ith  y o u  w h ich  I  h a v e  to  d o  b e c a u s e  y o u  n e v e r  n o w  
w h e n  it ’s  g o n n a  h a p p e n . ”
Int 7
T h e  o th e r  a s p e c t  is b o w e ls  w h ich  is  I  c a n  o n ly  im a g in e  in  m y  o w n  
m ind , th a t th e  s a m e  th in g  is  h a p p e n in g  w ith  m y  b o w e ls  (a s  w ith  
o e s o p h a g u s ) a n d  u n le s s  I  ta k e  s o m e th in g  e v e ry  fe w  d a y s ., th e n  I'm  a r ig h t  
fo r  a  c o u p le  o f  d a y s . T h e n  I  g o  th ro u g h  th is  n e x t  s ta g e  y o u  k n o w , it's  th e  
s a m e  th in g  o v e r  a g a in , a n d  th a t is th e  b ig g e s t th ing , y o u  k n o w  its  a ffe c tin g  
m y  life ”.
“T h a t's  a n o th e r  th in g  I ’v e  fo u n d  e m b a rra s s in g , i f  I  d o  ta k e  s o m e th in g , I 
m a k e  s u re  I  d o n 't  ta k e  it i f  I'm  g o in g  a n y w h e re . I  lik e  to  b e  n e a r  a  to ile t s o  
th a t I  c a n  g o . ”
Whilst bowel and bladder effects were mentioned by only a small number of 
interviewees, the intensity of their experience is clear. This subject is not
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easily revealed but the openness of some participants telling their 
experiences was frank. It was not possible to divide these quotes into the 
headings of the diagram as they are interwoven, but each aspect of the 
diagrammatic representation is reflected at some point in the quotes which 
follow
Int 10
7 c a n ’t h o ld  m e  w a te r  a s  I  u s e d  to  b e  a b le  to, y o u  k n o w  th a t  s e e m s  to  
h a v e  g o n e , th a t ’s  o n e  o f  th e  th ings  th a t's  h a p p e n e d .. . .  Y e s te rd a y  I  w a s  
h a v in g  a  n a p  in  th e  a fte rn o o n  a n d  I  w o k e  u p  a n d  th e  fa m ily  c a m e  in  
u n e x p e c te d ly ., a n d  I  m u s t h a v e  b e e n  a s le e p  a  lo n g  t i m e . . . .  I  w a s  a b s o lu te ly  
d e s p e ra te , I  s to o d  u p  a n d  I  th o u g h t w e ll I  d id n ’t d a re  to  s ta n d  u p  b e c a u s e  I  
k n e w  w h e n  I  s to o d  u p  I ’d  h a v e  to  g o  b u t  I  s ta y e d  a n d  I  ju s t  s a id  I ’m  g o in g  to  
th e  to ile t a n d  I w a s  ju s t  w e e in g  m yse lf, it was re a lly  e m b a rra s s in g . I  d o n 't  
th in k  th e y  e v e n  re a lis e d ”
Int 30
7 c a n ’t c o n tro l m y  b o w e ls  o r  m y  b la d d e r .. .  it  d o e s n ’t k e e p  m e  in  th e  
h o u s e  b u t I ’v e  g o t  to  b e  v e ry  w a ry  o f  th in k in g  i f  its  g o in g  to  b e  a  d a y  w h e n  I  
k n o w  I m ig h t b e  g o in g  o u t th a t I  n e e d  to  k n o w  w h e re  th e  to ile ts  a re , th a t ty p e  
o f  th ing. Y e s  it  is  a n  is s u e  ( fa e c a l in c o n tin e n c e ) a n d  i f  y o u  re a lly  d o  w a n t to  
g o  y o u  w a n t to  g o  th e re  a n d  th e n  a n d  th e r e ’s  n o th in g  I  c a n  d o  to  s to p  it, y o u  
k n o w  y o u  c a n ’t p u ll y o u rs e lf  b a c k  a n d  c o n tro l y o u rs e lf, it  d o e s n  1 w ork . I f  
y o u ’re  g o in g  to  g o  y o u  n e e d  to  g o  a n d  i f  y o u  c a n 't  g o  th e n  y o u  d o  g e t  so ilin g  
i f  y o u  c a n ’t g o ”.
7 d o n ’t lik e  it, th a t ’s  p a r t  o f  it  th a t  I  re a lly  d o n ’t  lik e  a n d  I  d o n ’t.. I  fe e l lik e  
I ’m  n o t in  c o n tro l m a in ly  o n  h o lid a y  in  F ra n c e  b e c a u s e  to ile ts  a r e  fe w  a n d  fa r
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between so I’m always thinking at the back of my mind perhaps maybe what 
I’m eating two days before because that’s perhaps when It will affect me if 
we’re out somewhere then I’m thinking I must make sure I've seen where 
there’s a toilet or there’s a bar where you can go to a toilet or something like 
that, that affects me quite a bit”.
5.3.1.2 Breathlessness
Figure 5.4 Breathlessness
Breathlessness was mentioned in various interviews, with people tending to 
operationalise breathlessness; that is they usually put breathlessness into a 
context within their everyday activity. This represented the impact of their 
breathlessness on the everyday activities they need to undertake.
Int 27
“I do like walking and I did used to belong to a hiking club, we used to 
go out. Then I realised the Scleroderma had affected my lungs, I couldn’t 
sort of keep up, and well, I gave up eventually but I do like to walk and I can 
no longer walk... I only hope that my lungs will keep going you know, that's 
the only worry I have with it really. ”
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Int 29
“A n d  I  d o  g e t  b re a th le s s  a s  w ell, w h ich  I ’d, I  n e v e r  u s e d  to  d o  y o u  k n o w , 
lik e  i f  I ’m  w a lk in g  u p  h ill I  d o  g e t  b re a th le s s  th e re ’s  n o  d o u b t a b o u t that, 
w h ich  I  p re s u m e  is  s o m e th in g  to  d o  w ith  it a l l .”
Int 25
"/ g e t  o u t o f  b re a th  a  lo t m o re  s in c e  I'v e  h a d  S c le ro d e rm a .. I  d o  g e t  o u t  
o f  b re a th  v e ry  e a s ily  w h e n  I  o n ly  d o  little  jo b s  a ro u n d  th e  h o u s e  lik e  d u s tin g  
o r  w a s h in g  u p  o r  a n y th in g  like  that. I  a ls o  g e t  o u t o f  b re a th  v e ry  e a s ily  w h e n  I  
c lim b  th e  s ta irs . I'm  v e ry  re lu c ta n t to g iv e  in to  th is ."
Int 33
“. . I  c a n ’t w a lk ;  I  w o u ld n ’t a t te m p t e v e n  g o in g  to  w a lk  u p  th is  hill. I f  I  g o  
to  to w n  I  o n ly  p a r k  in  c e rta in  p la c e s , h o p e fu lly  o n  a  fla t a n d  th in k ... g e ttin g  
th e re 's  o n e  th in g s  b u t a m  1 d o in g  to  b e  a b le  to  w a lk  b a c k  w ithou t, n o t dy ing , 
b u t c o u g h in g  a n d  sp lu tte rin g  a n d  n o t b e in g  a b le  to  b r e a th e ."
Oxygen therapy was discussed in one interview only. It was included as a 
sub-theme of breathlessness in order to capture an effect of the effect of 
oxygen therapy. This person felt it affected their pride to be seen using 
oxygen therapy. People also echoed this with the use of other medication in 
front of their children.
Int 33
(referring to oxygen use for air travel)
“T h e  o x y g e n  th in g s  was a He b e c a u s e  y o u  d id n ’t h a v e  to  p a y  it, th e  
w o m a n  s a id  y o u  c a n  h a v e  it a s  lo n g  a s  y o u  d o n ’t h a v e  to  h a v e  it  a l l  th e  t im e  
(o n  th e  flight). I d id n ’t  u s e  it a l l  th e  t im e  b e c a u s e  I  ju s t  th o u g h t., it's  a  p r id e
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thing. Yes, I think it’s a pride thing for me, its very difficult to use oxygen in 
front of people and in front of strangers and I wouldn't have sat on the plane 
with an oxygen mask on, I don’t think I would. ”
5.3.1.3 Eating
Figure 5.5 Eating
Eating was a strong theme running through interviews. This was related to 
the physical effects of SSc including microstomia (decreased mouth 
opening), oesphageal dysmotility (slowing of the passage of food through 
the oesophagus), and reduced hand function (leading to difficulties cutting 
food).
Int 7
“I developed this eating problem when I start a meal I really want to eat 
it, a few mouthfuls down and its stuck half way, you know between my 
stomach and my throat. It just won’t go down, and I find that my saliva 
glands start working overtime and sometimes the answer to it is to leave the
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ta b le  y o u  k n o w  a n d  th e n  b rin g  it b a c k  a g a in . A n d  th e n  e v e n tu a lly  a f te r  
w aitin g  a  w h ile , e v e n  d r in k in g  d o e s n 't  he lp , c a u s e  ¡ t a i l  b u ild s  u p  its  a s  i f  its  
s tu c k  a n d  g u ild s  u p  o n  to  o f  it  a n d  I  fin ish  u p  w ith  it. S o  I  h a v e  to  g o  to  th e  
to ilet, th e n  I  c a n  g o  b a c k , w a rm  m y  d in n e r  u p  a n d  p ro b a b ly  e a t  i t”
Int 27
“It  d o e s  a ffe c t  m y  m o u th , I  g e t  q u ite  a  lo t o f  s o re s  in  m y  m o u th  fro m  
t im e  to  t im e  a n d  I 'v e  h a v in g  tro u b le  w ith  m y  te e th  b e c a u s e  o f  th e  m o u th  
g e ttin g  s m a lle r  w e .., I  c a n ’t  o p e n  m y  m o u th  v e ry  w id e  w h e n  th e y 're  try in g  to  
g e t  im p re s s io n s .. .  m y  m o u th  d o e s n ’t ’ fe e l ju s t  th e  s a m e  o r  lo o k  th e  s a m e  I  
d o n 't th in k ."
Some people also talked about how their choice of food was affected and 
the need to accompany food with large amounts of water to wash down the 
food which feels to be stuck in their oesophagus.
Int 19
“W h e n  I ’m  s tre s s e d  I  d o  lo o s e  w e ig h t v e ry  eas ily , la s t  y e a r  I  g o t  s tre s s e d  a t  
w o rk  a n d  lo s t a  s to n e  a n d  it w a s  lik e  e a t  a ll  th e  fo o d  a n d  I  w a s  trying, b u t  
w h e n  m y  o e s o p h a g u s  is  p la y in g  u p  th a t ’s  w h e n  I  d o n ’t  w a n t  to  e a t  c e r ta in  
th in g s .. th e  o n ly  th in g  (ty p e  o f  fo o d )"
Int 19
“ / te n d  to  w o rry  a b o u t  in  a  re s ta u ra n t is  w ill I  h a v e  e n o u g h  w a te r. I  c a n  
e a t  a n y th in g  a s  lo n g  a s  I  h a v e  e n o u g h  w a te r  to  w a s h  it d o w n  b e c a u s e  m y  
o e s o p h a g u s  is  to o  s m a ll s o  th e  m a in  th in g  is  ju s t  w a te r  to  w a s h  it  d o w n  w ith  
a n d  th a t  w ill g e t  m e  s lig h tly  a n x io u s  a n d  i f  I ’m  w ith  m y  m u m  o r  d a d  th e y  w ill 
k n o w  th e  firs t th in g  th e y  d o  is  o rd e r  a  ju g  o f  w a te r . .. b e c a u s e  I  c a n t ’ e a t
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without it. I do find it uncomfortable and when it was very bad it would make 
me throw up and that would just put me off eating. I just did not want to eat 
in public because I couldn’t guarantee what my oesophagus was going to do 
no matter how much water I had and I was a university so I lost weight. ”
Figure 5.6 Fatigue
Fatigue was a theme that appeared to pervade into many aspect of people 
lives. It affected people’s physical and psychological ability to participate in 
aspects of life such as their work, hobbies, and social life.
Affect on social life/hobbies
Int 14
‘‘Well I’ve had a lot this week (fatigue) actually, and it's quite strange. 
Last week it just, generally I'd finish work and come home and just be tired, 
just the whole body seems to be tired, the mind just seems to want to shut 
down and all I want to do is sleep, so I'd want to watch the soaps so I’d
5.3.1.4 Fatigue
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w a tc h  th e m , h a v e  m y  te a  a n d  I  w o u ld  b e  in  b e d . A n d  o n  m y  d a y  off, I  fin d  
th a t I  te n d  to  ju s t  s le e p  a ll d a y  w h ich  I  d o n 't lik e  to  d o  b e c a u s e  I ’v e  g o t  th in g s  
to d o  b u t  I  ju s t  fin d  th a t I  c a n ’t  g e t  o u t o f  m y  b e d  b e c a u s e  I ’m  ju s t  lite ra lly  
t ire d .”
Affect on work
Int 3
"I c o u ld n ’t  w o rk  b e c a u s e  I  c o u ld n ’t k e e p  up , I  h a d  a  te a  ro o m  a n d  I  
c o u ld n ’t  k e e p , I  ju s t  h a d  to  lie  d o w n  a n d  h a v e  s o m e b o d y  to  lo o k  a f te r  th e  
b u s in e s s ”
Activity restriction
Int 26
‘‘M y  lim b s  g e t  v e ry  h e a v y  e a s ily  n o w , tired , a s  i f  I 'v e  b e e n  d o in g  a  h a rd  
d a y s  w o rk  a l l  d a y  w h ic h  I  h a v e n ’t, w h ich  I  u s e d  to  d o  w h ic h  n e v e r  u s e d  to  
h a v e  n o  e ffe c t o n  m e . A s  I  s a y  th is  o n ly  h a p p e n e d  th is la s t  tw e lv e  m o n th s , 
s in c e  I  w a s  d ia g n o s e d  w ith  S c le ro d e rm a , th a t th is  h a s  h a p p e n e d  a n d  it ju s t  
b e g g a rs  b e l ie f .. s o m e tim e s  I  fe e l a b s o lu te ly  s h a tte re d  a n d  th a t ’s  e v e n  w h e n  
I ’v e  d o n e  n o th in g . I  g e t  th e s e  d a y s  w h e re  I  ju s t  d o n ’t  w a n t to  d o  an y th in g , 
w h ich  is n ’t  m e . . .  I ’m  e x h a u s te d  w h e n  I  g e t  u p  in  th e  m o rn in g  b e c a u s e  I  
re c k o n  I ’v e  d o n e  to o  m u c h  th e  d a y  b e fo re . ”
Int 31
“W e ll s o m e tim e s  y o u  h a v e  a  g o o d  n ig h ts  s le e p  a n d  y o u  g e t  u p  a n d  s till 
fe e l t ire d  a n d  y o u  th in k , a m  I  t ire d  o r  a r e n 't ’ I, a n d  it w a s  d ifficu lt to  e x p la in  to  
p e o p le  b u t  re a d in g  a b o u t it, I  thought, y e s , th a t ’s  w h a t I  fe e l like . Y o u  th in k
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you shouldn’t be tired but I am and you’re doing things and you soon get 
weary."
5.3.1.5 Hand function (reduced)
Figure 5.7 Hand function
The effects of people’s hand function were diverse, but had particular effect 
on their abilities at work, with their housework and with hobbies. For 
example, this gentleman found great difficulties with the equipment required 
for his job as a mechanic.
Int 29
“I have a garage and its like working my fingers were all stiff, my fingers 
were all swollen, very badly swollen and I couldn’t sort of do spanner work 
like I ought to be able to do. My wrists were very limited in movement and
very sore...”
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Or this lady whose job was as a make up artist in a high-class salon 
expressed the difficulty of maintaining her job:
Int 14
“With this illness affecting my hands and I work as a make-up artist, so I 
do need my hands in my everyday job which again is restricted because I 
get people looking at my hands... ”
Difficulties with housework were a more frequent impact of SSc, with many 
people finding difficulties with use of household equipment such as tin 
openers, hoovers, washing machines as well as tasks such as washing up 









Many people mentioned hobbies, some people talked about how SSc had 
restricted their ability to carry on with their hobbies, and some who
v
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mentioned that their hobbies had changed or that they had more time for 
hobbies.
In 18
“E m o tio n a lly  I ’ve  h a d  to  m a k e  m a s s iv e , m a s s iv e , d e c is io n s  th a t  h a v e  
b e e n  h e a rtb re a k in g  -  th e  s e llin g  o f  a  y o u n g  p o n y  b e c a u s e  I  c a n  n o  lo n g e r  
w o rk  o u ts id e  w ith  h e r  in  th e  w in ter, a s  a  y o u n g s te r  s h e  n e e d e d  a  lo t o f  w o rk  
b e in g  b ro u g h t to  s a d d le  a n d  s h e ’s  h a d  to  b e  so ld ; a n d  a l l  m y  p la n s  a n d  m y  
h o p e s  fo r  th e  fu tu re  h a v e  b e e n  s to p p e d .”
Int 35
“I  lo v e  b ird  w a tc h in g  a n d  I  fin d  it v e ry  d ifficu lt to  h o ld  th e  b in o c u la rs  
a n y m o re  s o  w e  g o  to p la c e s  th a t h a v e  h id e s , s o  I  c a n  re s t m y  h a n d s  o n , o n  
th e  s h e lv e s  in, c o s  i f  I ’m  s to o d  lik e  th a t  E r ic  h o ld s  th e  b in o c u la rs  fo r  m e  y o u  
kn o w , its  y o u ’d  ju s t  c ry  o th e rw is e , y o u  ju s t  m a k e  a llo w a n c e s  d o n ’t y o u . . .  I  
m is s  g a rd e n in g  b e c a u s e  I  c a n 't  b e n d  d o w n , I  c a n ’t  g e t  d o w n . ”
However, for some people hobbies became a larger part of their life. This 
man had been forced to leave employment due to his SSc and therefore had 
more time for hobbies which he could still physically continue.
Int 11
“M y  in te re s t a n d  m y  h o b b ie s  h a v e  n o w  b e c o m e  m y  w a y  o f  life  w ith  th e  
c o m p u te r, y o u  k n o w  s o  th e  s h in e s  g o n e  o ff  th a t  a  little  b it  b u t it  s e e m s  lik e  
th e  o n ly  th in g  th a t I ’v e  re a lly  g o t  w h e re  I  c a n t  g o  o u t a n d  th e n  th e r e ’s  th a t  
m u c h  w h e re  I  c a n 't  g o  o u t th a t th a t ’s  a l l  I  w a n t to  d o  is  o n  th a t o n e  th in g ...  
b u t s o m e tim e s  I  c o u ld  k ic k  it  th ro u g h  th e  w in d o w ... b e c a u s e  it  m a k e s  m e  











The main impact of SSc in the context of housework was difficulties with 
carrying out household tasks, and required adaptation or assistance in order 
to carry out such tasks.
Int 33
“I mean, you can’t go to town, go shopping. I can't, I get out of breath 
hanging out washing. I get out of breath putting washing in the washing 
machine. ”
Int 31
“I think if anything its my hands that are the most trouble because they 
can be a bit stiff, but its probably strength, I drop things and have to pick it
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up... you don’t realise so I do tend to drop things and I’m slower as well, I 
hadn’t realised until I went on holiday with my sister and her husband self 
catering and we were preparing vegetables and I was just peeling and doing 
things as normal and she was doing it a lot quicker than me which I hadn’t 
realised until I saw her that I had slowed down. ”
Help from others
Int 7
“You know its gradually come on, with the use of my hands that make it 
, there’s quite a few jobs that aren't comfortable to do... I don’t have to force 
myself to do the potatoes, because I can't hold potatoes, quite a lot of jobs 
really, and he (husband) goes out for instance, in the cold weather that really 




Hygiene was again a theme which was expressed in terms of restriction and 
the adaptation and assistance which may be required in order to meet the 
individuals needs. Adaptations for the bathroom were described:
Adaptations
Int 12
“I  s till c a n 't  g e t  d o w n  o n  m y  k n e e s , I  d id  o n c e  b e c a u s e  I  ju s t  d id n ’t  th in k  
a n d  I  h a d  a  h e ll o f  a  jo b  g e ttin g  u p  a g a in , s o  I  d o n ’t d o  th a t a n y m o re . I ’v e  h a d  
h a n d ra ils  p u t in  th e  b a th ro o m  a n d  a  s h o w e r  p u t  in  s o  th a t I, y o u  k n o w , I  c a n ’t 
s it d o w n .. .  I  h o ld  o n to  th e  h a n d ra ils  w h e n  I ’m  h a v in g  a  s h o w e r  a n d  y o u  
k n o w . . . .”
Further insight into the difficulties of people living with SSc is given by 
the following interviewee who offers a description of the difficulties they 
experience when washing and dressing, underlying the need for test, the 
time taken to complete these tasks, and the upset this can cause:
Int 32
“I  h a d  to  g o  to  th e  to ile t., it to o k  m e  a g e s  a n d  I  th o u g h t, o h  c rikey , it 
re a lly  d id  u p s e t m e . It  w a s  th e  b re a th le s s n e s s ; I ’d  p u t  o n  m y  d re s s in g  g o w n  
o n  a  m o rn in g , o n e  a rm  a n d  th e n  I ’d  h a v e  to  s it  o n  th e  b e d , g e t  u p  a n d  p u t  
th e  o th e r  in. S it  d o w n  a g a in  a n d  th e n  I ’d  c o m e  in  h e re  a n d  s lu m p  in  h e re  a n d  
I  u s e d  to  th in k  to  m y s e lf, I  w o u ld  h a v e  d o n e  th e  s h o p p in g , c o m e  b a c k  a n d  
c le a n e d  u p  in  th e  t im e  it  ta k e s  m e  to  g e t  d re s s e d . I t  w a s  a  d a y s  jo b  g e ttin g  




When pain was expressed, it was described in terms of an experience which 
required them to adapt their behaviour to accommodate its effects; pain 
affecting many aspects of their lives. Even the most basic task, such as 
standing, was affected by pain.
Int 29
“I couldn't stand up for very long and the only place where I was really 
comfortable was when I was laid down in bed and that's the only place 
where I was really comfortable, where thankfully I didn't have any pain... I 
was In pain constantly and it were getting worse all the time. I wouldn’t wish 
it on any... it really is a bad, you know and you can’t sort of put your finger 
on because its all over your body sort of thing you know, it makes you feel 
really, really, pulled down or it did me... really, really poorly."
Int 34
“Its not very often thank God (rash on feet), touch wood, but I’ve had to 
crawl out of bed and in here and work my up the furniture because I just
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cannot put them to the floor its so painful, but it only lasts two or three days if 
that, and as I say sometimes it can be gone the day after. ”
5.3.1.10 Restriction/Mobility
Figure 5.12 Restriction/Mobility
Restriction in mobility and the wide consequences of that restriction was 
clearly described by interviewees, who describe the musculoskeletal, fatigue 
and respiratory effects of SSc.
Int 33
‘Td say it’s affected my life dramatically. I’ve gone from what I thought 
was a reasonably healthy person to being a person who takes a world of 
medication and can’t walk long distances or flights of stairs without getting 
out of breath and I can’t rush around. So there’s lots of things that I can’t do 
that I could do, in a very short space of time. “
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Int 25
“M y  jo in ts , m y  s tre n g th , a n d  s ta m in a  a n d  s tu ff lik e  th a t. I  c a n ’t  d o  hills, I  c a n t  
w a lk  u p  h ills ..''
Int 21
"It lim its  b e c a u s e  I  c a n t  d o  th in g s  th a t I  w a n t to : I  u s e d  to  g o  to  a e ro b ic s  
re g u la rly , I  c a n t  d o  th a t a n y m o re . I  c a n t  e v e n  w a lk  q u ic k ly  b e c a u s e  it's  
a ffe c te d  m y  lu n g s  n o w . S o  it a ffe c ts  m y  b re a th in g  s o  I ’m  lim ite d  to  w alk ing .
I ’m  lim ite d  re a lly  to  w h a t I  c a n  d o  g e n e ra lly  th a t  n e e d s  e x e rtio n  o r  a  lo t o f  
lifting  o r  a n y th in g  lik e  th a t, I  ju s t  c a n t  d o  it  a n y m o re .’’
Int 25
“I  c a n ’t  d o  th e  th in g s  th a t I  c o u ld  d o  b e fo re . ”
Many people talked about bad days and good days and that sometimes they 
would push themselves because there was something they really wanted to 
do, and that there would be consequences to this:
Int 13
7 d o  h a v e  lim its  o n  w h a t I  c a n  d o  a n d  i f  I  try  a n d  d o  to o  m u c h  th e n  I  ju s t  
e n d  u p  h a v in g  a  fe w  d a y s  w h e n  I  ju s t  fe e l re a lly  u n w e ll."
Int 14
“Y o u  d o n ’t  re a lis e  th a t  th e  little  th in g s  c a n  b e  re a lly  b ig  th in g s  th a t a r e  
a c tu a lly  p a r t  o f  y o u r  life  th a t  y o u  d o n ’t  re a lis e  b e c a u s e  y o u  ju s t  ta k e  it fo r  
g ra n te d  e v e ry  d a y  th a t  y o u  c a n  d o  c e rta in  th in g s ... b e in g  re s tr ic te d  in  ju s t  
d o in g  g e n e r a l th ings , firs t it  w a s  p ro b a b ly  th in g s  lik e  o p e n in g  a  ja r ,  ju s t  
b e n d in g  d o w n  to  g e t  s o m e th in g  w h ic h  o b v io u s ly  y o u ’re  re s tr ic te d  to  d o in g  




A way of coping and adapting to SSc was slowing or pacing of activities. 
People described the need to rest regularly during a task in order to 
complete it, and also doing things at a slower pace. The following ladies 
describes how they use pacing and rest in order to complete their daily 
activity needs.
Int 29
“Like if I’m gardening, cutting grass or ought like that you know except it 
takes me about three or four time as long to cut all this grass than what it 
used to you know because I used to whiz it round with the flymo, I just sort of 
take it easy and do a bit of it at a time now. ”
Int 26
“I've got to pace myself because it does affect me if I dash and hurry 
things, that’s when it affects me... I do try and go in the garden and do my
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gardening, I do potter around the house and do things, the thing is I have to 
stop and rest and then go back to it which at one time I have never had to 
do., it takes me at least an hour to get myself going and motivated in the 
morning. ”
Int 21
‘‘You have to accept and adjust so now instead of going out gardening 
for two or three hours, I just have to accept the fact that I do half and hour 
and then I come in, I have to have a little rest. ”
5.3.1.12 Sleep








T ired  for 
w o rk  and 
activities
Figure 5.14 Sleep
Sleep was identified as a theme by people who described how their sleep 
had been affected since living with SSc, also describing how sleep 
disturbance affected them during their daily activities.
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For example people described how they were sleeping during the day or 
how symptoms of SSc (in this example, cramp), were disturbing their nights 
sleep;
Int 1
"Its something to combat the terminal boredom when I can’t sleep at night. I 
can’t sleep at night. We’ve got to the stage where I was sleeping probably 
about five nights out of seven and then the five nights wouldn’t be much 
longer than seven hours. That about as much sleep as I got"
Int 4
“ my cramp disturbs my sleep and If you can't sleep them you don't 
operated very effectively the next day Its probably why I fall asleep in 
meetings, which can be very embarrassing ... I fall asleep in front of the telly 
at night. It annoys me, its irritating and sometimes it gets me rally wound up., 
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Treatment was discussed by some interviewees, specifically talking about 
drug therapies or their experience of treatment delivery through hospitals or 
healthcare workers. For some hospital visits were an intrusion, others talked 
about how the drug therapy made them feel.
Int 18
“I  re c e n t, I  u tte rly  u tte rly  re s e n t c o m in g  to  th e  h o sp ita l, e v e ry  tim e  th e  
p o s t c o m e s  a n d  th e r e ’s  a n  a p p o in tm e n t I  h a te  It, I  d e te s t  it b e c a u s e  th a t ’s  
n o t m e . I t ’s , i t ’s  a n  in trus ion . Th is  illn ess  h a s  in tru d e d  in to  m y  l ife .”
Int 20
“I  g e t  v e ry  d e p re s s e d  c o m in g  u p  to  th e  tre a tm e n t w e e k s , e rm , k n o w in g  
h o w  p o o r ly  it m a k e s  m e , b u t th e n  I  th in k  O H  w ell, its  g o n n a  m a k e  m e  b e tte r  
in  th e  lo n g  ru n  a n d  h o w  tire d  I  a m . A s  s o o n  a s  I  g e t  o u t o f  th e  h o s p ita l I  
c o m e  h o m e  s tra ig h t to  b e d  a n d  th a t ’s  m e  in  b e d  fo r  lik e  a  d a y  a n d  a  h a lf  u n til 
I  fe e l u p  to  g e tt in g  o u t o f  it"
For some, information was identified as an important aspect of their 
treatment, this particular individual expressing the desire to have open 
communication and information.
Int 26
7 d o  th in k  in fo rm a tio n  is  im p o rta n t a n d  I  th in k  th a t ’s  w h a t a  lo t o f  p e o p le  
d is re g a rd  re a lly  b e c a u s e  th e y ’re  fr ig h te n e d  o f  w h a t  th e y 're  g o in g  to  h e a r, 
w ell, th a t  d o e s n ’t  b o th e r  m e  b e c a u s e  I ’d  ra th e r  k n o w , I ’d  ra th e r  e v e ry b o d y  b e  
upfron t, e v e ry th in g  o u t in  th e  o p e n  a n d  la id  o n  th e  ta le ., w h ich  th e y ’ a l l  d o n e  
u p  to  p r e s s ."
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Several people valued the role of the health professional (specialist nurse) 
who had the time to listen to them and understand:
Int 10
"Its been really nice having someone as a supportive.. I think it's 




















w ith  w o rk
Figure 5.16 Work
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Work was a complex theme, with impacts across many other themes such 
as finance and physical restrictions. People talked about the effect of SSc on 
their work in two main ways, how it affected them when still at work, and how 
leaving work had affected them. The effect of SSc on people at work 
included elements of physical restriction particularly through hand function 
and fatigue.
Int 28
“W h ils t I  w a s  a t  w o rk  I  s u ffe re d  q u ite  a  lo t o f  jo in t  p a in s  a n d  I  w a s  
fin d in g  th a t I  w a s n ’t  h a v in g  a n y  e n e rg y  to  d o  m y  jo b . I  w a s  g e ttin g  t ire d  v e ry  
q u ic k ly  a n d  b re a th le s s  o n  w a lk in g  q u ite  a  lo t b e c a u s e  m y  jo b  in v o lv e d  
s u p e rv is in g  a b o u t 6 0  s ta f f  a n d  w ith  a ll  th e  ru n n in g  a ro u n d  I  h a d  to  do , I  fo u n d  
I  was e x h a u s te d  e v e ry  n ig h t w h e n  I  g o t  h o m e . I  h a d  to  k e e p  s ittin g  d o w n  
q u ite  a  lo t a n d  re s tin g  a n d  I  w a s  u n a b le  to  d o  q u ite  a  lo t o f  th e  th ings  ta t  
w o rk  d u e  to  th e  jo in t  p a in s  I  w a s  s u ffe rin g  a n d  th e  tire d n e s s . ”
Int 14
7 s o m e tim e s  fe e l th a t  th e , I ’m  n o t g iv in g  m y  b e s t  to  m y  jo b  b e c a u s e  o f  
th is  illn ess  a n d  th a t  I  a m  re s tr ic te d  s o  it m u s t m a k e s  m e  a n g ry .
Int 31
“W h e n  I  w a s  w ork in g , b e c a u s e  I  w o rk e d  in  th e  n u rs e ry , a n d  p a rtic u la r ly  
o u ts id e  to ys  a n d  th in g s  it  g o t  to  th e  p o in t, w e ll w ith  th e  s lid e  I  c o u ld n T g r ip  
e n o u g h  to  life  it  to  p u t  it  a w a y , lu c k ily  th e  tw o  p e o p le  I  w o rk e d  w ith  d id  w h a t I  
c o u ld n ’t  d o  o th e rw is e  I  p ro b a b ly  c o u ld n ’t  h a v e  c a rr ie d  o n  w o rk in g  a s  lo n g  a s
I  d id .
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There was also a concern not only about telling employers of their disease 
but of having time off work due to SSc.
Int 9
7 h a d  q u ite  a  lo t o f  tim e  o ff  w o rk  b e fo re  it was d ia g n o s e d .. .th e n  it w as  
d ia g n o s e d  I  e m , c u t d o w n  m y  h o u rs  a t  w ork. S o  I  w e n t p a r t  t im e  a n d  th e n  
e v e n tu a lly  I  ju s t  h a d  to  g iv e  u p  w o rk  b e c a u s e  it  w a s  to o  m u c h  fo r  m e .
It  a n n o y e d  m e ; it re a lly  a n n o y e d  m e  b e c a u s e  I  lik e  w o rk in g  .. it d id  
a n n o y  m e  b e c a u s e  I  d id  lik e  w o rk in g  b u t I  ju s t  c o u ld n ’t  d o  it s o .. I  w e re  h a v in g  
s o  m u c h  tim e  o ff  th a t  it  re a lly  w e re n ’t  fair. Y o u  k n o w  it w e re  lik e  h a v in g  4  o r  5  
m o n th s  o ff  a t  a  tim e , th e n  I  m ig h t w o rk  fo r  4  m o n th s  a n d  th e n  I  m ig h t n e e d  
a n o th e r  5  m o n th s  off. Y o u  k n o w  it w e re n ’t fa ir  re a lly  s o  e m .. I  g a v e  u p  
w o rk in g ”.
Int 19
“U n til a b o u t  tw o  y e a rs  a g o  I  n e v e r  to ld  w o rk  o th e r  th a n  o c c u p a tio n s  
h e a lth ,. . .  I  g o t  a w a y  w ith  it, th e  la s t fe w  y e a rs  I ’v e  h a d  m o re  ‘in -p a t ie n t ’ a b o u t  
5  in  th e  la s t tw o  y e a rs  so / w o u ld n ’t  h a v e  g o t  a w a y  w ith  it in  th e  la s t  tw o  
y e a rs , b u t  it  w a s  a b o u t tw o  y e a rs  a g o  w h e n  I  d e c id e d  th a t  I  w o u ld  te ll w o rk  
. . .  I d id n 't w a n t to  te ll th e m  b e c a u s e  I  w a s  w o rr ie d  th e y  w o u ld  th e n  m a k e  
a llo w a n c e s  fo r  m e  a n d  th a t th e y  w o u ld  th e n  s a y  th a t th in g s  w e re  b e t te r  th a n  
th e y  w e re  a n d  th e y  w o u ld n 't ju d g e  m e  o n  m y  a b ilit ie s  b u t  o n  th e  a b ilit ie s  o f  
s o m e o n e  w h o  is  c h ro n ic a lly  ill, w h ich  I  re a lly  d id n ’t w a n t. ”
For some, the effect of SSc became so profound that they were unable to 
continue with their job and described how that made them feel and the 
consequences which ensued:
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“I ’m  re t ire d  a t  3 2  a n d  I ’m  n o t v e ry  h a p p y  w ith  it  e rm .. th a t ’s  it  re a lly  
th a t ’s  a l l  I  c a n  s a y . I  d o n ’t . . .  m y  w o rk in g  a n d  e a rn in g  life 's  g o n e , i t ’s  to o k  th a t  
a w a y . I t ’s  to o k  a  b it o f  m e  re s p e c ta b ility  a w a y  a s  w e ll y o u  k n o w  b e c a u s e  I  
like , e a rn e d  w h a t I  g o t, a n d  th a t ’s  g o n e  a s  w ell. ”
Int 28
“E v e n tu a lly  I  h a d  to  g o  o n  s ic k  le a v e  a n d  s ta r te d  v is itin g  va rio u s  
h o s p ita ls  try in g  to  fin d  o u t w h a t w a s  w ro n g  w ith  m e . . . .
I  fo u n d  it  q u ite  h a r d  a t  firs t m is s in g  th e  p e o p le  w h o  I  w o rk e d  w ith  a n d  
a ls o  k e e p in g  m y  b ra in  a c tiv e  w h ich  w h ils t I  w a s  a t  w o rk  it w a s  v e ry  a c tiv e ., 
s in c e  I ’v e  b e e n  a t  h o m e  I ’ve  fo rtu n a te ly  c o m e  to  te rm s  w ith  n o t w o rk in g  
w h ich  I ’m  v e ry  g la d  a b o u t it. I  d o  m is s  th e  a c tiv ity  o f  it a n d  m e e tin g  o th e r  
p e o p le  a n d  so rtin g  th in g s  out. ”
There were some interesting observations about the effect of position at 
work and its effect on how work could be managed. This was particularly so 
for those interviewees who were owners of their own business, or who were 
managers:
Int 29
“I f  I ’d  b e e n  w o rk in g  fo r  a  b o s s  th e y ’d  h a v e  s a c k e d  m e  b e c a u s e  I  
c o u ld n ’t o b v io u s ly  d o  m y  jo b  lik e  I  w as , lik e  I  s h o u ld  h a v e  b e e n  a b le  to  d o .. .  
th e re  w e re  fiv e  o f  u s  in  th e  g a ra g e  so / c o u ld n ’t, I  c o u ld  s o rt o f  g e t  th ro u g h  
th a t  w a y ”.
Int 11
-173
“We're lucky we run a pub, we’re pub managers so we get paid 
regardless, as long as the work gets done it doesn’t matter whether we're 
doing it 50/50 or 90/10 or 100/0, do you know what I mean, we will get paid. 
We’ve got staff as well so when I'm well l‘ll go and I'll work and I enjoy it. If 
I’m not well or I’m tired or whatever, I don’t have to do it and I don’t do it and 
it doesn’t matter so we’re very luck because if I worked for somebody else, if 
I worked for instance for Marks and Spencer’s I’d have lost my job by now 
because I would have missed so much time and you know what I mean... 





The weather and its effects on those with SSc was related in terms of the 
Raynauds phenomenon (RP) experienced, and the consequences of 
prevention of RP such as not going out in the cold weather.
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“T h e  R a y n a u d s  h a s  a  b ig  e ffe c t th e re 's  a  lo t o f  p re p a ra tio n  y o u 'v e  g o t  to  
m a k e  s u re  y o u ’v e  g o t p le n ty  o f  th in g s  to  k e e p  y o u  w a r m . . . ”
Int 30
“I f  I ’m  d o in g  th in g s  (lik e  d riv ing , o u ts id e  s h o p p in g ) fo r  a  lo n g  tim e , th e n  
th a t a ffe c ts  th em , m o re  h a n d s  th a n  fe e t  rea lly . I ’ve  h a d  tro u b le  w ith  m y  fe e t  
o v e r  th e s e  la s t  fe w  w e e k s  a s  w ell, w h ich  m e a n s  th a t s ta n d in g  a ro u n d  a n d  
th in g s  lik e  t h a t .. I  n e e d  to  k e e p  m o v in g , o n c e  y o u  s ta n d  a ro u n d  a n d  th e y  
s ta r t g o in g  c o ld  th e n  I  fin d  its  d ifficu lt to  g e t  g o in g  a g a in . I ’v e  tro u b le  w a lk in g  
u n til I  g e t  m y s e lf  w a rm e d  up . ”
One individual relayed how this effect is present all year through, even when 
on holiday in warmer climates.
Int 25
“I t ’s  th e re  a ll  th e  tim e . I  m e a n  y o u ’re  la id  o n  a  b e a c h  in  th e  s o u th  o f  
F ra n c e  a n d  its r e d  hot, a n d  y o u  g o  in  th e  s e a  a n d  th e n  w h e n  I  c o m e  o u t m y  
h a n d s  o r  m y  fe e t  h a v e  g o n e  (R a y n a u d s ). It's  n o t co ld , i t ’s  ju s t  th e  c h a n g e  in  
te m p e ra tu re , o r  th e  b re e z e  y o u  k n o w . I ’v e  g o t  th e s e  b la c k  h a n d s  a n d  I  c a n ’t  
fe e l m y  fe e t  a n d  y o u ’re  s o rt o f  h o b b lin g  u p  th e  b e a c h . “
Int 31
“I  g o  e v e ry w h e re  w ith  g lo v e s , s c a rf, tigh ts  in  m y  b a g  in  c a s e  I  g e t  co ld , 





The overarching theme of self was made of up those themes which 
represented aspects or feelings internal to the individual; and was therefore 
made up of psychological components. It was a difficult definition with which 
to work as many elements of people’s discussion related to aspects of their 
individuality, but people expressed these feelings in a very personal way. 
They included aspects of control (self-efficacy), both over their lives and the 
disease; embarrassment which was frequently linked to symptoms; 
confidence which was underpinned by many aspects of the disease; and 
view of self which combined elements of visual appears, personality and loss 
of identity.




Control pervaded must of the transcripts, with this being conceptual 
interwoven into many themes. For example, in the earlier theme of 
frustration, most of this arose from the lack of control over their abilities to 
control the limitations of SSc. This relates closely to the construct of self- 
efficacy which is the persons ability to exert influence over events which 
effect their lives (Bandura 1994).
In the following examples control is mentioned as an explicit theme. This 
was expressed as the lack of control over their own life to the control of SSc 
over their life.
Int 1
"The control bit as well. It didn’t used to bother me, because I knew I 
could do virtually anything I wanted to, so no problem, no worries, no 
problems, I’d just go and do it. Now, I have to, I try to get as much control 
over my surroundings, or whatever's going on around me, because 
ultimately if it gets too bad one way or another, its going to affect me 
anyway. I don’t mind having a day, or two days in bed coming round after 
doing something daft, that is that I had control over...."
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“I’ve always been able to do everything for myself more or less, then 
this Scleroderma with my hands, which is the most affected part of my body, 
is more or less controlling my life now. ”
Int 33
(in relation to assisted air travel)
“you were just under these peoples control and you felt, I don’t you, I’m 
piled with all these bags on my lap or whatever but I actually felt quite.. I felt 
like disempowered, really disempowered, it was awful. It wasn’t a pleasant 
feeling and I know it had its perk and I needed to do it but I don't know if I’d 
do it again. “
Int 7




Confidence emerged as a theme which interviewees often related to 
reduction in confidence. This appeared to be linked to a variety of factors.
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For example, affects on their physical health, or as a consequence of others 
attitudes; these can be seen in the following experiences:
Int 10
"Things like shopping trips that I had on my own, going on the bus into 
Leeds, can’t do anymore. I just can’t. I've lost, I don't know if I’ve lost my 
confidence or what I've lost but I just will not do it on my own anymore. I've 
lost all that. ”
Int 14
"Well, it shows in a person if they're not confident with themselves, and 
I am to an extent things like my hands, just certain things, that I can’t do that 
my friends are going to do... ”
Int 5
"It started to affect me more, a lot was really, a lot more. And I became 
a lot less confident person than I ever was, really I think because my family 
fuss around me more, and don’t let me.... I think I’ve lost my confidence an 




Interviewees expressed a feeling of embarrassment linked to several 
aspects of their SSc such as eating in front of others, and the worry of 
incontinence.
Int 7
“Its  b e c o m in g  a n  e m b a rra s s m e n t. W e  w e n t a w a y  a  s h o rt w h ile  a g o  a n d  it 
h a p p e n e d  th e n  in  fa c t th e n  th e y  w a rm e d  m e  d in n e r  u p  o n c e  a n d  I  s till 
c o u ld n ’t  e a t  it s o  I  h a d  fo r  fo re g o  m y  d in n er, its  a n y th in g  th a t s e e m s  to  g e t  
in to  a  bu lk . I  lik e  m y  s o u p  y o u  k n o w , s o  y o u  k n o w , its  q u ite  e m b a rra s s in g , 
a n d  s o m e tim e s  a  b it d is tre s s in g ’’
This was also true for one individual who found sudden drying of her mouth 
which was a particular source of embarrassment when in a restaurant:
Int 30
7 d o n ’t  a lw a y s  h a v e  it  w ith  m e  (m o u th  s p ra y ) b u t  it  d o e s , th a t c a u s e s  
m o re  e m b a rra s s m e n t I  th in k  re a lly  s o m e tim e s  I f  y o u  s ta rt, y o u  c a n  s ta r t  
ta lk in g  a n d  th e n  a ll  o f  a  s u d d e n  y o u  c a n ’t  ta lk  b e c a u s e  its  g o n e  d ry  a n d  th e n  
y o u  ju s t  c o u g h  a n d  c o u g h  a n d  c o u g h  u n til y o u  g e t  a  d rin k  o r  s o m e th in g ...  its  
e m b a rra s s in g  i f  y o u ’re  o u t in  a  re s ta u ra n t a n d  th in g s  lik e  th a t a n d  s ta r t  
c h o k in g  a n d  c o u g h in g  a n d  th in g s  lik e  th a t .”
The experience of incontinence was a key focus for embarrassment in those 
people suffering from this implication of SSc. This was of significant concern 
for the individual, particularly when they were in social environments.
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“I used to go to rugby... I don’t do that now because I just don’t know when, 
you know so I don't put me self in a position where if I’m going to have loose 
bowels I’m going to be embarrassed”.
5.3.2.4 View of Self
Int 9
Figure 5.22 View of Self
View of self is a theme which encompasses those elements of the 
interviewees where people directly mentioned impacts which were not 
specific emotions, but which referred impacts of the disease on the 
individuals inner self. This included elements of their personality, 
appearance and feelings of isolation and loneliness.
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“I ’m  c o n s c io u s  o f  lu m p s  o n  m y  k n e e s  a n d  m y  a rm s  y o u  kn o w , i f  I ’m  n o t  
c o v e re d  up, th e y  d o n ’t  lo o k  v e ry  n ic e . . . th e s e  s p o ts  o n  m y  fa c e , n o w  I  fo rg e t  
I ’v e  g o t  th e m , s o m e tim e s  I ’m  a w a re  w h e n  I ’m  o u t th a t m a y b e  c h ild re n  m o re  
th a n  ad u lts , m a y b e  lo o k in g  a t  m e , y o u  kn o w , ’w h a t a r e  y o u  lo o k in g  a t ’, i f  I  
h a v e n ’t  g o t  m y  g la s s e s  o n  I  d o n ’t  n o tic e  th e m  b u t  I  ju s t  w o n d e r  i f  o th e r  
p e o p le  n o tice . It  w o u ld  w o rry  m e . ”
Int 18
“I th in k  I  lo o k  o ld  a n d  a n c ie n t. To  m e  th e  p h y s ic a l fa c ia l c h a n g e s  a r e  
h o rre n d o u s  y e t  y o u  lo o k in g  a t  m e  w o u ld  p ro b a b ly  n o tic e  n o  d iffe re n c e  a t  all, 
b u t I  do . I  s e e  it in  th e  m irro r a n d  th a t is o n e  o f  th e  w o rk  th in g s , I  s e e  th e  
c h a n g e s ."
Personality
Int 34
“Y o u  fe e l a  lo t o f  th e  tim e  a s  y o u ’re  m is s in g  o u t o n  th in g s  a n d  th a t  
p e o p le  th in k  y o u ’re  s illy  o r  a  b it u s e le s s . "
Int 18
“Y o u ’v e  lo s t y o u r  p e rs o n a lity , y o u ’v e  lo s t y o u r  p r iv a c y "  
Loneliness/isolation
For some there was an experience of isolation, aptly described by one 
gentleman who had to give up work due to his SSc.
Int 27
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“you may not like where you work, but at least you had somebody to talk to 
while you were there., come winter time it gets very back, like being in 
prison... ”









Figure 5.23 Impact with/from others
A theme, which ran through many interviews, was how the disease or its 
consequences had affected others, or how the person feared it might affect 
others. This was very much a social theme, including aspects of 
relationships and social networks. On occasion this theme was related to the 
direct effects of illness and particularly a fear of the future impact on family 
members. However, it also included interactions with the public and a
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concern about the attitudes of others towards them, or how their attitudes 
towards others had been changed since having SSc.
Many people also expressed how the impacts of SSc had meant they were 
not able to meet their own needs and had become dependent upon others, 
or indeed that they feared this dependence in the future.
5.3.3.1 Social impact
Figure 5.24 Social Impact
The impact of SSc on the individual’s social life was expressed by many 
interviewees and has been alluded to in other themes such as eating and 
planning (sub-theme in the Family theme). The social impact of SSc has 
several sub-themes which relate to the specific restriction of eating out, but 
also include the wider physical restrictions relating to going out, the
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difficulties in social planning and the effects of social impact on close 
relationships.
Int 20
“I  c a n ’t g o  o u t w ith  m y  frien d s  a n y m o re , w e ll I  d o  g o  o u t b u t  fe e l lik e  I ’m  
b u rd e n in g  th e m  b e c a u s e  i f  y o u  g o  to  a  n ig h t c lu b  it g e ts  to o  w a rm  a n d  I  c a n ’t 
b re a th e  a n d  i f  it ’s  a  s m o k y  p la c e  th a t g e ts  o n  m y  c h e s t a n d  e v e ry th in g  s o  
th a t ’s  a  b it o f  a  d o w n fa ll b e c a u s e  I  fe e l I  fe e l I ’m  o n ly  y o u n g  s till a n d  I  w a n t  to  
g o  o u t a n d  e n jo y  m y s e lf  b u t I  c a n ’t  b e  in  a  c o n fin e d  p la c e  w h e re  it g e ts  to o  
w a rm  o r  to o  s m o k y  b e c a u s e  th a t ’s  w h e n  I  n e e d  to  g o  o u ts id e  a n d  th e n  th a t  
m e a n s  m y  frien d s  n o t e n jo y in g  th e m s e lv e s  b u t th e y ’re  g o o d  a b o u t th a t, th e y  
u n d e rs ta n d  th a t  I ’m  n o t w e ll. . .  I 'v e  lo s t d o in g  m y  e x e rc is e d , I  c a n ’ e v e n  d o  
th a t  a n y  m o re , e v e n  g o in g  s w im m in g  I  c a n 't  ta k e  th e  k id s  s w im m in g  b e c a u s e  
it  g e ts  fa r  to o  c o ld  to o  fa s t fo r  m e . .”
These physical effects on social life are not the only influence. The next 
interviewee describes the effect of lack of motivation on social life:
Int 32
“I  re a lly  h a v e  n o  in te re s t in  g o in g  o u t w ith  m y  fr ie n d s ...  a n d  g o in g  o u t  
fo r  s o m e th in g  to  e a t, I  c o u ld n ’t  e a t  it  a n d  I  d id n ’t ’ w a n t it  a n d  it w a s  a n  
e ffo rt.....I  re a lly  lo s t a l l  in te re s t ..”
Int 25
“Its  ju s t  d iffe re n t, i t ’s  a  m o re  s e d e n ta ry  s o c ia l life  n o w , y o u  s it  in  a  p u b , 
o r  y o u  s it in  a  th e a tre  o r  y o u  s it  in  th e  p ic tu re s  ra th e r  th a n  g o in g  o u t a n d  
d o in g  th ings.
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I  d o n 't fe e l a s  th o u g h  I  c a n  d o  ju s t  w h a t I  w a n t to d o  o r  g o  w h e re  I  w a n t  
to  g o  o r  y o u  k n o w , e a t  w h a t  I  w a n t to  e a t  o r  y o u  k n o w  th a t  w ay , its  a f fe c ts .. . .  
I t ’s  n o t th a t I  w a n t to  g o  o u t a ll  th e  tim e  ju s t  th a t I 'd  lik e  to  b e  a b le  to  g o  a n d  
n o t h a v e  to  th in k  o f  ta k in g  s p a re  k n ic k e rs  a n d  p a d s  a n d  y o u  k n o w  o n e  th in g  
a n d  a n o th e r  w ith  y o u  w h ich  I  h a v e  to d o  b e c a u s e  y o u  n e v e r  n o w  w h e n  it's  
g o n n a  h a p p e n . ”
Difficulty planning
Int 34
“Its  like , w e  w e re  in v ite d  to  a  w e d d in g  o f  s o m e  g o o d  fr ie n d s  o f  m y  
p a re n ts  w h ich  h a s  b e e n  b ro u g h t fo rw ard . I t ’s  a  £ 4 0  a  h e a d  w e d d in g  a n d  I ’v e  
tu rn e d  it d o w n  b e c a u s e  w ith  s o m e th in g  lik e  th a t it  p u ts  to o  m u c h  p re s s u re  o n  
m e , I  c a n ’t, b e c a u s e  I  find, I  m ig h t b e  w rong , b u t  I  f in d  th a t  i f  I  a m  u n d e r  
p re s s u re  a n d  I ’m  w o rry in g  a b o u t a n  e v e n t  I  c a n  b e  w o rs e  h e a lth  w ise . I f  I'm  
w o rry in g  I ’v e  g o t  to  b e  a lr ig h t fo r  th e  d a y  s o  I  c a n  g o , c h a n c e s  a r e  I  w o n t  b e  
a n d  a t  £ 4 0  a  h e a d  I  d a r e n t  n o t tu rn  up. S o , i t ’s  ju s t  e a s ie r  to  s a y  I ’m  n o t  
g o in g  b u t y o u  k n o w  its  n o t n ic e  rea lly . I  w o u ld  lik e  to  h a v e  g o n e . .. y o u  fe e l  
lik e  y o u ’r e  m is s in g  o u t a  lo t o f  th e  tim e . Y o u  fe e l a  lo t o f  th e  t im e  a s  y o u 're  
m is s in g  o u t o n  th in g s
Int 21
“I t ’s  d ifficu lt (to  p la n )  o u tin g s  w ith  fr ien d s . I  h a v e  th is  fr ie n d  a n d  w e  ju s t  
u s e d  to  g o  s o rt  o f  w a lk in g , g o  o u t fo r  th e  d a y  fo r  w a lk in g  a ro u n d  g a rd e n s  a n d  
th e  h o u s e s  a n d  th in g s  lik e  th is  w h ich  I  h a v e n ’t  b e e n  a b le  to  p la n  w h e n  I ’ve  
g o t  a  f la re  u p  lik e  th is  b e c a u s e  I  d o n ’t ' k n o w  n o w  I ’m  g o in g  to  fe e l th a t  




“Relationships with men, its always a fine line deciding when to have 
the conversation (about the condition), how to have the conversation and 
what you want from them because immediately a lot of men will want to 
protect you and you want to say oh, it’ll be alright, well not it won’t be alright 
but I can live with it so I want you to and I think certainly from that grounds I 
mean I have told all my boyfriends and they've dealt with it in different ways 
and probably not as well as I would like quite a lot of the time. ”
Int 19
“With friends, its I think I’m slower to trust because I feel once I do trust 
someone I trust them with a lot and I tend to try and judge people before I 
do, do I think they can handle it and most people are fine when you say what 




When considering how to label this theme, it was a choice between the label 
of Dependence or Independence. The reason for this debate was that 
people spoke in terms of a loss of independence due to their SSc, or of a 
fear of becoming dependent upon others in the future.
Int 5
" / h a v e n ’t d r iv e n  fo r  y e a rs , b e c a u s e  m y  h a n d s , s o  I  lo s t m y  
in d e p e n d e n c e  th e re , I ’v e  lo s t m y  in d e p e n d e n c e  s in c e  th e  fla re  u p ”
Int 12
7 g o t  a  b id  d o d g y  o n  m y  le g s  s o m e tim e s  s o  I  w a s  a  b it  c o n c e rn e d  
a b o u t g o in g  o u t o n  m y  o w n , sh o p p in g . P e o p le  th in k  i f  y o u  w a lk  a lo n g  a  r o a d  
a n d  y o u ’r e  s ta g g e r in g  a  b it, p e o p le  th in k  y o u 're  a  k in d  o f  d ru n k a rd , p e o p le  
a r e  th in k in g  lik e  th a t a b o u t m e , s o  I  te n d e d  n o t to  g o  o u t u n le s s  th e re  w a s  
s o m e o n e  w ith  m e . ”
Int 5
7 c a n t ,  I  d o n ’t fe e l a b le  to  d o  th in g s  o n  m y  o w n  a s  I  d id ”.
From the perspective of potential dependence on others there were a range 
of feelings which all expressed a strong theme of avoidance of dependence 
of others. These were expressed in terms of the firm belief that it was the 
responsibility of the individual with SSc to remain independent, and the 
desire not to be fussed over.
Int 18
7 th in k  e v e ry o n e  s h o u ld  c a r ry  th e ir  o w n  b u rd e n  a n d  th a t e v e ry o n e  
a ro u n d  m e  d o e s n t  n e e d  to  c a rry  th is  y e t  s im p ly  b e c a u s e  I  c a n  k e e p  it a  
s e c re t:  I ’m  n o t d e p e n d e n t o n  a n y o n e .”
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Int 33
“It may sound really bad but I’m getting pampered and its doing my 
head in, not in a nasty way but I’m just getting, you know, that I can’t do for 
myself and I’m thinking, God, if I get any worse and people have to do for 
me, I think I’ll be the worst patient ever, I think I will. I’ll be the worst patient. I 
don’t like not being able to do for myself; I think that’s really hard. ”
5.3.3.3 Information
Figure 5.26 Information
Information was a topic that was expressed by many people but in many, 
often contradictory, ways. Whilst some keenly felt the desire for information 
and truth, the desire to know the minimum to get by was needed by others. 
For many, information represented the power to plan their life, for others it 
represented a vision of how their life may become with which they felt they 
couldn't cope.
A common comment however was that when they gave information 
regarding scleroderma to friends and family, no-one had heard of it.
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Int 26
“ / d o  th in k  in fo rm a tio n  is  im p o rta n t a n d  I  th in k  th a t ’s  w h a t a  lo t o f  p e o p le  
d is re g a rd  re a lly  b e c a u s e  I  th in k  a  lo t o f  p e o p le  d o n ’t lik e  to  a s k  q u e s tio n s  
b e c a u s e  I  th in k  a  lo t o f  p e o p le  a r e  fr ig h te n e d  o f  w h a t th e y ’re  g o in g  to  h e a r :  
w e ll th a t  d o e s n ’t b o th e r  m e . I ’d  ra th e r  kn o w , I ’d  ra th e r  e v e ry b o d y  b e  up fron t, 
e v e ry th in g  o u t in  th e  o p e n  a n d  la id  o n  th e  ta b le  a n d  th e n  e v e ry b o d y  k n o w s  
h o w  th e y ’re  g o in g  o n  a n d  y o u  k n o w  w h a t to a s k ”
Int 33
“n o t b e in g  a b le  to  p la n  m y  life  e ffe c tiv e ly  I  th ink. I ’v e  g o t  tw o  c h ild ren , 
I 'm  m a rr ie d .. .  n o t b e in g  a b le  to p la n  fin an c ia lly , I  th in k  a  b e t te r  
u n d e rs ta n d in g  in  th e  e a r ly  d a y s  o f  w h a t w a s  g o in g  to  h a p p e n  to  m e  w o u ld  
h a v e  p u t  m e  in  a  b e tte r  p o s itio n  f in a n c ia lly ..”
In 19
“ its  n o t a  d is e a s e  y o u  c a n  s e e  a n d  p e o p le  d o n ’t k n o w  I ’v e  g o t  i f  u n le s s  
I  te ll th e m , s o  th a t fo r  m e  a t  th is  p o in t is  th e  m a in  im p a c t a n d  p a r t  o f  it  is  



















Finance was a complex theme which emerged in the context of several 
areas of life, such as insurance, financial planning, reduced finance and in 
the case of one individual, improved financial status due to the effect of SSc.
People expressed finance usually when questioned, but had introduced 
aspects of finance such as insurance and the effect of work loss on finance.
Int 28
“Financially at first when employers didn’t know what was wrong with 
me, I was on sick leave for about four years so they were very good to me
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a n d  I  w a s  o n  fu ll p a y . . .  I  m a n a g e d  to  g e t  a  d e fe r re d  p e n s io n  a f te r  a b o u t  
th re e  y e a rs , b a c k d a te d  fo r  a b o u t tw o  y e a rs  w h ich  h a s  h e lp e d  q u ite  a  lo t a n d  
I ’v e  p a id  o ff  m y  m o rtg a g e  w ith  m y  re d u n d a n c y  m o n e y  s o  re a lly  I ’m  q u ite  
a lr ig h t n o w , I ’m  n o t lo a d e d  b u t I  c a n  m a n a g e r  a lrigh t. I ’v e  n o  m o n e y  
p ro b le m s . ”
Int 33
“I  m e a n  n o t b e in g  a b le  to  p la n  fin an c ia lly . I  th in k  b e t te r  u n d e rs ta n d in g  in  th e  
e a r ly  d a y s  o f  w h a t w a s  g o in g  to  h a p p e n  to  m e  w o u ld  h a v e  p u t  m e  in  a  b e tte r  
p o s itio n  fin a n c ia lly  b e c a u s e  th e  k n o c k  o n  a ffe c ts  fo r  m e  fin a n c ia lly  n o w  a r e  
e v e ry th in g  th a t y o u  h a v e  y o u  s h o u ld  h a v e  d e c la re d . D o  y o u  k n o w  w h a t I  
m e a n , a n y  in s u ra n c e  th in g  th a t y o u  h a v e  y o u  a r e  s u p p o s e d  to  h a v e  d e c la re d  
s o  a s  I  d id n 't re a lis e  I  w a s  s o  b a d  i t ’s  n e v e r  s o m e th in g  I  e v e r  re a lly  th o u g h t  
o f .. .a n d  n o w  I ’m  a t  th e  c ru x  w h e re  I ’m  th inking , w e ll y o u  k n o w  it  m a y  b e  th a t I  
m ig h t n o t g e t  to  w o rk  th e  re s t  o f  th is  y e a r  b e c a u s e  th a t ’s  n o w  th e  fu tu re  
h o ld s  fo r  m e . I  m a y  h a v e  to  s to p  w orking , i f  I ’d  h a v e  k n o w n  th e n  I  w o u ld  
h a v e  in v o k e d  c e rta in  th in g s  e a r lie r .”
Insurance was mentioned in the context of life insurance and holiday 
insurance, people commenting on both the difficulty and expense in 
purchasing these products. This was frustrating, being expressed neatly in 
the feeling that they were being penalized twice, once with the illness, 
secondly by then having to pay additional cost for insurance when the 



















It is perhaps unsurprising that interviewees frequently described the wider 
effect of SSc, in particular effect on their relationships and their family and 
friends.
As Figure 5.28 suggests, this effect was broad, with direct effects on family 
members, and impacts on other relationships. For example, interviewees 
talked about their desire to protect their loved ones from the effects of SSc, 
in the present, and in the future.
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Protection for family members
“Int 18
I ’v e  b e c o m e  s o  s e c re tiv e  a n d  e v a s iv e , p ro te c tin g  e v e ry o n e  e ls e  w h e n  
p ro b a b ly  it  s h o u ld  b e  th e  o th e r  w a y  a ro u n d . I  w ill n o t d is c u s s  it  w ith  a n y o n e  
s o  th e  o n ly  p e rs o n  w h o  k n o w s  I ’ve  g o t  th is  illn ess  is  m y  h u s b a n d . I  ju s t  
c a n n o t b e  b o th e re d  to  b u rd e n  o th e r  p e o p le  w ith  w h a t I  c o n s id e r  to  b e  a  
c a ta s tro p h e .”
Int 34
“I ’v e  g o t  th re e  ch ild ren . I  d o n ’t  te ll th e m  m u c h  b e c a u s e  I  d o n 't ’ w a n t  
th e m  to  w o rry  u n d u ly  s o  I ’m  n o t o n e  o f  th e s e  p e o p le  w h o  m a k e s  o u t to  th e m , 
o h  I ’v e  th is  te rrib le  illn ess , I  ju s t  m a k e  lig h t w h ich  is, th a t ’s  w h a t I  w a n t to  d o  
a n y w a y ,. I  d o n ’t w a n t it  to  b e  a n y th in g  te rrib le  s o  I  ju s t  s a y  w e ll to  th e  
y o u n g e s t  o n e , I  ju s t  w a y  I ’m  g o in g  to  th e  h o sp ita l. I  d o n ’t ’ e v e r  g o  in to  a  lo t  o f  
d e ta il. I  ju s t  d o n ’t w a n t th e m  to  w orry, w h y  s h o u ld  th e y  w o rry  a b o u t it, I  d o n ’t 
w a n t th e m  to  s o  I  ju s t  m a k e  it v e ry  light. ”
Int 33
“I t  m a d e  m e  fe e l q u ite  s a d  th a t m y  s o n  s h o u ld  th ink, I  k n o w  th a t th e  
w o rrie s  a b o u t m e  a n d  I  d o n ’t  th in k  a t  th irte e n  y o u  s h o u ld  b e  w o rry in g  a b o u t  
y o u r  m o th e r. I  th in k  y o u  s h o u ld  b e  w o rry in g  a b o u t y o u r  p la y  s ta tio n  g a m e s  
a r e  w o rk in g  p ro p e r ly  o r  d o  y o u  k n o w  w h a t I  m e a n . I  k n o w  h e  d o e s  se rio u s ly , 
s e r io u s ly  w o rry  a b o u t m e  b e c a u s e  w e  a r e  tight, h e ’s  m y  firs t b o rn  s o n  a n d  a ll  
th a t. I  d o n ’t  th in k  a n y  c h ild  s h o u ld  lo s e  th e ir  p a re n ts  w h e n  th e y ’r e  y o u n g  b u t  
th e y  m a y  h a v e  to  g o  th ro u g h  th a t a n d  I  w o rry  a b o u t th a t  b e c a u s e  I  d o n ’t 
th in k  it s  fa ir .”
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Guilt/Not able to do things with family
Int 10
“(a f te r  tre a tm e n t) ... I  fe e l g u ilty  b e c a u s e  I  c a n 't  g o  w ith  th e  kids. ”
Int 20
“I  try  n o t to  i f  w e  try  to  ta k e  th e  k id s  lik e  b o w lin g  th e y  p la y  a n d  I  w a tch , I 
c a n ’t h o ld  th e  b a lls , th e  b a lls  e v e n  a  c h ild ’s  b a ll is  fa r  to o  h e a v y  fo r  m e  s o  w e  
still g o  to  th e s e  p la c e s  y o u  kn o w , b o w lin g  a n d  s tu ff  b e c a u s e  I  d o n ’t w a n t  
th e m  to  m is s  o u t o n  th in g s  b u t its y o u  kn o w , its  lim itin g ..”
Close relationships
Int 4
“M y  h u s b a n d  is a  w o rrie r a n d  h e ’s  d e fin ite ly  a  w o rr ie r  a n d  a lth o u g h  h e  
d o e s n 't  s a y  s o  to  m e , h e ’s  d e fin ite ly  v e ry  w o u n d  u p  a b o u t it  a n d  I  s u s p e c t  
th a t  is  a t  th e  b o tto m  o f  h is  fla re  u p . . . .  H e  d o e s n  1 ta k e  it v e ry  w e ll (m y  
d is e a s e ) s o  h e  g e ts  a ll  s t r o p p y .. W e  a ll  w in d  e a c h  o th e r  u p  y e s , y e a h , „  m y  
co n d itio n  m a k e s  it  w o rs e  h e ’s  w o rry in g  a b o u t it  a n d  h e  d o e s n 't  ta lk  a b o u t it “
Int 33
I t ’s  re a lly  h a rd  fo r  p e o p le  w a tc h in g  a n d  its  re a lly  h a rd  fo r  m y  m u m  a n d  
its  m u m  a n d  d a d  a n d  m y  b ro th e r  a n d  s o m e  o f  m y  c lo s e  fr ien d s . A ll  th e y  d o  is  
g e t  to  h e a r  a ll  th e  b a d  s tu ff  a n d  th e y  c a n ’t  d o  a n y th in g  a b o u t it  a n d  I  th in k  i t ’s  




“Y o u  c a n  g e t  in tim a te  w ith  s o m e o n e  a s  y o u  w o u ld  h a v e  b e e n  b e fo re  
b e c a u s e  y o u ’re  re s tr ic te d  w ith  y o u r  jo in ts  a n d  i  m e a n  w h e n  I  w a s  in  a  
re la tio n s h ip , I  w a s  w ith  h im  fo r  fiv e  a n d  a  h a lf  y e a rs , I  k n o w  it h a d  a  s tra in  o n  
him , m e  b e in g  ill, b u t  ju s t  y o u  k n o w  o b v io u s ly  w e  w o u ld  h a v e  s e x u a l  
in te rc o u rs e , I  w o u ld  b e  re s tr ic te d  to w h a t I  c o u ld  d o  b e c a u s e  o f  th e  fa c t th a t  I  
c o u ld n ’t b e n d  m y  leg s , o r  I  c o u ld n ’t, I ’d  g e t  p a in s  o r  ju s t  g e n e r a l th ings. S o  it 
h a s  re a lly  re a lly  a f fe c te d  th a t a r e a  a n d  I  th in k  th a t ’s  w h y  I'm  p ro b a b ly  m o re  
s c a re d  to  m e e t  s o m e o n e  b e c a u s e  h o w  to  y o u  s a y , w e ll I  c a n  o n ly  d o  c e rta in  
p o s itio n s  y o u  k n o w . It  is  re a lly  h a rd  to  d e a l w ith  th a t .”
Int 9
“I  th in k  w e ’v e  a c c e p te d  th e  e ffe c t ( la c k  o f  s e x  d riv e ) n o w "
Affect on children 
Int 1
“T h e  c h ild re n  a r e  m o re  ju m p y . T h e y ’re  o n  e d g e  a ll  th e  t im e  w h e n  I  
c o m e  o v e r  to  h o sp ita l, e v e n  i f  its  fo r  ju s t  a  n o rm a l o u tp a tie n t a p p o in tm e n t. ”
Int 2
“S h e  g e ts  s o  u p s e t  (d a u g h te r) w h e n  I  c a n ’t  d o  th ings, a n d  I  g e t  u p s e t  
a b o u t it  a n d  w h e n  I  g e t  fru s tra te d  I  y e l l  a t  th e  k id s . M y  s o n  w o rrie s  a b o u t  
th in g s  lik e  ta b le ts . H e  h a te s  th e  ta b le ts  w ith  a  p a s s io n , h e  g e ts  v e ry  c ro ss  
b e c a u s e  I  h a v e  to  ta k e  th e m . H e  g e ts  c ro s s  th a t I  s tru g g le  ta k in g  th e m  s o m e  




Attitudes emerged as a theme which was commonly expressed within the 
interview transcripts. Attitudes of others towards the individual with SSc were 
one of the aspects of this theme and commonly linked to the individuals 
feeling that others were judging them. This could be because they were 
unable to fulfill the physical activities which they would normally have done. 
This can be seen in the following transcript example.
Int 20
“You know some people do judge you because even though you're 
walking, they think you have to be disabled not to walk, they don’t realise its 
other problems so I think that a lot of people might judge, I feel like people 
judge me because of that, because I’m not walking with a limp so they can’t 
see that I’m like breathing heavily and stuff. ’’
The attitudes of others was continued within this theme, with people feeling 
that others didn’t understand the effect of the disease on them, and that 
because symptoms of the disease weren’t always physically obvious, 
sympathy and understanding of others was limited:
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“Y o u  c a n  o n ly  try  a n d  e x p la in  it  to  th e m , c a n ’t  y o u ?  I  d o n ’t th in k  p e o p le  
u n d e rs ta n d  th a t it  d o e s  a ffe c t  o th e r  p a r ts  o f  y o u r  b o d y  th a t c a n ’t  b e  s e e n . .”
Int 21
"If y o u ’ve  g o t  a  b ro k e n  lim b  a n d  its  in  p la s te r  th e n  y o u ’v e  g o t  
e v e ry b o d y ’s  s y m p a th y ; w h e n  I  h a d  th e  u lc e rs  o n  m y  fo o t I  g o t  e v e ry b o d y 's  
s y m p a th y  b e c a u s e  th a t to e  w a s  a ll  b la c k  a n d  g u n g y  a n d  h o rrib le  lo o k in g  a n d  
it  w a s  g r e a t  b u t  w ith  this, th e r e ’s  n o th in g  to  s e e , y e s  m y  h a n d s  a r e  s w o lle n , I  
m e a n  th a t ’s  n o t e n o u g h  to  g iv e  e v e ry b o d y  s y m p a th y  to w a rd s  y o u  a n d  s o  
th e re ’s  n o th in g  th a t th e y  c a n  s e e  s o  th e  s y m p a th y  is  re a lly  z ilch , s o  th e y  
d o n 't u n d e rs ta n d . ”
The effect of the attitude of others is shown by potential effects on the 
individuals view of themselves, potentially leading to the feeling of a need to 
justify themselves or their symptoms. Lack of understanding of others was a 
clear perception on those living with SSc.
Int 34
"Y o u  fe e l  th a t p e o p le  th in k  th a t y o u ’re  s illy  o r  a  b it  u s e le s s ., lik e  w h e n  
w e  w e re  o n  h o lid a y  la s t  y e a r  w e  w e re  in  M a jo rc a  a n d  it w a s  d e c id e d  w e  
w e re  a ll  g o in g  o u t o n e  n ig h t w ith  s o m e  frie n d s  w e  d e c id e d  w e  w e re  g o in g  
o u t s h e  d e c id e d  w e  w o u ld  w a lk . 1 c a n ’t  w a lk  th a t fa r, a n d  ta lk  a t  th e  s a m e  
t im e  b u t  p e o p le  d o n ’t u n d e rs ta n d  u n le s s  y o u  te ll th e m  e v e ry th in g  a b o u t it 
th e y  d o n T  u n d e rs ta n d  a n d  th e y  th in k  w ell, s h e ’s  o n ly  y o u n g  a n d  s h e ’s  a  
h y p o c h o n d ria c , y o u  k n o w  w h a t I  m e a n , oh , th e r e ’s  a  lo t o f  th in g s  y o u  te n d  to  
w ith d ra w  y o u rs e lf. ”
Int 7
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The need for a positive attitude of those around the individual is also 
demonstrated:
Int 26
“I’ve had friends that have had people that’s poorly and its got them 
down and its affected them and they blame the person that's poorly for 
making them like they are and I think its not the person that's poorly that’s 
always to blame, you can't always say that its them that’s caused it. It think 
its the attitude of the other person what they’ve got to come across with, 
they’ve either got to take a positive aspect of it, of the person who is till and 
try their best to help them out, else they don’t, the don't bother.. I've been 
lucky because I’ve got two great daughters. ”
5.3.4 Emotions
Figure 5.30 Emotions
Emotions were identified as an overarching theme as they represent a group 
of psychological themes which were expressed widely throughout the 
qualitative data. For some, these were emotions which were positives such
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as a determination not to become depressed, or a feeling that they had 
adapted to the impacts of SSc on their ability to meet their own needs. For 
others these were strong negative emotions, in particular a fear of the future 
and what that could mean to both them and those around them, and feelings 
of anger and frustration which were predominantly directed against the SSc 
and how it had effected their lives. Some directed their anger against others 
such as healthcare professionals, but this was a rare expression of this 
theme.
The themes which make up ‘Emotions’ follow, together with examples of 




Adaptation was an underlying theme in interview transcripts. Interviewees 
talked about adaptation in terms of acceptance, changing the way they 
thought about things or altering their expectations. For example:
Int 1
“I  a c c e p t  th a t  th e re  a r e  d a y s  w h e n  I  c a n  b e  u p  a t  a  d e c e n t  tim e  in  th e  
m o rn in g  a n d  I  s h a ll g o  b a c k  to  b e d  in  th e  a fte rn o o n . Y o u 'v e  g o t  to  d o  w h a t  
y o u  c a n  fo r  a s  lo n g  a s  y o u  c a n "
Int 14
“Y es , I  th in k  w ith o u t re a lis in g  y o u  d o  th a t y o u  d o n 't ' p la n  to  c h a n g e , a n d  
y o u  d o n ’t  p la n  th e  c h a n g e  th e  w a y  y o u  th in k  a b o u t th ings , b u t  y o u  d o  
b e c a u s e  y o u  k n o w  y o u ’v e  g o t  th is  illn ess  a n d  h o w  it  a f fe c ts  p a r ts  o f  y o u r  
b o d y  a n d  th e  w a y  y o u  d o  th in g s  a n d  I  th in k  w ith o u t re a lis in g  I  h a v e  c h a n g e d . 
J u s t th ings, little  th in g  re a lly , like , i f  I  k n o w  th a t I ’m  g o in g  to  h a v e  tro u b le  
g o in g  s o m e w h e re  o r  d o in g  s o m e  th in g s  I  w o u ld n ’t g o , y e s  y o u  d o . I  c a n ’t 
th in k  rig h t n o w  o f  a n  e x a m p le  b u t I  h a v e  p ro b a b ly  c h a n g e d  th e  w a y  th a t I  
th in k  a b o u t th in g s  a n d  d o  things".
Int 5
“I  le a rn e d  to  live  w ith  it"
Int 7
“Y o u  w o rk  a ro u n d  th e  illn e s s "
Principally adaptation was related to two main areas, Physical adaptation 
and Psychological adaptation. Within these two sub-themes, interviewees 
expressed positive statements suggesting that they had adapted, and 




“I  m ig h t s ta y  th e  s a m e  a n d  th a t ’s  fine, w e  c a n  liv e  w ith  this. ”
Int 4
“T h e re  a r e  p le n ty  o f  u n p le a s a n t p h y s ic a l s y m p to m s  y o u  le a rn  to  liv e
w ith .”
Physical - Not adapted
Int 33
"I ’v e  a lw a y s  d o n e  th in g s  I  d o  w h a t y o u ’v e  g o t  to  d o  to  g e t  b y  a n d  
w h a te v e r  a n d  n o w  I  c a n ’t  d o  th a t a n d  th a t ’s  re a lly  h a rd  fo r  m e  to  c o m e  to  
te rm s  w ith  a n d  th a t's  re a lly  h a rd  to  s to p  y o u rs e lf  d o in g  w h a t y o u  s h o u ld n 't b e  
d o in g  b e c a u s e  th a t ’s  g o in g  to  c a u s e  y o u  to  b e  ill s o  e v e n  ru s h in g  o u t to  
m o v e  th e  c a r  I ’m  s u p p o s e d  to  d o  th a t  s lo w ly  b u t  y o u  ju s t  d o n 't  fu n c tio n  lik e  
t h a t , y o u  d o n 't g o  s lo w  s o  th e n  y o u  g e t  (g a s p in g  s o u n d ) a n d  y o u  th in k  o h  
g o s h , s h o u ld  h a v e  s lo w e d  d o w n  b u t its re a lly  h a rd  to  c h a n g e  th e  h a b its  o f  a  
life  t im e  a n d  i t ’s  o n e  o f  th e  th in g s  th a t d o e s  g e t  to  m e . . .  ”
Psychological - Not adapted
Int 2:
“I  w ish  I  d id n ’t ’ h a v e  it. I  s till h a v e n ’t  c o m e  to  te rm s  w ith  it".
Int 33
“I ’v e  a lw a y s  d o n e  th ings, I  d o  w h a t y o u ’v e  g o t  to  d o  to  g e t  b y  a n d  
w h a te v e r  a n d  n o w , I  c a n ’ t  d o  th a t  a n d  th a t ’s  re a lly  h a rd  fo r  m e  to  c o m e  to  
te rm s  w ith . I t ’s  v e ry  h a r d  to  s to p  y o u rs e lf  d o in g  w h a t y o u  sh o u ld n  t  b e  d o in g
-2 0 2
b e c a u s e  th a t ’s  g o in g  to  c a u s e  y o u  to  b e  ill, s o  e v e n  ru s h in g  o u t to  m o v e  th e  
c a re . I ’m  s u p p o s e d  to  d o  th a t s lo w ly  b u t y o u  ju s t  d o n ’t  fu n c tio n  lik e  th a t. Y o u  
d o n ’t  g o  s lo w  s o  th e n  y o u  g e t  (m a k e s  g a s p in g  s o u n d ) a n d  y o u  th ink, o h  
g o s h , s h o u ld  h a v e  s lo w e d  do w n . B u t its re a lly  h a rd  to  c h a n g e  th e  h a b its  o f  a  
life tim e  a n d  i t ’s  o n e  o f  th e  th in g s  th a t d o e s  g e t  to  m e .”
Int 26
“Y o u ’v e  g o t  to  c o m e  to  te rm s  w ith  y o u r  w a y  o f  life , th a t  y o u ’v e  g o t  to, 
y o u ’v e  g o t  to  m a k e  a  p la n  o f  a c tio n  a n d  y o u ’v e  g o t  to  try  a n d  s tic k  to  it  a n d  
y o u ’v e  g o t  to  d o  th in g s  th a t  y o u  th ink, y o u  k n o w  y o u ’re  c a p a b le  o f  d o in g  a n d  
n o t g o  b e y o n d  th e  b o u n d s  o f  it, th a t ’s  g o in g  to  m a k e  y o u  b a d ly ."
Psychological Adaptation
Int 12
“Y o u  ju s t  g o  o n  a n d  a d a p t  a n d  er, y o u  g iv e  w a y  o n  th is  a n d  y o u  w o n l  
g iv e  w a y  o n  th a t a n d  er, I'm  fe e lin g  s o  m u c h  b e t te r  m e n ta lly , e m o tio n a lly  a n d  
p h y s ic a lly  s in c e  I'v e  b e e n  o n  the, a s  I  c a ll th e  tre a tm e n t, a n d  a s  I  s a y  I'm  
v e ry  g ra te fu l fo r  it  b u t th e  b ig g e s t p ro b le m  fo r  m e  p e rs o n a lly , I  th in k  w a s  n o t  
s o  m u c h  th e  p h y s ic a l b e c a u s e  I  k n e w  w h a t w a s  h a p p e n in g  th e re , I  c o u ld  s e e  
a n d  fe e l a n d  I  c o u ld  u n d e rs ta n d  w h a t w a s  h a p p e n in g  th e re , b u t e m o tio n a lly  
a n d  m e n ta lly  I  th in k  th a t  w a s  th e  b ig g e s t h u rd le  I  h a d  to  o v e rc o m e . I  d o n ’t 
g iv e  in  e a s ily  a n d  I  d id n 't w a n t to  th in k  y o u  c a n ’t d o  this, a n d  y o u  c a n t  d o  
th a t  a n y m o re  b u t  I  h a d  to  c o m p ro m is e .. I  d id n t  g iv e  in, n o  w a y  d id  I  g iv e  in, 
b u t I  d id  c o m p ro m is e  a n d  I  fo u n d  life  h a s  g o t  fa r  b e t te r  fo r  m e . ”
-203
Int 3
“I’ve go to the stage where...ummm I don't feel 100%, I never will do, I 
know that I won’t but, but that's the thing, I’ve got things sorted out in my 
own mind, yeah which is a good thing. I feel I can control it an urn and all 
your emotions are urn, that helps a lot. Sort yourself out in your mind and 
know what’s going to happen and also because I’ve had a lot of help. ”
Int 4
"But you adapt to anything so I just get used to it and just get on with it. ’’
Int 8
“I've had to adapt. ”
5.3.4.2 Anger/Frustration
Figure 5.32 Anger / Frustration
Anger and frustration were statements which frequently occurred within the 
interview transcripts. They were expressed with varying degrees of intensity, 
many of the statements below illustrating the strength of feelings of anger
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and frustration experienced. Frustration and anger were often mentioned 
together, with frustration being particularly related to the limitations imposed 
by SSc.
Int 26
“W h a t I  c a n  d o  a n d  w h a t I  c a n ’t  d o  (is  c o n tro lle d  b y  th e  d is e a s e )  a s  I  
s a id  b e fo re , a n d  y o u  g e t  fru s tra te d , m a d  a b o u t it, b e c a u s e  y o u  c a n ’t d o  th e  
th in g s  y o u  c o u ld  b e  d o in g , d o  b e fo re , a n d  y o u  g e t  fru s tra te d ... 1 c a n ’t  d o  
jo b s  fo r  m y  d a u g h te rs  w h ich  I  u s e d  to  do , w h ich  I  u s e d  to  e n jo y  d o in g  a n d  
th a t ’s  w h e re  I  g e t  fru s tra te d  in  th a t w a y  b e c a u s e  I  c a n ’t  d o  th in g s  fo r  p e o p le  
th a t I  c o u ld  d o  b e fo re ”
Int 9
"It a n n o y e d  m e ; it  re a lly  a n n o y e d  m e  b e c a u s e  I  lik e  w o r k in g .. it  d id  
a n n o y  m e  b e c a u s e  I  d id  lik e  w o rk in g  b u t  I  ju s t  c o u ld n 't d o  it s o .. I  w e re  h a v in g  
s o  m u c h  tim e  o ff  th a t it re a lly  w e r e n ’t  fair. . . . I ’m  a n n o y e d  b e c a u s e  I  w o u ld  
lik e  to  k e e p  w o rk in g  a  little  bit, y o u  k n o w , I  w o u ld  lik e  to  k e e p  w o rk in g  b u t  
a h ., its  ju s t  n o t w o rk in g  o u t .”
Int 29
“I  th in k  y o u  d o  fe e l  a  b it fru s tra te d  s o m e tim e s  y e a h , w h e n  y o u 'v e  b e e n  
u s e d  to  d o in g  ju s t  w h a t y o u  w a n te d  to  d o  a n d  th e n  y o u  c a n ’t  d o  y o u  do , 
y e a h , b u t  lik e  I  s a y  I  ju s t  t h in k "W e ll I  s h o u ld n ’t  b e c a u s e  It, I  s h o u ld n ’t  
g ru m b le  b e c a u s e  it c o u ld  h a v e  b e e n  s o m e th in g  m u c h  w o rs e ”
Sometimes however, anger and frustration were discussed in the context of 
anger against the disease itself:
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Int 2
“Frustrated, angry and upset, yeah I do feel sometimes that I'm letting 
them down and I get very angry because I feel sometimes like its bad 
enough having the disease but the punishments that come with are a 
hassle”
Int 12
“I was very angry about it... I felt this was so unfair and I was the one 
who was suffering for it and I hadn’t' done anything to bring this on. It was 
completely, you know, out of the blue .. ”
Int 18
“And so within me there is a real burning anger which again is part of 
me and it has to be accepted. I have a screaming, burning anger against the 
GP that gave me those drugs and that sounds awful but it will never, never 
go away you know. And that’s another burden that I have to carry because 




Anxiety was mentioned by interviewees in the context of their behavior and 
feelings, rather than anxiety about SSc itself. This did not emerge as a 
widely expressed theme but was clearly stated as illustrated in the following 
quotes.
Int 7
“Little things seem to make me anxious, you know I seem to worry 
about little things which aren’t important. But other than that I don't think I'm 
particularly anxious about the illness because it’s just something you've to 
learn to live with. ”
Int 28
“I think I do get anxious more than I used to, but I’m trying to not get as 
anxious or control it, I get worked up more than I used to or worry about 
things more but I don’t' know why so really as far as I know I haven't 




Depression was a subject which was introduced in many interviews, but in 
varying degrees of severity. For example, people would talk about not letting 
it get them down, feeling low, or the need to be positive. The actual term 
‘depression’ also arose in many peoples’ transcript.
Int 13
“I  d o n 't w a n t to  th in k  a b o u t th e  b a d  th ings a n d  th e re  a r e  d a y s  w h e n  y o u  
s o rt of, y o u  fe e l a  b it  d o w n  a n d  th ink, oh , I  h o p e  I'm  n o t  g o in g  to  g e t  re a lly  
d e p re s s e d  a g a in ”
Int 21
“W h e n  its  in  a  fla re  u p  a s  it is  a t  th e  m o m e n t life  is  v e ry  d e p re s s in g , its  
frustra tin g , I  g e t  q u ite  lo w  a t  t im e s  w ith  it  s im p ly  b e c a u s e  it  lim its  m e  to  w h a t  
I  c a n  d o . . .  I  c a n  g e t  q u ite  d e p re s s e d  a n d  I  te n d  th e n  ju s t  to  s a y  in  th e  h o u s e  
w h ich  I'v e  d o n e  lik e  th e  p a s t  c o u p le  o f  d a y s . ”
Int 12
“I  u s e d  to  g e t  re a lly , re a lly  d e p re s s e d , re a lly  d e p re s s e d  a n d  th a t ’s  n o t  
lik e  m e  a n d  m y  fa m ily  g o t  re a lly  c o n c e rn e d  a b o u t m e  b e c a u s e  I  w o u ld  b e  
ta lk in g  to  th e m  o n  th e  p h o n e  a n d  ju s t  s u d d e n ly  th e y  w o u ld  s a y  s o m e th in g  




Interviewees talked about the effects of SSc on the future or their feelings 
about the future. Many people expressed uncertainty about their future and 
how SSc would effect them, and in turn, that of those around them such as 
children.
Int 33
“I can only hope that things will turn out, or I’ll last a bit longer to at least 
let the kids finish school and stuff but I don’t know, so that's hard, that’s very 
hard."
Int 20
“I worry a lot about them (children) thinking “am I going to pass it onto 
them, what are they going to do then?” but its like if I keep fighting you know, 
I will beat it, but I’m scared that I'm going to die and leave them."
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Some interviewees were particularly concerned about how SSc may cause 
physical deterioration in the future.
Int 32
“I  th o u g h t I'm  g o in g  to  e n d  u p  in  a  w h e e lc h a ir  h e re  b e c a u s e  th a t ’s  h o w  I  
fe lt a t  th e  t im e . . .”
Int 7
7 re a lis e  h o w  b a d  s o m e  p e o p le  c a n  g e t  it  a n d  y e t  I  ju s t  h o p e  I  n e v e r  g e t  
it lik e  th a t”
Int 26
“It  d o e s  (m a k e  y o u  th in k  a b o u t th e  fu tu re ) b e c a u s e  y o u  d o n 't  k n o w  
w h a t’s  g o in g  to  h a p p e n , y o u  d o n ’t k n o w  w h e re  y o u ’re  g o in g  to  e n d  u p  b e in g  
a b le  to  d o  n o th in g , I  m e a n  tw e lv e  m o n th s  s in c e  I  h a d  n o  tro u b le  w h a ts o e v e r  
w ith  m y  h a n d s , I  c o u ld  d o  an y th in g , w h ich  n o w  I  c a n ’t . "
For others the loss or alteration of the future which they had originally 
planned or anticipated was an impact of SSc.
Int 18
7 d o n ’t  m e a n  I ’v e  s to p p e d  living, b u t I ’m  n o -lo n g e r  th e  p e rs o n  I  w a s  s o  I  
c a n ’t h a v e  th e  s a m e  g o a ls . S o , m y  h o p e  fo r  th e  fu tu re  w a s  to w o rk  a m o n g s t  
re s c u e d  h o rs e s  - 1 c a n ’t  d o  it, I  c a n ’t  w o rk  o u ts id e . ”
5.4 Formation of the Descriptive Framework
Following this thematic analysis, the descriptive framework of QoL in SSc 
was developed as reported in Chapter 4. The descriptive framework consists 
of the themes identified in the transcripts of those with SSc who were
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expressing how they felt SSc had affected their QoL, and is shown in Figure 
5.36.
5.5 Comparison of themes generated by one to one interview and focus 
group methodologies
Thematic analysis of data from interviews and focus group were carried out 
simultaneously. A comparison of the themes identified from both data 
sources revealed that there were no new themes produced from the 
participants in the focus group setting in comparison to their individual 
interviews. Therefore, no further focus groups were conducted, as they did 
not add to the thematic generation. Observation notes of the focus group are 
shown in appendix 6.
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Key - The shapes represent a theme generated by the interviews relating to 
QoL in SSc, colours representing either SSc QoL, a theme or an over 
arching theme. The length of the arrow or placement of the theme has no 
significance
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5.6  Data Saturation
5.6.1 Data saturation of themes
Data saturation is the term used to describe the stage in qualitative research 
when no new information (in this case themes) are observed in the data.
This is not to be confused with the interviewees giving different ways of 
expressing these themes. Data collection within this study was stopped after 
31 interviews and one focus group as no new themes were being generated 
and, as far as possible, all cells within the sample frame were recruited.
Analysis of the Excel database demonstrates no new themes were 
generated after interview 4 in this study.
5.6.2 Data saturation for items
The 29 items retained in the final version of the SSc QoL, were identified 
from a wide range of the interviews (as seen in Table 6.8). Some of the 
items were taken directly from a transcript, some of the items were a 
composite of a variety of statements, and some of the items were matched 
with conceptually similar items from the existing needs based item bank.
Of the 29 items, seven items derived directly from a statement within the 
interview transcripts, twenty two items were based on a composite of several 
statements which were made into an acceptable format (that is generalisable 
to the SSc population without reference to gender, age etc).
5.6.3 Summary of Chapter 5
Chapter five has presented the qualitative results of the study including the 
descriptive framework of patient-perceived SSc QoL, and given details of the
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themes identified within it. Four overarching themes were identified: Physical 
restriction, Self, Emotions and Impact with/on others.
Data saturation for themes was identified after four interviews, but items 
were still being identified from the final interview. An additional focus group 
did not produce any different themes to those produced by interviews.
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6. The SSc QoL - results
This chapter presents the results of the development, validity and reliability 
testing of the SSc QoL. It begins by looking at the demographics of those 
who responded to the questionnaires, and then proceeds to describe the 
results of the item selection and item reduction processes. Finally, results of 
the psychometric testing of the SSc QoL are presented.
6.1 Responder demographics
The sample groups for the postal questionnaire and test-retest analysis were 
identified in Chapter 4, table 4.3, and the questionnaires were posted out as 
described in Chapter 4. The following sections, including Tables 6.1 and 6.2, 
describe the demographics of the respondents at each stage of development 
of the SSc QoL.
Table 6.1 Responder demographics -  First postal questionnaire
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6.1.1 First postal questionnaire
Of the 336 questionnaire booklets sent out (sample described in Chapter 4, 
Table 4.3), the researcher was notified of seven patients who had deceased. 
Of the 329 remaining, 203 were returned completed. This gave a return rate 
of 61%. The demographics of the first questionnaire responders can be 
found in table 6.1.
There was a similar distribution of males and females across the disease 
sub-types of the sample frame, with males in a minority in both disease sub- 
types. In those who responded, there are fewer males in the limited group 
than the diffuse group; (Table 6.1), which reflects the distribution of the 
original sample frame. Very little missing data was shown in the responder 
group, however thirty-three gender responses, and thirty-five age responses 
were missing. There were more respondents in the over 50-year age group 
than the under 50 age group (Table 6.1), but there was no significant link 
demonstrated between age and gender of the respondents (chi sq of 0.62 
and a p value of 0.489)
Those with ISSc are significantly older than those with dSSc (Table 6.1) and 
those with ISSc have a higher proportion of those with disease duration of 
greater than 5 years.
6.1.2Test/Retest questionnaire
A total of 369 participants were sent the rest-retest questionnaire (sample as 
described in Table 4.3, chapter 4). Of the 159 responders, 119 responded to 
the retest questionnaire within four weeks, giving a response rate of 74.2%.
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Table 6.2 Responder demographics -  Test/rest questionnaires
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The demographics of the test and retest responders are summarized in 
Table 6.2. No statistical significance was found for age (t test 0.624, p 
0.533), gender (Chi sq 0.976, p 0.412), sub-type (Chi sq 0.111, p 0.856) 
between the retest responders and non-responders.
Further analysis of the responder data
Within the postal questionnaire respondents were asked their disease sub- 
type as it was recognised within the literature review that disease 
classification of sub-type is not a standard process within clinical care. 
Responder’s knowledge of their disease sub-type was compared with their 
sub-type as recorded on the National Scleroderma database. This 
demonstrated that 91.7% of dcSSc responders, and 84.6% of IcSSc 
responders gave a sub-type which matched that on the database. Therefore
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only 15.4% of those with IcSSc and 8.3% of those with dcSSc did not 
correctly identify their disease sub-type.
As the items of the SSc QoL were generated from qualitative interviews from 
a specific sample frame, the demographics of the respondents of the 
questionnaire were analyzed according to that sample frame. The results are 
shown in Table 6.3. The results indicate that both age and disease duration 
varied significantly across disease sub-type.
Table 6.3 -  Relationship between Sub-type, Age, Gender and Disease 
Duration
DcSSc LcSSc Total ‘p’ value*
Age above 
50 years
60.9% 80.2% 69.7% 0.003
Female 82.8% 90.1% 85.9% 0.177
D Duration > 
5 years
82.8% 94.5% 87.6% 0.007
A level and 
above
38.4% 37.4% 37.9% 0.880
*p value from Mann Whil ney
A variety of measures were included in the questionnaire for potential use in 
the SEM process. This allowed analysis of the levels of impairment (fatigue 
and psychological impairment), health status and QoL within the responder 
group, results of which are shown in Table 6.4. The levels of impairment 
(fatigue and psychological impairment as well as general health status and 
QoL are not significantly different between disease sub-type (Table 6.4). For 
example, the Fatigue Severity Score (FSS) shows a mean score of 5.78 
(4.50 -  6.17) in dcSSc, and 5.89 (4.33 -  6.75) in IcSSc (Mann Whitney p 
0.494). However, functioning as shown by both the HAQ and UK Function 
Index (UKFI), demonstrate significant difference between dSSc and ISSc
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subtypes. This analysis is not fundamental to the hypothesis testing but 
offers further insight into the responder group.
Table 6.4 -  Relationship between measures of Health Status and disease 
subtype, Overall health and VAS QoL across subtype and total responders.
DcSSc LcSSc Total p value *
FSS 5.78
(4.50-6.17)
5.89 -  
(4.33-6.75)
5.78
(4.50 -  6.56)
0 .494
Anxiety 7 (4 -1 0 ) 7 (5 -1 0 ) 7(4-10) 0.440
Depression 5 (3-9) 6 (2.75 -  
9.25)
6 (3 -9 ) 0.933
RSE 19 (14 -24 ) 20 (16-24) 20 (15 -24 ) 0.252
GPSE 30 (28 -  
36.75)
30 (26-35) 30 (27 -  35) 0.096
HAQ 1.25 (0 .53- 
2.13)





UKFI 1 3 (6 -1 9 ) 9 (2 -1 9 ) 11 (4 -1 9 ) 0.040
EQ5D 0.59 (0.52- 
0.76)








72 (62.40 -  
87.60)
72.50





55 (37 -71 ) 53 (29 -75 ) 54 (35 -  73) 0.659
QoL (vas) 59 (40 -  79) 57 (34-80) 58.50 (37.25 
-80.00)
0.975
*P  value from M ann W hitney test
Scoring form at for the com parator m easures: F S S  - higher score (m axim um  of 7 ), higher 
fatigue level; H A D  - each item scored 0  -  3, 7  items for each , anxiety and depression. 
Higher scores indicate higher levels; R S E  -  1 0 - 4 0 ,  higher score, higher self-esteem ; 
G P S E  -  Score 1 0 - 4 0 ,  higher score m ore self-efficacy ; H A Q  -  M axim um  score of 3  for 
worst function; E Q  5D  -  W eighed  score, calculated by syntax; LH S  -  0  -  100  range. 0  -  
m axim um  handicap, 100  =  no handicap; V A S  -  100  m m  range, the higher score the better 
Q o U H ea lth ; UK FI -  0 -  3  each item with an overall score 0 - 3 3
6.2 Development of the questionnaire
Results of development of the SSc QoL are divided into section 6.2.1 
describing results of the item selection process used to produce the items to
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go into the draft SSc QoL, and section 6.2.2 which describes results of item 
reduction which occurred during psychometric testing of the measure 
following its postal administration.
6.2.1 Item selection to develop the draft SSc QoL
The process of selection of items for the draft SSc QoL has been outlined in 
section 4.2.1, and this process resulted in identification of 90 items for use in 
the SSc QoL. Details of the outcome at each item selection process are 
described below.
S ta g e  o n e  -T h e  researcher identified 1790 statements from the 31 interview 
transcripts; these represented key statements with no criteria applied.
S ta g e  tw o  - Interview transcripts were analysed by independent assessors 
who applied the needs based model to the statements and identified items. 
At this stage 710 items remained.
S ta g e  th re e  - Items were removed at this stage chiefly for the reasons of 
duplication, they were not applicable to all potential responders or were 
ambiguous. Three items were exchanged from the item bank into the draft 
questionnaire as their meaning was agreed to be the same as that identified 
in the item selection of the SSc QoL, but that the wording of the item bank 
item better fitted the item selection criteria. These items were:
• I worry that I let people down
• I cannot rely on how I will be tomorrow
• I worry about the effects on others
At the end of stage three, ninety items were identified to go forward into the 
draft SSc QoL measures, the SSc QoL 90.
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6.2.2 Item reduction during the psychometric testing of the SSc QoL
An iterative process of Rasch analysis was undertaken during development 
of the SSc QoL (shown in detail in section 6.3), which resulted in item 
reduction at each stage of analysis. A summary of item reduction of the SSc 
QoL during the stages of its development is seen in Table 6.5.
Item reduction during the first stage of Rasch analysis (the first postal 
questionnaire) resulted in item reduction from a 90-item SSc QoL to a 39- 
item SSc QoL.
Test/retest reliability of the 39-item SSc QoL (as described in section 4.2.6) 
generated data for the second element of Rasch analysis. Item reduction the 
during test/retest stages of SSc QoL development can be seen in Table 6.5 
from stage 23 onwards. Item reduction in this stage of Rasch analysis 
(shown in detail in section 6.3), resulted in the final 29 item SSc QoL 
measure seen at stage 30 in Table 6.5.
-221
Table 6.5. Item reduction (together with rationale for removal) during the first 











1 78 ,81 ,a 3 4 D IF 87
2 2 2 ,2 6 ,3 1 ,3 2 ,7 4 ,7 0 1 7 ,5 0 ,7 3 D IF 78
3 4 ,9 ,3 8 ,8 7 D IF (ag e) 74
4 2 4 ,5 7 ,7 6 ,3 6 ,4 8 ,5 4 ,4 4 1 9 ,2 0 ,3 3 ,3 7 ,7 D IF
5 13,15 ,8 Item  chi sq 62
6 14 Item chi sq 59
7 18 Fit residual 58
8 12 Chi sq 57
9 79 Chi sq 56
10 6 1 , 6 8 High chi sq 54
11 71 Low chi sq 53
12 41 F stat 52
13 89 F stat 51
14 10, 90 Positive pea 49
15 64 ,58 Positive pea 4 7
16 65 D IF 4 6
17 40 F stat 4 5
18 86, 62 Positive pea 43
19 47 Low chi sq 4 2
20 53 Low chi sq 41
21 30 Low F stat 4 0
22 89 F stat 39
Second Rasch Analysis (following administration of the SSc Q oL 39)
23 18 Fit res and Chi 
sq
38
24 2 4 ,2 9 Chi sq 3 6
25 5 Chi sq and item  
fit
3 5
26 15 Redundancy  
and Chi sq
34
27 16 Chi sq 33
28 22 , 33 Low Chi sq 31
29 17 D IF  and Chi sq 3 0
30 30 D IF 2 9
Key: D IF -  Differential Item Functioning: Fit res -  Fit residual: -  For further explanation see section 4.2
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Following postal administration of the SSc QoL 90, the items were found to 
have a highly variable affirmation rate. Table 6.6 highlights the five most and 
least affirmed items in the first postal questionnaire. The most affirmed item 
is the item ‘I just don’t know what I’m going to be like in the future with 88.1% 
of responders stating this item to be true.
Table 6.6 -  Five most and 5 least affirmed items from the SSc QoL 90
Response rate to the items of the SSc QoL 90
Item Percentage affirmed
J25 I don’t know w hat I’m going to be 
like in the future
8 8 .1 %
J28  No-one around m e has heard of 
this disease
8 3 .7 %
J5 I have had to slow down 8 3 .7 %
A 41 can ’t do w hat I used to 8 3 .7 %
J1 I need to rest m ore often 8 2 .3%
J33 I do not like being touched 2 5 .2%
J16  I can ’t cope in the house on my 
own
19.3%
J19 I can ’t go out on my own anym ore 18.8%
J 2 2  Talking about my Scleroderm a  
upsets m e
17 .8%
J15  I can ’t cope at all 3 .3 %
Origins of items of the SSc QoL
The items that entered into questionnaire development were all derived from 
patient views. In order to explore if the items within the SSc QoL were 
representative of this patient data, Table 6.7 links the items of the final 
version of the SSc QoL back to the themes of the descriptive framework and 
the interviews from which they originated.
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Table 6.7 Items of the SSc QoL related back to the interview from which they 
were identified
Item of the SSc QoL Interview source of 
the item
Theme represented by 
the item
1 can't do anything without really 
thinking it through
composite Future -  Emotions
Its always on my mind Int 31 composite Anxiety -Emotions
1 worry that 1 let people down Int 1 composite Family/Relationships -  Impact 
with/on others
My condition m akes me angry Int 2 ,1 2  composite Anger/frustration - Emotions
1 get upset when 1 can’t do things Int 14 composite Anger/frustration - Emotions
1 often get frustrated Int 1,2 composite Anger/frustration -  Emotions
1 cannot rely on how 1 will be 
tomorrow
Int 21 composite Future -  Emotions
1 feel like I’m fighting all the time Int 2 Anger/frustration - Emotions
My condition m eans 1 have 
disturbed sleep
Int 1,5 composite Sleep -  Physical restrictions
It has affected m e a lot socially Int 5 composite Social impact -  Impact with/from  
others
It has affected the health of people 
around me
Int 4 Family/Relationships -  Impact 
with/from others
My hands don't work as well as they 
did
In1 composite Hand function -  Physical 
restrictions
It puts a strain on my personal 
relationships
Int 1,2 composite Family -  Impact with/on others
1 need to rest more often Int 16, 27 composite Slow pacing -  Physical restrictions
Any sort of activity Is difficult composite Restriction/mobility -  Physical 
restrictions
1 avoid certain social situations 
because 1 am  embarrassed
Int 1 2 ,1 6  composite Social impact -  Impact with/from  
others
1 take to heart things which wouldn't 
have worried m e before
Int 9 Anxiety - Emotions
Life is just not what it was Int 10 View of self -  Self
1 can't cope at all Int 3 ,10 View  of self -  Self
Sleeping badly has affected m e a 
lot
Int 4 composite Sleep -  Physical restrictions
1 feel very isolated Int 9,10 Family/Relationships -  Impact 
with/on others
Household tasks can be a problem Int 2 composite Housework -  Physical restrictions
1 have had to stop som e of my 
hobbies
Int 2 Hobbies -  Physical restrictions
1 feel guilty at being ill Int 17 Family/Relationships -  Impact 
with/on others
1 struggle to wash myself as 1 would 
like
Int 14,15, 17 composite Hygiene -  Physical restrictions
Pain limits what 1 can do Int1,14,15,21 composite Pain -  Physical restrictions
1 feel helpless Int 34  (1 feel disempowered) Control • Self
Pain tires me out Int 19 Pain -Physical restrictions
1 miss being able to sort things out Int 28 Control -  Self
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Table 6.7 shows that the items of the SSc QoL originated from a wide range 
of interviews. When described as ‘composite’, this refers to items is coming 
from a variety of interviews. Also, it is clear from Table 6.8 that the items of 
the SSc QoL represent all four of the over-arching themes of the descriptive 
framework, with eight from ‘Emotions’, seven from the ‘Impact with/from 
others’ over-arching theme, ten from the ‘Physical restrictions’ over-arching 
theme and the remaining four items came from the ‘Self’ over-arching 
theme.
6.3 Psychometric properties of the questionnaire -  construct validity 
and test/retest reliability
The psychometric properties of the SSc QoL were tested throughout its 
stages of development. Rasch analysis of the data from the first postal 
questionnaire gave an item reduction from the original 90-item 
questionnaire, to a 39-item questionnaire. This analysis is summarised in 
Table 6.9. Initially there was considerable misfit to Rasch model expectation 
(discussed in section 6.3,Table 6.8, analysis 1). Eventually, a 39-item 
solution was obtained which satisfied model expectation (Table 6.8, analysis 
15).
The test for uni-dimensionality of the SSc QoL at this stage of analysis was 
0.041, lower than 0.05 threshold and so showing acceptable 
unidimensionality.
The discarded items (discard pile), were examined using Rasch analysis for 
the presence of an alternative scale, however no solution could be achieved.
This left a 39-item scale, SSc QoL 39, to go forward to the test-retest stage
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Table 6.8 - Summary of Rasch analysis of the SSc QoL 90
Item  Fit 
R es id u a l
P e rs o n  Fit 
R es id u a l
C h i-S q u a re
In te rac tio n
PSI
Analysis
S S c Q oL  
90
M ean S D M ean SD Value (df) P
1 -0 .35 4 2 .0 99 -0 .169 1.041 8 35 .1 9 2 0.0000 0.96091
2
-0 .339 2 .1 0 0 -0.161 0 .952 8 75 .3 0 7 0.0000 0 .9 61 4 2
3 -0 .27 7 1.733 -0 .166 0.881 5 41 .7 3 0 0.0000 0.96551
4 -0 .308 1.764 -0 .144 0 .846 4 5 1 .0 1 7 0.0000 0 .9 59 3 9
5 -0 .31 7 1.696 -0 .14 9 0 .818 4 14 .5 3 7 0.0000 0 .9 57 5 8
6 -0 .26 9 1.336 -0 .176 0 .755 2 2 5 .3 2 0 0.0000 0 .9 51 7 0
7 -0 .29 6 1.297 -0.181 0 .732 1 98 .534 0 .0 0 0 0 0 5 0 .9 50 0 6
8 -0 .30 7
.235
-0 .186 0 .728 196 .795 0 .0 0 0 0 0 4 0 .9 5 1 7 0
9 -0 .29 3 1 .204 -0 .18 9 0 .725 1 82 .835 0 .0 0 0 4 7 0 .9 50 6 0
10 -0 .29 4 1.175 -0 .190 0 .719 1 68 .267 0 .0 0 0 4 7 2 0 .9 5 1 7 6
11 -0 .29 7 1 .157 -0 .190 0 .704 159 .516 0 .0 0 1 4 4 5 0 .9 51 3 2
12 -0 .31 3 1 .108 -0 .18 7 0 .653 1 56 .844 0.000991 0 .9 4 9 9 0
13 -0 .27 9 1 .134 -0 .19 0 0 .642 145 .036 0 .0 0 4 9 0 3 0 .9 50 8 3
14 -0 .2 9 2 1.124 -0 .18 9 0.641 131.091 0 .2 7 7 0 5 0 .9 49 3 4
15
3 9  item  
scale
-0 .2 3 8 1 .102 -0 .18 7 0.583 81 .78 8 0 .362451 0 .9 3 5 9 2
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Second stage of Rasch analysis
The data from the 39 items of the SSc QoL were then subjected to further 
Rasch analysis. Items displaying DIF and misfit were deleted, resulting in a 
shortened 29-item scale (Table analysis 6.9, analysis 10).












T-Tests (Cl)Mean SD Mean SD
Value
(df) P
1 -0 .328 1.523 -0 .199 0 .7 59 260 .3 6 9 0 0 .9 53
2 -0 .38 1.523 -0 .199 0 .759 260 .3 6 9 0 0 .953 11 .92%
3 -0 .352 1.372 -0 .212 0 .762 232 .6 8 3 0 0 .9 52 8 1 0 .81 %
4 -0 .375 1.283 -0 .223 0 .734 190 .923 0 .0 00 0 02 0 .9 50 9 1 3 .13 %
5 -0 .39 7 1.206 -0 .229 0 .7 15 166 .027 0 .0 00 1 4 0 .9 5 1 7 11 .28%
6 -0 .37 6 1.165 -0.21 0 .666 161.04 0 .0 00 1 79 0 .9 49 4 8 .2 7 % (0 .0 6 -0 .1 1)
7 -0 .03 9 9 1.159 -0 .214 0 .6 59 147 .164 0 .0 01 2 26 0 .9474 7 .7 8 %  (0 .0 5 -0 .1 )
8 -0 .38 6 1.154 -0 .21 7 0 .64 121.573 0 .0 25 0 04 0 .9 4 3 6 9 .7 3 %  (.0 7 -0 .1 2 )
9 -0 .403 1 .117 -0 .225 0.641 126 .332 0 .0 06 9 85 0 .9 4 9 8
6 .6 1 %  ( 0 . 0 5 -  
0 .9 )
10 -0 .37 8 1.088 -0 .222 0 .6 22
107 .359  
df =87 0 .0 68 4 59 0 .9 38 9
5 .8 4 %  (0 .03 2 -  
0 .0 85 )
A  Lower 9 5 %  C l-Proportion  low er than or equal to 0 .0 5  show s acceptab le  unidim ensionality.
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6.3.1 Non-parametric testing of the SSc QoL across time points
Non-parametric analysis of the test-retest correlation of the SSc QoL 
measure is presented in Table 6.10.
Table 6.10 Test retest correlation (Spearman) of the SSc QoL 29 items
S S c  Q o L  2 9  
(S e c o n d )
S S c  Q o L  2 9 C u rre n t  
O v e ra ll h e a lth  
(V A S )
Quality of Life 
(VAS)
SSc Q oL 29  
(Second)
1 .000
S S c Q oL 29 .764 1.00
Current overall 
health (VAS)
-.480 -.515 1 .0 00
Quality of Life 
(VAS)
-.587 -.612 .781 1.000
Quality of Life 
V A S  (Second)
-.633 -.524 .591 .705
Current overall 
health VA S  
(Second)
-.453 -.394 .681 .597
The test-retest correlation of the two time points of the SSc QoL 29 was 
0.764, Table 6.10. To put this in context, the test-retest correlation for the 
summary Health and QoL Visual analogue scales was 0.681 and 0.705 
respectively. Correlation between the SSc QoL 29 with other summary 
scales, such as overall health and quality of life, were of an expected 
magnitude. For example, the correlation between the SSc QoL 29 and the 
HAQ was 0.592 (Spearmans).
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6.3.2 Non-parametric testing of the study hypothesis (differences in the 
SSc QoL by disease subtype)
The SSc QoL (29 items) when summed into a simple ordinal scale showed 
no statistical significance for disease sub-type (p - 0.836) in the first postal 
dataset.
6.3.3 Summary of Chapter 6
The needs-based SSc QoL, (29 items), fits modern psychometric 
requirements of Rasch analysis and is more reliable across two time points 
than a VAS of Overall health or QoL as estimated by patients. The SSc QoL 
(29 items) when summed into a simple ordinal scale showed no statistical 
significance for disease sub-type (p - 0.836) in the first postal dataset.
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7. Testing the hypothesis -  Modelling of QoL in SSc
Non-parametric testing of the study hypothesis has been presented in 
section 6.3.2. Chapter presents the results of multivariate testing of the study 
hypothesis using structural equation modelling.
7.1 Structural Equation Modelling -  Testing the hypothesis
The study hypothesis is that there will be differences in the level of QoL 
between people with different subtypes of SSc.
This has been tested in two ways; a simple non-parametric test of the 
difference between two groups, and the multivariate approach of SEM which 
acknowledges that patient perceived QoL may be determined by the 
associations within the broader biopsychosocial model.
7.1.2 SEM testing of the hypothesis
Preparation of data for use in SEM was carried out using the Rasch 
transformed score for each comparator measures, as well as the SSc QoL 
items. The individual person fit estimate for each measure was exported for 
use in the SEM model.
7.1.3 Presentation of SEM models
AMOS 7 software was used for this analysis. SEM models have conventions 
as to their appearance (Schumacker and Lomax 2004). Shapes are used to 
represent key aspects of the model, the measured variable, error and the 
latent variable as shown in figure 7.1
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Explanation of the model developed to test the study hypothesis (Figure
L2L
Figure 7.2 is a diagrammatic representation of the model of SSc QoL which 
was the result of the SEM process for this study. This model can be 
described as ‘parsimonious’, that is it is a simple model which meets the 
statistical levels of fit required for an SEM model (levels of fit described in 
section 4.3.1).
The shapes in the diagram have been explained above, and within each 
shape is the title or abbreviation of a measure that was distributed within the 
development of the SSc QoL. The measures used in this model were 
prioritized for inclusion in the model due to their emphasis within the SSc 
literature. More measures were available for use but were not included 
within the model, as parsimonious fit had already been achieved.
Assessment of the hypothesis through this model, is made by tracing the 
impact of each measure following the arrows coming from the measured 
variable (rectangle), through the latent variable (oval) to the focus of the 
study, SSc QoL. Figures attached to the lines are regression weightings 
imported with the Rasch transformed score. The figure ‘1’ is attached to 
each grouping as a standard within the SEM model
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Figure 7.2 Diagram of the Specification model for the SSc QoL Structural 
Equation Modelling
0.32894
HAD-A -  Hospital Anxiety and Depression measure -  Anxiety 
HA D-D  -  Hospital Anxiety and Depression measure -  Depression 
UKFI- UK Functional Index 
FSS -  Fatigue Severity Scale
SSc QoL -  29 item Systemic Sclerosis Quality of Life measure 
Subtype -  disease subtype, that is DcSSc or LcSSc
Figures attached to the lines are regression weightings. The figure *1' is attached to each grouping as a standard 
within the SEM  model
- 2 3 2
The shapes labeled with blue (In Figure 7.2) indicate disease sub-type 
(dcSSc and IcSSc), function and SSc QoL. There is no arrow leading directly 
from sub-type to SSc QoL. However, there is an indirect link made by arrows 
leading from sub-type to function and then to SSc QoL. This indirect link 
would not been seen in univariate non-parametric testing, nor in a regression 
analysis. Therefore, this model supports the study hypothesis that sub-type 
does have an effect on SSc QoL, this being an indirect effect through 
function.
The summary fit statistics (as described in 4.3.2) of the SEM model were:
• Chi Sq -  5.074
• R M S E A -0.000 
• G F I - 0.991
Therefore, this parsimonious model fits the summary fit statistic 
requirements of SEM. The direct, indirect and total effects of disease 
subtype and health status measures are shown in Table 7.1 in their 
numerical form (standardised beta co-efficients).
Table 7.1 Standardised Direct, Indirect and Total Effects of Disease Sub- 
type and health status variables upon QoL
Direct effect Indirect effect Total
Depression 0 .7 85 0 0 .7 85
Fatigue 0 0 .693 0 .6 93
Function 0 .2 0 4 0 .3 0 2 0 .5 06
Anxiety 0 0 .3 80 0 .3 80
Sub-type 0 -0 .11 2 -0 .11 2
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This shows that depression has the greatest impact upon QoL followed by 
fatigue and function. The former, together with anxiety and disease sub-type 
have significant but indirect upon QoL, and this contrasts with the univariate 
analysis which shows no significant association between QoL and disease 
sub-type
7.1.4 Summary of findings from the SEM model
The SEM specification model (Figure 7.2), and standardized direct and 
indirect effects (Table 7.1), have been summarised to present the following 
findings:
• Disease sub-type effects QoL indirectly through its effect on function
• Fatigue effects QoL through anxiety, function and depression
• Depression has a direct effect on QoL
• Anxiety has an indirect effect on QoL by effecting Depression
• Function has a direct effect on QoL, but also and indirectly through its
effect on Depression and Anxiety.
To summarise, the finding of this SEM process show that a parsimonious 
model of SSc QoL reveals an indirect link between SSc QoL and disease 
sub-type mediated by disability. This would support the hypothesis that 
disease sub-type is reflected in QoL for those with SSc.
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8. Discussion
8.1 Overview
This study has developed a needs-based QoL measure for people with SSc. 
During the course of this development, the experience of living with SSc has 
been explored and a descriptive framework of QoL in SSc has been 
developed.
The principle findings of this research are:
• The descriptive framework of SSc QoL consists of overarching themes
of Physical restriction, Emotion, Self, and Impact on/with others. 
These were made up of thirty themes representing the physical, 
social and psychological aspects of patient-perceived SSc QoL.
• The needs based SSc QoL fits modern psychometric requirements of
Rasch analysis
• The SSc QoL has good test-retest reliability.
• Non-parametric testing shows no significant difference in levels of
patient perceived QoL between disease sub-types (as measured by 
the SSc QoL)
• SEM testing of the research hypothesis demonstrates that disease sub-
type has an indirect effect through impact on QoL, working through 
function.
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• There is a significant link between disease sub-type and function: 
higher impact on function being seen in those with dcSSc than those 
with IcSSc.
8.2 The impact of living with SSc
People with SSc vividly expressed the many ways in which SSc had affected 
their lives and their ability to meet their individual needs. The richness of the 
collective transcript data brings alive the wide-ranging effect SSc can have 
on the life both of the individual and those around them. This is reflected in 
the descriptive framework of SSc QoL which has been developed in this 
study. The overarching themes identified in the study were Physical 
restrictions, Emotion, Self, and Impact with/from others.
What is first apparent from the overarching themes is that only one of them 
is a chiefly physical theme, the other three primarily relating to the 
psychological and social impacts of SSc on both the individual and those 
around them. The overarching themes therefore present a biopsychosocial 
picture of patient perceived SSc QoL.
Two previous qualitative research studies have looked at the impact of SSc, 
(Joachim and Acorn 2003; Suarez-Almazor et al. 2007); each with differing 
methodologies. One study was very restricted in its focus, this focus being 
the effects of scleroderma as a disease with visible symptoms (Joachim and 
Acorn 2003). The second study reviewed the literature relating to the known 
impact of SSc arriving at a script of questions related to the effects of 
disease on QoL: perceptions of disease progression; overall symptom 
burden; and specific organ symptoms (Suarez-Almazor et al. 2007). What is
- 2 3 6
interesting is that despite this, patients still identified themes beyond the 
interview questions, including themes of being normal, and facing the future 
(Joachim and Acorn 2003) and social relationships (Suarez-Almazor et al. 
2007).
This study differs from these previous publications by acknowledging the 
patient as the expert informant. Whilst having a conceptual basis for the 
interviews and focus group, this study utilized prompting techniques (topic 
list) only, as opposed to exclusive use of a formal interview question 
schedule.
Whilst it is difficult to compare the outcomes of the Joachim study due to the 
narrowness of their questioning, many of the themes identified in this 
research study are echoed in the themes identified by Suarez and 
colleagues (Suarez-Almazor et al. 2007). These common themes include: 
self-efficacy (control); coping; adaptation; positive and negative views of the 
future; physical symptoms such as gastrointestinal, skin and fatigue; 
emotional distress; appearance; lifestyle; marital/sexual problems and social 
issues (including social relationships).
Another aspect common to both this study and that of Suarez and 
colleagues (Suarez-Almazor et al. 2007), is that participants did not simply 
identify and rate symptoms, they operationalised them into the context of 
their lives, and how the symptoms affected their ability to do what they 
needed to do as individuals. This is echoed in the transcripts of this study of 
SSc QoL.
When interviewees spoke of the impact of SSc, they described these 
impacts in a way which can be related back to the components of the ICF,
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impairment, activity limitation and participation (section 2.5). For example, 
when people described the physical impairment of gastrointestinal SSc they 
did not simply explain that they had gastrointestinal dysmotility, which would 
have been describing the impairment. Instead, they talked about difficulty in 
swallowing and related this to how their social life was affected, as they were 
often embarrassed to go out to eat. This reflects activity limitation (difficulty 
swallowing), and participation in their withdrawal from eating out socially. 
Activity limitation and participation is seen throughout the qualitative data, 
impairment (that is describing the impact of the disease on body structure 
and function), was used much less with only a few interviewees describing 
the purely medical aspect of their disease.
The descriptive framework of QoL in SSc did not venture to explore more 
detailed levels of analysis. For example the link between themes such as 
cause and effect, and interactions across the whole framework. This is a 
reflection upon the analytical approach used, thematic analysis. Whilst 
thematic analysis provided an appropriate and pragmatic tool to describe the 
qualitative data, it does not provide a means of making those more in-depth 
analytical links between themes. An alternative approach, such as 
phenomenological analysis, may have offered a more in-depth 
understanding of QoL in SSc, and may be a useful tool for future analysis 
and insight.
A further reflection on the qualitative data analysis is that it was not used to 
explore the qualitative experience of QoL in SSc from a perspective of 
disease sub-type. This approach may have provided complementary 
information for discussion of the study hypothesis that disease sub-type is
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reflected in their QoL. This would be an interesting approach for further 
research into the impact of disease sub-type in SSc.
8.3 Physical and psychological influences of patient-perceived SSc 
QoL
The primary purpose of this study was to test the hypothesis that the sub- 
type of SSc will be reflected in the level of patient-perceived QoL. SEM 
suggests strongly that disease sub-type is an indirect influence on patient- 
perceived QoL in SSc, working through function (Figure 7.2). This study 
also found that those with dcSSc reported a higher impact on their physical 
function than those with IcSSc (Table 6.4). This correlates well with previous 
findings that the physical impact of SSc is greater in those with dcSSc than 
IcSSc (Georges et al. 2006), and an earlier study,(Benrud-Larson et al.
2002), which also report patients with dcSSc have a higher level of impact 
on their function that those with IcSSc.
Therefore, clinically we can expect that patients with dcSSc will have higher 
levels of functional impairment than those with IcSSc. The needs-based 
model of SSc QoL tested in this study, presents new knowledge in this area. 
SEM analysis illustrates that sub-type has an indirect effect upon QoL 
through function.
The effect of function on patient-perceived QoL has been clearly 
demonstrated in both the qualitative results of this study, with physical 
restrictions forming one of the four overarching themes. Therefore, impact 
on physical function is both a quantitative and qualitative finding of this 
study.
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The parsimonious SEM model used in this study also shows the importance 
of other factors such of depression, and their relationship with patient- 
perceived QoL. Depression was found to have a direct effect on SSc QoL, 
and anxiety showed an indirect effect upon SSc QoL, again through 
depression (Figure 7.2). In previous studies the link between the physical 
and psychological aspects of SSc has been shown to vary (2.11.5). The 
strength of the SEM technique, has allowed this study to show the complex 
patterns of associations between physical and psychological dimensions of 
SSc QoL (7.1.4), particularly those between depression, anxiety fatigue and 
function.
The ability of SEM to reveal both direct and indirect effects, as shown in this 
study, is a beginning. Further explorations of potential indirect relationships 
in disease models may help clarify many enigmas, for example, the disability 
paradox (section 3.4.1) and its role in chronic disease.
The disability paradox represents those non-physical elements which 
influence people with severe physical disability to rate their QoL as good. 
Other concepts related to this finding may be adaptation (see section 3.4). It 
has been noted that one of the difficulties of studying patient-perceived QoL, 
is that it can mean different things to the same person over a disease 
trajectory (Schwartz and Sprangers 2000). Adaptation to chronic disease is 
a complex concept, which cannot be explored in the confines of this 
discussion, however it is a concept that requires acknowledgement.
Attempts to incorporate any effects of adaptation in the design of this study 
were principally the inclusion of disease duration into the sample frame 
requirements of the qualitative participants. These participants provided the
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qualitative data both for the theoretical framework of SSc QoL, and the 
potential items of the SSc QoL measure. Results of this study show a 
mixture of statements relating to the theme of adaptation (5.3.4.1), 
illustrating both the physical and psychological, adapted and not-adapted 
aspects interviewed. This provides some evidence of the range of adaptation 
present in the qualitative sample.
Another profound effect of SSc on patient-perceived QoL was that of 
impacts with and on those around the person with SSc (5.3.3). This included 
relationships within a family, with friends, loss of social contact through job 
loss, or the inability to meet role needs such as that of being a parent or a 
partner. Social relationships were clearly identified in an earlier study of 
people with SSc, who told researchers of how they relied on friends, 
supports groups and networks. Some people reported that others 
misunderstood and mistook their illness because they did not appear 
physically ill (Suarez-Almazor et al. 2007), and indeed some examples 
recounted in the Suarez publication are echoed in the interviewees in this 
study. And an example common to both studies, is that people expressed 
concern that those around them did not understand the disease and did not 
acknowledge its effect because their disabilities were not always visible.
8.4 Implications for Clinical Practice
The descriptive framework of patient-perceived SSc QoL developed in this 
study, demonstrates the physical, psychological and social impacts of living 
with SSc. Currently, clinical provision is focused around health care, often 
working in isolation. Care frequently focuses on physical symptoms of SSc, 
(section 2.12), and may be unlikely to meet the needs of individuals as
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illustrated In this descriptive framework of SSc QoL. This suggests a need 
for a wider model of care, which can address psychological and social 
issues, asset within a biopsychosocial model of care.
8.4.1 Addressing the impacts of SSc on patient-perceived QoL though 
a pragmatic care pathway
A guideline for the care of patients with a range of connective tissue 
diseases is currently available (ARMA 2007), however whilst it does aim for 
a user-centred approach, it has a health focus based on a medical model 
and is not specific to SSc. Many of the aspects of patient-perceived QoL 
identified in this study are not represented.
This study adds significantly to our current body of knowledge of the effect of 
SSc on patient-perceived QoL. In order to turn this knowledge into a 
pragmatic tool for clinical practice, a care pathway has been developed 
drawing on both the qualitative and quantitative findings of this study (Figure
8.1
Also, as the SSc QoL has been found to fit modern psychometric 
requirements and to be reliable over two time points, it provides a tool ready 
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Key elements of this care pathway are:
• Use of a biopsychosocial model of care
• Consistent use of the SSc QoL measure
• Depression screening and appropriate treatment/referral
• Fatigue screening and appropriate treatments/referral
• Screening for restrictions in physical function and referral to multi­
disciplinary team for appropriate treatment
• Discussion of relationships and/or sexual impacts of SSc, linked with
appropriate information/referral
• Counseling to support the psychological impacts of SSc on patient-
perceived QoL
• Information sharing appropriate to each individual.
U s e  o f  th e  p a th w a y  in  c lin ic a l p ra c tic e
The care pathway illustrated would be a shared document and prompt both 
the healthcare professional and patient to consider each of the issues that 
have been identified. It would provide a tool to identify the needs of the 
individual in order to improve their patient-perceived QoL.
More detail of some elements of the care pathway is now given. This has 
been organised into the overarching themes of the theoretical framework: 
physical restrictions; emotions and self; and impact on/with others.
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8.4.2 Physical restrictions
P h y s ic a l s u p p o rt a n d  re h a b ilita tio n
The effects of SSc on physical function have been clearly demonstrated. 
The care pathway seeks to address these impacts by appropriate therapies 
to promote physical function in those with SSc; in particular, those with 
DcSSc. Therefore, therapies should be part of the treatment pathway for 
people with SSc, namely routine referral to physiotherapy, occupational 
therapy and podiatry services who can provide specialist knowledge of the 
management of function in those with SSc.
These services should work in tandem with other treatments such as drug 
therapy, or skin treatments such as PUVA and paraffin hand baths (Vincent 
and Wilson 2006) for other physical symptoms. Research into appropriate 
and effective physical therapies in SSc is limited, with a small exercise study 
indicating some benefits (Reay et al. 2002). This is clearly a gap in our 
knowledge of the treatment of functional impacts of SSc, and is a potential 
area for future research to inform clinical provision.
W o rk
Work emerged as a complex theme in the qualitative data. It was explained 
in two key impacts, the difficulties in maintaining work, and the implications 
of work loss through the effects of SSc. The potential for work loss, work 
instability, is an issue in other chronic diseases and there are assessments 
available to identify those at risk of job loss (Gilworth et al. 2003; Gilworth et 
al. 2006; Gilworth et al. 2007). Whilst no specific assessment exists for SSc, 
there are more generic assessments available (Allaire 2003; Gilworth et al.
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2008). Clinically, this information translates into the need for those working 
with people with SSc to establish the work status of patients on diagnosis of 
SSc. Information on the type of employment (self-employed, employed, 
unemployed), can then be documented and built up to establish the potential 
support available to maintain employment. These services include 
occupational health, job centre plus work-place assessment, and ideally the 
involvement of a supportive employer. It is important to ensure patients have 
information for all these services and access to advocacy when required.
These measures may prevent or delay job loss, but for many people job loss 
or taking early retirement had already occurred (5.3.1.14). These people had 
mixed emotions, some feeling this to be good in that there was no longer 
pressure to spend energy at work, for others this was a profound loss 
affecting their self-esteem. If all adaptation has been exhausted within the 
workplace, the possibility of job loss may need to be considered, and 
prepared for. The most appropriate path for the patient must be foremost. 
For example, patients may feel too ill to deal with extensive paperwork and 
simply leave work. They may not appreciate the long-term financial benefits 
of acknowledging the role of SSc in their inability to continue in work by 
leaving work through ill health. These are issues that require both accurate 
information and support through these decision-making processes. The 
qualitative data of this study suggest that people may not be open with their 
employer regarding their disease, and therefore there needs to be a clear 
understanding of the information patients are happy to share.
This may be a new undertaking for some healthcare professionals, although 
for some, such as occupational therapists, this is a more acknowledged
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aspect of their role. There are currently insufficient resources to lead on this 
aspect of care in many healthcare teams. However, healthcare professionals 
can and should identify those at risk of work instability or suffering from the 
effects of work loss and direct them to appropriate services who can lead on 
this element of the individuals care.
F a tig u e  m a n a g e m e n t
SEM modeling has clearly demonstrated the direct effect of fatigue on 
patient-perceived SSc QoL (Table 7.2). Qualitative data of the interview 
transcripts have also given insight into the experience of living with fatigue 
associated with SSc, and the Fatigue Severity Scale (FSS) was scored 
highly as a comparator measure in this study (Chapter 6, table 6.4). To put 
this into context, available figures for the FSS in a ‘normal’ population give a 
mean of 2.3 (st+/- 0.7) (Krupp et al. 1989), showing fatigue scores in SSc to 
be over twice that of the available ‘normal’ (Reay 2007).
For those living with chronic disease who often rely on the support and 
strength of relationships with those around them, we begin to see how 
fatigue can extend beyond the purely physical. People are often unable to 
participate in any of their desired activities or relationships in any regular or 
reliable way, as they cannot predict the level or frequency of their fatigue.
The combination of evidence generated from this study underlines the 
significance of fatigue for those living with SSc. It is alarming to note that 
there is no standard care for the management of fatigue in SSc. The need 
for this provision was identified in presentation of emerging results from this 
study (Reay 2007). The clinical implication of this knowledge is the need to 
formally recognise fatigue as a significant co-morbidity in SSc and to screen
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patients for their fatigue levels. Once identified, fatigue management 
strategies can be jointly developed between healthcare professional and 
patient (and those around them if possible).
Examples of management strategies for fatigue in other chronic diseases 
are available (White 1998; Harrison 2007), and offer a tool to research 
effective management of fatigue in those living with SSc. This research 
could be conducted alongside the development of service provision to 
manage this debilitating symptom.
8.4.3 Emotions and Self
The two overarching themes of Emotions and Self have been brought 
together in this discussion of clinical implications as, whilst they are 
conceptually different, service provision to address their impact is likely to 
overlap.
P a tie n t-P e rc e iv e d  Q o L
A primary implication of this study is the use of the SSc QoL measure in 
clinical practice. This provides a measure of patient-perceived QoL, which 
conforms to psychometric expectations, is reliable over time, and is a sum 
score, which can be easily calculated in the clinical setting. It consists of two 
sides of A4 paper with 29 questions and therefore offers both a pragmatic 
and psychometrically proven measure of patient-perceived SSc QoL.
P s y c h o lo g ic a l s u p p o rt
This study has identified existing evidence of the psychological associations 
with SSc (Chapter 2), and added to this body of knowledge with the
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demonstration of how depression and anxiety influences QoL as described 
by the SEM model in Chapter 7.
Current NHS services for people with SSc frequently focus on the health of 
the patient with SSc and are likely to have few service provisions to address 
the psychological impacts of SSc. This study has demonstrated both the 
modeled and lived evidence of the effect of depression, (and anxiety), 
across both dcSSc and IcSSc (Chapter 6, Table 6.4, Chapter 7, Figure 7.2). 
It therefore lends evidence to support the existing call for screening of SSc 
patients for depression (Thombs et al. 2007).
Wider psychological support services for those with SSc are therefore a 
clinical implication of this and previous research. In order to provide this, 
skills in identification of psychological association of SSc are required. It is 
possible for existing staff involved in the care of these patients to acquire a 
level of competencies to screen, deliver basic counseling, and refer 
appropriately to higher level services when required. There may however be 
resource implications of such a screening programme, which may increase 
referrals into clinical psychology and counseling services.
8.4.4 Impact on/with others
In fo rm a tio n
Information was an issue that emerged through many interviews. In some 
contexts this was the request for appropriate information at appropriate 
timing in relation to SSc, its treatment or its potential effects. For others 
information was mentioned in the context of withholding information, often 
from friends and family members either to protect them, or to protect the 
patient from having to deal with the reactions of others. For clinical practice,
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this translates into a need to discuss information with the patient, including a 
private conversation, in order to agree a strategy for the exchange of 
information between professionals and the patient, and the level of 
information to be discussed with those around the patient. There is little 
existing evidence regarding the sharing of information in SSc, with only two 
studies found (Samuelson and Ahlemen 2000; Ndosi et al. 2008). The earlier 
study presents a SSc patient education programme, evaluated in only six 
female patients, showing variable results and highlighting the need for 
further study in this area. The later study, (Ndosi et al. 2008), provides 
evidence to support the use of the Educational Needs Assessment Tool 
(ENAT), in patients with SSc.
The rigour of patient information held on databases will be explored in 
section 8.6.5. However, it a clinical implication, that all patients should be 
offered the opportunity to have their data entered on the National 
Scleroderma Database, as this will increase their access to research studies 
such as this one.
F in a n c e
Finance was highlighted as a concern for some people with SSc, and 
particularly those who had given up their work role. Whilst it may not be 
within the resources of rheumatology healthcare teams to offer detailed 
advice, it is important that they signpost patients towards the possibility of 
financial support such as disability allowances, blue parking badge and 
incapacity benefits to ensure that patients have information of what is 
available, and can then seek out specialist advice from more appropriate 
services.
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R e la tio n s h ip s
Whilst relationship counseling may extend beyond the skills of many 
healthcare workers, holistic assessment will help to identify these 
relationship difficulties and may trigger the need for listening, counseling or, 
in some cases, specific relationship counseling to meet the individuals needs 
for social relationships.
8.5 Testing the hypothesis
The hypothesis of the study was that there will be differences in the level of 
QoL between people with different subtypes. This was tested in two ways, 
by simple univariate non-parametric testing of the difference in QoL between 
subtype, and by multivariate SEM. The results of this testing are presented 
in chapters six and seven. The non-parametric test showed no association 
between disease sub-type and QoL as measured by the SSc QoL. However, 
SEM revealed that disease subtype had a significant indirect effect upon 
QoL, mediated by disability. Thus a significant effect of disease subtype was 
observed, but revealed only by the more sophisticated analytical approach of 
SEM.
8.6 Contribution to Methodological Developments
This study has investigated several aspects of research methodology, the 
results of which may inform future research practice.
8.6.1 Data saturation
As a novel addition to the development of the SSc QoL, the amount of 
interviews required to reach data saturation was analysed. Data saturation,
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that is the point at which no new themes were generated, was reached after 
four interviews. This compares with twelve interviews presented in previous 
research (Guest 2006). The interviews were continued past this point in 
order to ensure that, as far as possible, the demographics within the sample 
frame were represented.
Whilst it can be concluded from this study that four interviews were sufficient 
to generate all the themes of SSc QoL, it must be considered that this may 
have been dependent upon the four interviewees themselves. Interviewee’s 
experiences and the data they give vary; therefore a conclusion that any four 
interviews will provide data saturation is not supported by this study. In order 
to prove the number of interviews required to consistently provide data 
saturation, a further study would be required with randomly selected groups 
of interviews/interviewees.
8.6.2 Item mapping
An interesting contrast is seen in this study between data saturation for 
themes, and data saturation for items. Whilst the themes were all present 
within the first four interviews, the items of the SSc QoL, (Table 6.7), were 
still being generated up to and including the final interview.
As demonstrated in chapter six, the items of the SSc QoL came from a 
variety of interview sources, many items being a composite of several 
statements to form an item which conformed to the requirements of items 
(McKenna et al. 2004).
A possible rationale for this difference in the amount of interviews required 
for thematic data saturation and those required for item generation lies in the 
use of this data. Themes are broad and do not have statistical requirements
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of validity applied to them. Items however, have strict requirements on their 
conceptual background (that is they need to apply to the needs-based model 
of QoL), they have to conform to wording criteria in order to be applicable 
across the SSc population, and they need to conform to the statistical 
requirements of Rasch analysis, providing a range of items across the scale. 
Therefore, it is reasonable to anticipate that it will require more data in which 
to locate items which meet these requirements, rather than themes which 
are emergent from the data itself and do not have to meet such strict 
requirements.
8.6.3 Use of a focus group
The addition of a focus group to the established method of qualitative data 
collection for a needs-based QoL measure, allowed comparison of themes 
generated between the two data collection methods. The focus group 
produced no new themes, in comparison to the interviews and therefore was 
not pursued within this study. However, there are alternative types of 
analysis that may further inform this comparison. For example, the focus 
group transcript was not analysed for the items generated, which has been 
demonstrated by the results of this study to be unrelated to the data 
saturation required for generation of themes.
Also, the observational notes (see Appendix 6) suggest the potential to alter 
the format of the focus group if repeated. For example, it may be that more 
data is generated from an all male or all female gender group where perhaps 
more personal topics could be discussed freely. The focus group within this 
study consisted of four women and one man.
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8.7 Limitations of the research
The process of qualitative data gathering generated several reflections upon 
the methodology used within this study and the lessons to be learnt for 
future research. These reflections are now discussed in order to contribute 
to a body of experience of qualitative research interviews.
8.7.1 Male participants
Despite the additional interviews, several cells of the sample frame were not 
recruited, namely males with dcSSc age 49 and below, males with IcSSc 
with disease duration below five years and age 50 and above. The scarcity 
of male participants had been anticipated due to the fact that SSc is a rare 
disease and predominantly effects females. All males within the recruiting 
centre were approached, one of whom refused, the others all participated in 
the study. It was at this point that the qualitative interviews were stopped, as 
it was clear that no further cells of the sample frame could be recruited.
An expected paucity of male participants with SSc was also reflected in the 
postal returns of the questionnaire booklets, and is likely to remain a 
limitation for future research into this disease population.
8.7.2 Response rates
When reviewing response rates in market research average response rates 
of 36% are suggested (Byrom and Bennison 2000). Within healthcare 
research it has been suggested that judgment of response rates should use 
norms in similar studies as their comparison (Parahoo 1997). Therefore, 
whilst improvements in response rates are desirable, the response rates of 
this study equate well with published norms.
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8.7.3 SEM
The SEM model constructed in chapter 7 utilized comparator measures 
selected for their representation of the ICF and their prominence as 
associations with SSc identified in the literature review. These were included 
in the model specification together with the measure of patient-perceived 
QoL, the SSc QoL. Whilst this presents a parsimonious model, which 
conforms to the requirements of SEM, it does not incorporate all the 
comparator measures. Further research may explore the possible models 
created by use of a varying selection of comparator measures to see if other 
models are possible.
8.7.4 Discarded items and use of the item bank
During the process of item selection many items are discarded. This may 
give rise to concerns regarding the importance of the items discarded, and 
therefore the implications of using an item selection tool such as the Galen 
tool (Galen 2006) used in this study.
There are several systems in place within the SSc QoL development 
protocol to address this concern. Firstly as demonstrated by the fact that all 
themes identified in this study were present in the first four interviews, 
analysis of the additional twenty-seven interviews generated large amounts 
of repetition in the themes and content of the potential items identified. 
Therefore the majority of the items were discarded for reasons such as 
duplication.
For example, in transcript 26 there were four items on tiredness, in transcript 
28 there were three, and in transcript 31 there were four items on sleep. 
Therefore conceptually each item was repeated many times. The
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researchers tried to preserve items on the same theme. This is reflected in 
Table 5.2 where the source of some items is described as ‘composite’, 
meaning that the single item represented duplicates.
Item selection criteria (described in section 4.2.1) were applied to those 
items remaining after deletion due to duplication. Clearly, all items generated 
by interviewees have importance to that individual, however it is essential if 
the QoL measure is to be applicable for use with all people with SSc. This is 
essential so that respondents are not excluded from any questions. Items 
were removed if they were not applicable to all potential respondents. 
However, prior to removal, the item was reviewed by the study researcher 
and an independent researcher to see if altering the wording of the item and 
provide a statement which was universally applicable. An example of this 
would be:
“ I can't wear high heels anymore"
Could be altered to:
“ I can’t wear the shoes of my choice anymore”
This example was used in the first postal of the SSc QoL (item j7 in the first 
postal questionnaire 90 item SSc QoL).
Therefore, whilst it may appear that these items are lost, they can in fact be 
minimally adapted to create a universal meaning that applies to all 
respondents whilst maintaining the interviewees words as far as possible. 
The example above represents the more extreme of the alteration of an 
items wording: the item selection group felt strongly that items such as this 
were key to include as they linked to other key concepts of the theoretical 
framework, this case, appearance.
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The item selection guidance tool (Galen 2006), has been used in the 
development of other needs-based QoL measures (Keenan 2008), but its 
use does apply strict criteria to the item selection process. However, it is 
rigid in order to ensure the measure is both applicable to a wide population, 
uses simple language and establishes a tool which fits criteria for future use 
in different languages.
Another technique utilized to ensure that conceptually significant items are 
not disregarded, is that of analysis of the items discarded from during the 
initial Rasch analysis process. Of the items selected from the discard pile of 
items rejected during Rasch analysis of the first postal questionnaire, a small 
number were felt by the researcher to have conceptual validity for those 
living with SSc (based on the qualitative analysis). Therefore, these were 
incorporated into the test/retest booklet stage of the SSc QoL development 
(as a separate item scale). Rasch analysis of these items revealed that they 
did not represent a sub-scale of items in that they did not fit the Rasch model 
requirements.
U s e  o f  th e  ite m  b a n k
Another potential methodological issue is the use of items from the item 
bank (4.2.1.1). It may be a concern that after such efforts to acknowledge 
the SSc patient as the expert informant, and to gather specific data from 
people with SSc, items from measures used in other diseases would form 
the SSc QoL. However, only three items within the SSc QoL have been 
drawn from the item bank. This substitution showed only a small number of 
items were interchangeable with the item bank, suggesting that generic
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items do not widely represent patient-perceived QoL in SSc. This also 
supports the argument for this disease-specific SSc QoL.
8.7.5 Use of databases for research
This study identified significant issues around the use of a database for 
patient recruitment. To summarise, these issues included:
• One third of the database entries did not have a disease sub-type
entered
• There was no direct link to the hospital patient administration system
(PAS) to check patient status
• There was no funding for staff to maintain the database information
hence current patient status was not always accurate.
• 11.67% of patients identified by the database were deceased.
This has significance beyond this study. The ethics of this research was 
beneficence, that is to do no harm. To send out questionnaire booklets to all 
those people on the database who were actually deceased may have 
caused significant distress to their relatives. Indeed, even with these 
rigorous procedures in place, questionnaires were sent to nine people who 
had died. The impact of this was demonstrated in a letter from the husband 
of a lady who had died the day the questionnaire booklet had arrived.
Obviously this was unavoidable but what was perhaps most striking was that 
of all the responses saying that the patient had died, there was a clear 
message that the patient would have welcomed the opportunity to be 
involved into research into SSc. The learning from this experience was 
shared through publication: these issues of accessing databases have been
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published as a consequence of the experiences of this study (Firth and Reay 
2008).
As England now has detailed guidance regarding data protection of patient 
records (DoH 2006), there are direct implications for the handling of patient 
information in research. Data created by an NHS employee has to be 
handled in line with this 2006 guidance, which means that it has to be 
anonymised if sent electronically and cannot be carried on a standard data 
stick unless anonymised. As a consequence, the researcher had to 
physically access data from the database, anonymise it and then send it 
electronically. The data had to be coded in order to match it up with the 
address information required for the printing of address labels for the postal 
questionnaire aspect of this study. The time implications of this were 
substantial and should be a key methodological consideration in future 
studies.
There were consequences of the guidance for data analysis also, with 
several aspects of data not available for use in this study, particularly those 
of the non-responder group. In future studies, the researcher would plan a 
data strategy which would aim to accommodate the governmental guidance, 
but would allow full demographic data to be gathered on the sample 
population, so as to identify potential research bias. The issues generated 
from the effect of the Records Management Guidance 2006 (DoH 2006) on 
research have been published in response to the experiences gained in this 
study (Reay and Firth 2008).
8.7.6 Difficulties in measurement of QoL in healthcare
C o n c e p tu a l a g re e m e n t  o n  Q o L
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The variety of conceptual backgrounds to QoL assessment has been 
outlined in this study, illustrating the lack of consensus, not only on models 
of QoL, but even on definition of QoL within healthcare. Contention around 
QoL measurement in healthcare has been highlighted in a negative review 
of QoL measurement (Hunt and Leplege 1997) which highlights both the 
lack of definition and conceptual consensus in QoL measurement.
Earlier in this study, the many models and dimensions of QoL were 
described. It is clear that QoL is a term used in publications to describe a 
range of conceptual approaches, from that of subjective well being as seen 
in the needs-based QoL model, to that of HRQoL, and indeed, to 
publications which do not identify the conceptual basis for their QoL 
measurement.
In order to explore this potential confusion within SSc QoL, three electronic 
databases, EMBASE, MEDLINE and CINHAL (Feb 2008), were accessed in 
order to explore models of QoL used in SSc. As no needs-based SSc QoL 
measures had been identified in the literature review of this study, it was 
unsurprising that a needs-based model of SSc QoL was not found. However, 
further exploration revealed that the SSc QoL articles found, were either 
based either upon a HRQoL model, did not propose any conceptual base for 
their QoL assessment, or proposed their use of one model and used 
another.
This does not directly reflect as a limitation of this study, because a clear 
conceptual model of QoL was identified prior to data collection, together with 
the rationale for its choice. However, it is a limitation of QoL studies in SSc 
where conceptual frameworks of QoL may be absent or misleading.
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8.8 Directions for Future Research
The findings of this study have highlighted several implications for clinical 
practice, and also identified gaps in the knowledge of care management in 
SSc.
Directions for future research Indicated by this study are:
• Research Into promotion of physical function in those with SSc.
Currently there is little evidence regarding models of therapy or 
treatments which effectively promote physical function in those with 
SSc. As research findings suggest those with dcSSc have higher 
levels of functional impact than those with IcSSc, future research 
should ensure that models of care are effective for both disease sub- 
types.
• Further understanding of the impact of disease sub-type in SSc on QoL
may be gained through analysis of qualitative data gathered from 
people living with each sub-type to explore commonalities and 
differences between dcSSc and IcSSc. This could be supported by a 
different analytical approach, such as phenomenological approach to 
analysis, to allow the development of a theoretical framework of QoL 
in SSc.
• Evaluation of the Care pathway resulting from this study (8.4.1). The
care pathway of patients with SSc in the UK Is currently unclear. 
Whilst there has been some research conducted in Canada (Johnson 
et al. 2006), the patients journey through service provision remains 
largely unmapped. In order to assess the Impact of the proposed
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Care Pathway, initial research into current patient pathways would be 
required in order to provide baseline data. Following this, a re- 
evaluation of implementation of the pathway could be carried out 
together with evaluation of patient outcomes and subjective patient 
views of their experience. Therefore, the Care pathway could be 
evaluated in terms of its implementation, outcomes, and patient 
experience.
• This study identified fatigue as a key issue for patients, and highlighted
levels of fatigue in SSc patients to be twice that of a ‘normal’ 
population (Reay 2007). It is likely that many patients with SSc do not 
receive specific fatigue management services, however there is no 
empirical knowledge of current levels of fatigue management 
provision in SSc services. Initial mapping of current provision is 
required, followed by design of fatigue management strategies which 
can then be implemented and evaluated in a multi-centre research 
programme.
• Links between the psychological, social and physical associations of
SSc are unclear and require further study, using valid and reliable 
Patient Reported Outcome Measures in a population including 
patients with dcSSc and IcSSc. SEM modeling of the data would build 
upon the findings of this study, and provide a broader insight into the 
direct and indirect relationships between physical impacts, 
psychological impacts and disease sub-type in SSc.
• Methodological evidence from this study suggested data saturation for
qualitative themes to be four interviews. Further study is required to
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test this finding in randomly selected transcripts. The hypothesis to be 
tested would be that data saturation in the development of needs- 
based QoL measures is achieved with four one to one interviews. A 
nested study would also test the number of interviews required to 
achieve item saturation in the development of needs-based QoL 
measures.
• Research into information requirements of people with SSc and the
best mode of delivery (group/individual, timing and content of 
information), is sparse. A further study into these aspects of 
information sharing with SSc patients is indicated. Possible methods 
for this study could involve use of the ENAT tool to design education 
around the needs of the individual (Ndosi et al. 2008).
8.9 Summary
The principle findings of this research are:
•A  descriptive framework of patient-perceived SSc QoL has been 
developed, consisting of overarching themes of Physical restriction, 
Emotion, Self, and Impact on/with others. These are made up of thirty 
themes representing the physical, social and psychological aspects of 
patient-perceived SSc QoL.
•The needs-based SSc QoL has been developed and fits modern 
psychometric requirements of Rasch analysis. The SSc QoL has 
been found to demonstrate good test-retest reliability.
• Non-parametric testing shows no significant difference in levels of
patient perceived QoL between disease sub-types (as measured by
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the SSc QoL). SEM testing of the research hypothesis demonstrates 
that disease sub-type has an indirect effect through impact on QoL, 
working through function. Therefore, multivariate analysis has 
identified an indirect link between disease sub-type and patient- 
perceived SSc QoL
• There is a significant link between disease sub-type and function, with 
higher impacts on function being seen in those with dcSSc than those 
with IcSSc.
- 2 6 4
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Table Appendix 1 -  Evidence for microchimerism
A p p en d ix  1 E v id en ce  fo r m ic ro ch im e rism
Evidence Reference
Female preponderance in SSc
Idiopathic SSc is much commoner in 
women, suggesting that the 
constellation of events leading to it’s 
development occurs more in females
Englert et al 1992
Timing with respect to child-bearing
Onset of the disease or deterioration 
is often observed 1 -5 years after 
child-bearing
Silman and Black 1988
HLA considerations
Similarly, between maternal and child 
HLA haplotype is greater for mothers 
who develop SSc. This would 
potentially predispose to persistence 
of foetal cells.
Arlettet al 1998
Foetal DNA in SSc patients blood
Increased levels (and perhaps 
frequency) of foetal DNA in SSc 
mothers.
Nelson et al 1998
Foetal DNA in lesional tissues in SSc
Demonstration of foetal DNA in 
lesional tissue of SSc patients. Also 
demonstrated increased frequency of 
foetal DNA in SSc patients’ blood 
compared with controls.
Arlett et al 1998
Animal model -  chronic GVHD
Minor mismatch bone marrow 
allograft can produce an animal 
disease with feature similar to human 
SSc. Also human GVHD skin disease 
has some features of diffuse SSc
(Casciola-Rosen et al. 1997) 
Charley et al 1982
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Table Appendix 2 -  Oxidative Stress
Adapted from Denton and Black 1999. Potential Involvement of oxidant 
stress n SSc Pathogenesis (Herrick et al. 2001).
A p p en d ix  2 O x id a tive  s tress
Evidence Reference
Elevated isoprostanes in urine.
Increased urinary levels of oxidative metabolites 
of prostaglandin’s in patients with SSc suggests 
in vivo oxidative stress.
(Witztum and 
Steinberg 1991)
Reduced micronutrient antioxidants in SSc.
Levels of vitamin C, vitamin E and other dietary 
antioxidants lower in SSc patients -  suggests 
increased susceptibility to reactive oxygen 
species.
(Salonen etal. 1992)
Reduced in vitro LDL oxidation lag-time in SSc
Oxidation lag time in vitro is reduced for LDL 
isolated from SSc patients serum. Suggests 
greater susceptibility to oxidation in vivo. 
Oxidised LDL are potentially injurious to 
endothelial cells.
(Herrick et al. 2001)
Oxidant stress effects on fibroblasts. 
Increased fibroblast proliferation and matrix 
synthesis induced by oxidative stress in vitro.
(Pearson 1991 )
Fragmentation of SSc-associated auto-antigens.
Oxidative fragmentation of SSc-associated auto­
antigens in the presence of heavy metal ions.
(Maddison 2002)
Beneficial effects of antioxidant administration. 
Many patients report subjective benefit from diet 
rich in antioxidant nutrients. The synthetic 
antioxidant produbol has apparent benefit in 
treatment of Raynauds phenomenon.
(Denton and Black 
2005)
Antibodies against oxidized low-density 
lipoproteins in systemic sclerosis. Binding to 
oxidized LDL antibodies increased in patients 
with DSSc and LSSc. Circulating anti-oxidized 
LDLD increased in DSSc patients compared with 
controls. Lends weight to argument that 
oxidation of LDLD contributes to vascular 
pathology in SSc.
(WHO website 2001. 
Accessed online Nov 
2006)
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Micro and macro-vascular disease in SSc
Theories of the pathogenesis of micro vascular involvement in SSc are being 
explored. Included in this is the role of antibodies against oxidized low- 
density lipoproteins (LDL) in SSc. Oxidation of LDL has been presented as a 
key factor in atherogenisis ((Kilbourne et al. 2002), and antibodies to this 
may predict the progression of atherosclerosis in the carotid vessel (Stastny 
et al. 1963). Exploration of this principle as applied to SSc showed binding to 
oxidised LDL to be increased in patients with both LSSc and DSSc in 
comparison with controls. Also, elevated circulating levels of oxidised LDL 
were seen in patients with DSSc. This strengthens the argument that 
oxidated LDL has a role in vascular damage, particularly in DSSc, but it is 
suggested that further longitudinal studies would be required in order to 
investigate associations between this and vascular damage in SSc (Jaffe 
and Claman 1983).
The endothelium in SSc
Included in the micro vascular aspect of SSc, is the endothelium. The 
endothelium is thought to regulate aspects vascular homeostasis, as well as 
its traditional role as a selective barrier between the blood and tissues. It 
responds to molecular signals which may be generated locally or from other 
areas of the body, hence its role in the control of cellular and metabolic 
events. (Silver 1991).
Endothelial cell dysfunction is thought to have a key role in the vascular 
injury seen in SSc, including:
A p p en d ix  3 M icro  and  M acro -V as cu la r D isease
Up-regulated expression and increased circulating levels of 
endothelial adhesion molecules.
Altered levels of endothelial cell products







Toxic Oil syndrome (TOS) first appeared in 1981. It affected 20,000 people 
in Spain who had used rapeseed oil with a contaminate, aniline, thought to 
be the cause. Its label as a Scleroderma like syndrome has arisen from the 
similar symptoms such as skin tightening. With over 800 deaths, long term 
symptoms such as skin tightening, peripheral neuropathy and pulmonary 
hypertension persist and associated deaths continue .
Graft versus host disease (GVHD)
Graft versus host disease is a condition seen in some patients who have 
bone marrow transplant and Its presentation shares many symptoms similar 
to SSc, notably skin thickening. Links in the literature were made over 40 
years ago by Stastny, Stembridge et al who highlighted the resemblance 
between GVHD and SSc. The potential for use of GVHD as a model for SSc 
has been explored who induced GVHD in mice and followed the 
progression of skin involvement. Whilst a preliminary, laboratory based 
study, the authors findings were particularly interesting as they noted in one 
of their mice groups that the skin pathologies were not present by Day 78 of 
the study. The conclusions of the study are somewhat vague however, and 
no further work seems to be published directly on GVHD and SSc.
Eosinophilia-mvalaia syndrome (EMS)
Another recent condition is EMS, first described in 1989. EMS is thought to 
be associated with contaminated batches of the drug L tryptophan which 
was used to treat insomnia and depression . The symptoms are thickening
A p p en d ix  4  S c le ro d erm a  -  like  d iseas es
- 2 8 8
of the skin; erythmatosus macules on the skin arthralgia, myalgia and 
dyspnoea alongside other haematological and pathological findings. 
Appropriate treatment for this condition is unclear although some reduction 
of symptoms is noted with the use of glucocorticoid medication. However 
even with this treatment patients are left with symptoms including skin 
lesions, myalgia and neurocognitive dysfunction.
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Appendix 5 The International Classification of Functioning Disability 
and Health.
Table Appendix 5 - Presenting the Structure of the ICF
Part 1 : Functioning and 
Disability
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5 participants (Numbers 1,2,3 and 5 were female and Number 4 was male) 
Overall impressions
1, 3 and 5 were the more vocal and tended to be more attentive to the 
other group members.
2 tended to focus on Naomi and smiled a lot (? to hide any discomfort).
4 tended to look down and seemed at times separate from the group 
but did answer direct questions, from both Naomi and other group members, 
particularly later.
There was more obvious interaction when the main tape was turned off and 
Naomi left the group. When Naomi returned, she appeared to be made 
much more part of the group by the participants rather than being seen as 
‘the interviewer’. The participants used her as a source of information (and 
perhaps reassurance)
A p p en d ix  6 Focus g ro u p  O b s e rv e rs  notes
Note -  ‘Urn’ -  assumes ‘agreement’
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Themes Discussed Interactions Notes
Naomi explains the 
purpose of the FG
Participant 3 joins the 
group
How does scleroderma 
affect life?
Work? 3 talks about pain 
restricting ability to 
perform tasks at work
1 attentive to 3
2 smiles looking 
between 3 and N
4 looking down
Period of sickness 
before left work?
3 talks about frustration 
and attitudes of others
1 and 2 nod /urn 
4 looking down
1 talks about effects on 
enjoyment of letter- 
writing
1 looking at N -  
answering N rather 
than engaging with 
group
2 looking at N
Response of other 
people
N directly asks 4 about 
his experience
All attend to 4
3 nodding as 4 
describes the pain 
experienced
Need to adapt and pace 
life
3 ...cannot do aerobics 
...‘could be worse’
1 looks very serious
2 smiles and looks to 
N
1 . .. ‘only when think 
about it’
4 more
engaged with 1 - 
interrupts to agree 
and then looks down 
when interaction 
complete
How adapted ? 3 talks about expert 
patient programme
1 asks how became 
involved
1 very attentive to 3
2 smiles a lot - 
appears to becoming 
less comfortable
4 continues to look 
down
Relationships with other 
people? Changed 
/narrowed?
1 talks about 
difficulties in standing
Friends -  vanish into 
the wood work ... find out
3 - small nod
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who your real friends are
N directly asks 4 about 
his experience
4 becomes more 
obviously involved 
when asked direct 
question -  others 
attend to him
Participant 5 joins the 
group
N introduces 5 to theme 5 talks about giving up 
w ork... made redundant 
but would have had to 
leave
1 and 2 -  ‘urn’ and 
look to 5. 2 nods
Struggling? No ...just diagnosed All looking at 5.
They appear more 
relaxed together - as 
if the interruption of 5 
joining has provided 
a ‘breathing space’
(Methodological Note
I wonder if the group 
becoming larger has 
made a difference)
Effect around the house 
and family ?
5 answers N 
directly
What about others 
(in group)?
N goes around the group
2 answers directly 
...manage most things
4 ...manage most things
3 nods
4 looking at N
Any more? 4 talks about being self- 
employed.... otherwise 
would have been sacked
....do get very tired
2 and 3 attending 4 
and nodding
Need to prioritise tasks? 2 ... live alone ..please 
myself
3 ...same ... live alone
Looks directly at N 
and then at 1 and 2 
(seeking 
reassurance?)
3 looks at 4 who is 
looking down
(Cannot see 5)
N -  direct question to 1 -  
You live with your 
husband
1 talks about what is
unable to do ... what
husband and daughter do 
™---------1-
1 looking at N
- 2 9 3
... effects of Raynauds
5 to 1 ........ you seem to
have more problems
1 and 5 engage with 
each other.
? whether others 
seem ‘outside’ this 
conversation
N to 1 .. as a family ...? 1 ...have had to do more
.nothing wrong with 
th a t.. men don’t...
3 watching 1 very 
closely
group laugh - 
seem to relax again
Memory? 3 .....age rather than
scleroderma?
concentration rather than 
memory
5 ...if anything happens 
you automatically think it 
is (scleroderma)
( Cannot see 5 well)




Change in ability to 
cope with stress?
2 ... no .. very 
stressful
No response 
from others -  looking 
at N or down
Emotions? 3 ... feel down, isolated ...
Talks about living alone 
and fears
1 ...always helps to do 
something physical
3’s eyes fill with
tears
3 looks to 2 
(?seeking agreement 
as both live alone)
1 looks to N
Sleeping? 1 ... a vicious circle
3 ... is it part of 
getting older?
N looks to 2 -  2 
nodding
Anyone else? 4 .. not waking up .. 
pain effects getting to 
sleep
2 ...sometimes 
cannot get to sleep... 
getting older?
5 ...if not physically
tired
3 ...usually busy
4 looks directly 
at N and then looks 
down again
All seem to be 
addressing N rather 
than talking with 
each other -  seem 
awkward
Financially? 3 ...not for me 3 shrugs
4 shakes head - no 
2 shakes head - no
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Bringing up Children? 1 talks about nephews - 1 is looking down
Things cannot do? 
Stamina?
adaptations to cope with 




2 ....looked after group)
grandchildren
2 shakes head as
....no problems speaks
Affect individually? 5 ...positive for me 4 continues to look 
down but
occasionally looks up 
towards 5
Others all attending 
to 5
5 addresses 4 directly 
....being a man...?
5 looks between N 
and 1 and 2 (Is she 
seeking reassurance 
that alright to ask 4 a 
direct question?)
4 ....changed life Group look to 4
...frustrating.... go to 3 nodding
do things automatically 2 and 3 - low laugh
...brain still works and both nodding





good...just get on with it.
3 could be worse ... 
returned from holiday in All appear to take
China... cannot do 
steps... gets frustrating ...
more interest at 
mention of China -  
look towards 3 Seem
... grateful more animated.
4...could get me down.... 
frustrating...
All attend to 4
5 nods
Future? 5 ... like 3 says-w ill do 3 smiling and
Faith? more holidays nodding
Religion? 1 ...sam e... spending inheritance
4 nods
2 looking at N
2...No don’t think much
.....not particularly





Personal Hygiene? 3 No .but difficulty 
getting in and out of bath..
2 ...Yes
4 ...getting out is problem
3 ... walk-in shower and 
top and tail
2 ... empty water and 
then stand cannot pull on
4 ... slippy as well
1 ...went to parents., 
couldn’t get in (bath)...
General ‘urns’ and 
nods from others
2 indicates rails(?)
All lean forward 
into the group and 
towards each other -  
urns
Urns from 5 and 3
1 Does it affect anyone’s 
sex life?
2 and 3 ... have 
wondered
5 ... don’t think so
1 ... does.....explains
how and what does to 
adapt
... no-one ever asks 
about it
2 and 3 laugh
4 looks up and then 
down again
Emotional as well as 
physical?
1 ....humour 1 and 5 looking at 
each other
2 looking between 1 
and N
4 looking down
Has it affected the 
relationship?
1 ... it did ... getting older No obvious response 
from group
How does it make you 
feel?
1 ..frustrated ... big 
aspect ..comfort... being 
found attractive..
4 looks up and 
smiles
Anyone else? 1.. dry vagina
Anyone else?
Tape turned off
N leaves group for while
I had forgotten that there were two tapes and so 
concentrated more on trying to capture the 
conversation rather than non-verbal interaction -  
women generally more engaged with each other.
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4 did not seem so engaged -  still looking 
down but obviously listening as interjected re. 
treatment
5 ... toe nails dropped off Others - shaking 
heads
Much more verbal 
interaction -  appear 
to be talking about 
more issues now the 
tape is turned off
Anyone else had calcium 
problems?
2 .. warts? 5...calcium 
can poke out1... can 
squeeze out
5 gets up and has a 
look
3,1,2 very engaged
The group becomes 
more a discussion 
group - begin to ask 
N questions
Talk about difficulty with 
diagnosis
Women attending to 
each other when 
sharing experiences
4 not so obviously 
engaged but does 
keep looking up.
Talk about difficulties in 
dressing
1 involves 4 ... What 
about you 4 -  do you 
have trouble with bra’s
4 ... yes .... with 
socks
All laugh including 4
Anything specific to 
being a man?
When N turns the 
direct questioning to 
4 all are engaged 
and attend to him.
In final stage of the 
discussion appear 
more engaged with 
each other -  more 
nods and looking at 




I wonder whether or not I should have revealed so much about living in 
Holmflrth and whether or not this may have influenced any of the local’ 
participants. The group seemed to work well -  perhaps because the 
participants knew Naomi. She was able to say that ‘other people with 
scleroderma experience...’ either as a leading question or as a reassurance 
if a participant asked a direct question regarding whether their experience 
was unusual (therapeutic aspect of focus group?). I wonder what the 
dynamics of the group would be if single sex? I do not know the ratio of men: 
women affected. If group of men would they reveal more to a male facilitator 
or would they actually be happy with a familiar female such as Naomi?
Notes re. process of observation
Positioning of participants -  sometimes it was difficult to see No 5 when she 
leant forward and N leant forward and perhaps I should have noted this fact 
more in the observational notes -  perhaps increased attentiveness when 
leant forward. There were times when I got the number of the participant 
wrong. It may be easier for the sake of my own notes use real names/initials.
I found at times that I was so fascinated by what was being said that I found 
my concentration being drawn to listening rather than observing the 
interactions as closely as I should.
Using lined rather than plain paper may be better -  and pre-number pages.
Need to note when Naomi turns one tape off -  rather anxious that could not 
capture all the conversation but had not remembered that there were two 
tapes! I found it hard to keep track of non-verbal interaction. The strategy 
was very effective in getting the group to talk more freely and to expand on
-298
previous themes or begin to talk about aspects which had previously not 
seemed to be problems/issues for them.
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Appendix 7 The SSc QoL
Please tick the relevant box for each question True Not True
I can’t do anything without really thinking it through I I I
It’s always on my mind I I I
I worry that I let people down I I i—
My condition makes me angry I I .—
I get upset when I can’t do things I I I
I often get frustrated I I I
I cannot rely on how 1 will be tomorrow I 1 I
I feel like I’m fighting all the time I_____ I I__
My condition means I have disturbed sleep I_____ I |__
I------- 1 I—It has affected me a lot socially |_____ | |__
It has affected the health of people around me | | |
My hands don’t work as well as they did I I I
It puts a strain on my personal relationships^ |_____ | |__
I need to rest more often | | |
Any sort of activity is difficult | | |
I avoid certain social situations because I am I I I
embarrassed
I take to heart things which wouldn’t have worried me | | |
before
- 3 0 0
Please tick the relevant box for each question
Life is just not what it was 
I can’t cope at all
Sleeping badly has affected me a lot 
I feel very isolated 
Household tasks can be a problem 
I have had to stop some of my hobbies 
I feel guilty at being ill 
I struggle to wash myself as I would like 
Pain limits what I can do 
I feel helpless 
Pain tires me out
I miss being able to sort things out
True Not T rue
]  C
Many thanks for filling in this questionnaire
For staff completion: Date Total score
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Appendix 8 Potential Comparator Measures









Depression Hospital Anxiety and  
Depression (HA Ds) 
Scale
M ontgom ery-Asberg  
depression rating scale
Ham ilton depression  
scale
Beck’s depression  
inventory
Hospital Anxiety  
and Depression  
(H A D s) Scale
C lear division into anxiety  
and depression items.
Anxiety As above As above
Finance London Handicap  
Scale. Euroqol 5D . 
Stand alone question. 
Benefits questionnaire?
London Handicap  
Scale. Euroqol 5D
Question appeared  to 
fit with conceptual 
fram ew ork and other 
aspects of the LH S  






Emotion and loneliness 
scale.
S ense of coherence  
scale.
Fatigue Fatigue Severity Scale Fatigue Severity  
Scale (F S S )
Conceptual m atch to the  
things said at interview. 
Q uick to com plete.
Travel/holiday
s
London Handicap Scale London Handicap  
Scale (LH S)
W ork London Handicap Scale London Handicap  
Scale.
Recent work  
dem ographic detail
Hobbies London Handicap  
Scale.
Fatigue severity scale.
London Handicap  
Scale.
Fatigue severity  
scale.
A p pear to match  
conceptually with w hat was  
raised at interview
Pain M aGill Pain  
questionnaire. Visual 
analogue scale.
Visual analogue  
scale
P recedent for use in 
previous SSc studies
Talking to S ense of coherence G eneralized Self- Concise to com plete.





scale. G eneralized Self- 
efficacy scale. Hostility 
and direction of hostility 
questionnaire. 
Emotional and Social 
loneliness scale
Efficacy scale
Confidence G eneralized Self- 
efficacy Scale  
Rosenberg’s self­
esteem  scale
As above As above
Control - over 
life/d isease/
future
G eneralized Self- 
efficacy Scale. Health  
related hardiness scale
As above As above
Coping W ays  of coping 
checklist. Emotional 
and social loneliness 
scale. G eneralized Self- 
efficacy scale.
Personal resource 
questionnaire -  P R Q  
85
As above As above





S H A Q  Disability 
Index. S F 3 6 . Symptom  
distress checklist.
S S c  Functional
Index.




Rosenberg self-esteem . 







R educed hand  
function
Arthritis hand function 
scale. Systemic  
Sclerosis functional 
index.




S H A Q  Dl. SSc  
functional index.





Sym ptom  distress 
checklist
Friends and  
family
Social Netw ork Index 
(S N I). Personal 
Resource
Q uestionnaire P R Q -8 5 . 
Emotional and social 
loneliness scale.
London Handicap  
Scale.
LHS
Social life Social Netw ork
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Index(SN I). Emotional 
and social loneliness 
scale.
Sex life C reated  single item




adjustm ent to illness 









Mobility Systemic Sclerosis 
Functional Index. 
S H A Q  Disability Index.
Healthcare Illness perceptions  
questionnaire. G eneral 
perceived self-efficacy  
Scale
